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List of abbreviations 
µLED  Micro light-emitting diode 
AAV  Adeno-associated virus 
ABR   Auditory brainstem response 
aABR  Acoustic auditory brainstem response 
AC  Alternating current 
ACE  Advanced combinational encoder 
AMPA α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid 
AP  Action potential 
AZ  Active zone 
CAP   Compound action potential 
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CI  Cochlear implant 
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DC  Direct current 
DPOAE Distortion product otoacoustic emissions 
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eCI  Electrical cochlear implant 
EYFP  Enhanced yellow fluorescent protein 
ES  Endoplasmic reticulum-export signal 
FSP  Fine structure processing 
FP  Fluorescent protein 
GFP  Green fluorescent protein 
HC  Hair cell 
hSyn  Human synapsin 
IHC  Inner hair cell 
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oABR  Optical auditory brainstem response 
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OHC  Outer hair cell 
P  Postnatal day 
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s.d.  Standard deviation 
s.e.m.  Standard error of the mean 
SGN  Spiral ganglion neuron 
SNHL  Sensorineural hearing loss 
SPEAK Spectral peak 
SPL  Sound pressure level 
SR  Spontaneous rate 
TS  Plasma membrane-trafficking signal 
VCSEL Vertical-cavity surface-emitting lase 




Optogenetic stimulation of the auditory nerve is a promising alternative to restore hearing. Since 
light can be focused on the target tissue, the optical cochlear implant (oCI) might support a 
major improvement in frequency resolution compared to current electrical CIs (eCIs). However, 
the slow kinetics of the first generation of optogenetic actuators hindered controlling the fast 
spiking spiral ganglion neurons (SGNs) with high temporal fidelity.  
In this work, I evaluated the ability of two fast-gating opsins (Chronos-ES/TS and f-Chrimson) 
to improve temporal fidelity of optogenetic stimulation of murine SGNs in vivo. Following 
postnatal injections of adeno-associated virus (AAV) via the round window, channelrhodopsin 
expression under the human synapsin promoter rendered SGNs light-sensitive without 
detrimental effects in neuronal survival.  
Improved plasmalemmal expression of Chronos-ES/TS in SGNs ensued from the usage of the 
potent AAV.PHP.B capsid and the addition of endoplasmic reticulum export signals (ES) and 
plasma membrane trafficking signals (TS) to the Chronos transgene. High and homogeneous 
expression levels of Chronos-ES/TS in SGNs throughout the cochlea (~70%) allowed high spike 
probability and temporal precision of spiking up to 1 kHz with moderate energy thresholds 
assessed by optically-evoked auditory brainstem responses (oABR) (~7 µJ per pulse).  
On the other hand, the fast-gating opsin f-Chrimson opened up the new avenue of fast red-
shifted cochlear optogenetics. AAV2/6-mediated expression of f-Chrimson was high and 
homogeneous in the injected ear (~80%), allowing optical activation of the auditory pathway 
with low oABR energy thresholds (down to a minimum of 0.5 µJ per pulse) and restoring 
auditory activity at pulse rates up to 250 Hz in hearing-impaired mice 9 months post-injection. 
Further characterization at the single-neuron level revealed sub-millisecond temporal jitter of 
spiking up to pulse rates of 400 Hz and improved average dynamic range of optogenetic coding 
compared to electrical stimulation (~4 dB vs ~1 dB) that rose up to ~8 dB at the population 
level.  
Therefore, these preclinical results pave the way for an increased frequency and intensity 
resolution in cochlear prosthetics and advance cochlear optogenetics by overcoming major 
obstacles that had so far hampered clinical translation of the oCI: enabling physiological 






2 General introduction 
2.1 Sound and the auditory system 
Sensation arises from the capacity of living organisms to perceive information conveyed by 
stimuli of different nature. Throughout evolution, mammals have developed highly specialized 
structures and systems that allow them to deal with the distinct sensory modalities. Despite being 
very diverse, sensory pathways share a few common roots: sensory processing begins when a 
receptor helps to transduce the energy associated with a stimulus into neural signals, and higher 
neural centers then interpret them. In humans, the basic senses comprise somatic sensation, 
balance, gustation, olfaction, audition and vision. Although the nature of humans is highly 
visual, the auditory system plays a major role in communication, detection of threats and 
enjoyment e.g. through the appreciation of music.  
Sound can be physically described as a pressure wave that propagates spherically from the 
source and produces a periodic compression and rarefaction of an elastic medium, e.g. air. Sound 
waves feature four major characteristics: amplitude, frequency, phase and waveform. In terms 
of perception, the amplitude and frequency of a sound wave at the ear correlate to loudness and 
pitch, respectively. The vast majority of natural sounds comprise complex waveforms that can 
be represented as the sum of diverse pure sinusoidal waves of varied amplitudes, frequencies 
and phases through a mathematical process dubbed the Fourier transformation. Notably, an 
equivalent process occurs at the level of the inner ear, where sound is decomposed into its 
constituting frequencies. 
Each mammalian species is able to perceive a different range of frequencies and intensities of 
sound stimuli. Regarding sound intensity, the human auditory system can encode sounds over a 
remarkably broad dynamic range from 0 to 120 dB SPL, i.e. 6 orders of magnitude (Kandel et 
al., 2012). Factors like functional head size show an inverse relation to the ability to perceive 
high frequencies (Heffner and Heffner, 2008). While the human hearing range roughly spans 
frequencies from 20 Hz to 20 kHz (Purves et al., 2004), mice are sensitive to sounds ranging 
from 1 to about 100 kHz (Ashmore, 2008). Despite this difference, the mouse has become the 
most commonly used mammal in auditory neuroscience, largely due to the rise of inbred strains 
and their advantages concerning genetic manipulation (Ohlemiller et al., 2016). 
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2.2 The external and middle ear 
The external ear of mammals consists of the pinna and the ear canal (Figure 2.1). The pinna acts 
as a collector, focusing airborne sound into the ear canal, where it is channeled onto the tympanic 
membrane. The pinna also changes the frequency spectrum, thereby providing a cue for sound 
source localization along the vertical axis and also prevents front-back confusions (Heffner and 
Heffner, 2008).  
Figure 2.1: Schematic of the human ear  
The human ear is divided into three main compartments: the external, middle and inner ear 
(lower right). The tympanic membrane is connected to the oval window via the ossicle chain of 
the middle ear, positioned between them. (Modified from (Purves et al., 2004)). 
 
The tympanic membrane is the anatomical barrier that separates the external and middle ear 
(Figure 2.1, upper right). The middle ear further comprises the middle ear cavity and a chain of 
interconnected ossicles: the malleus, incus and stapes. These ossicles are attached to the 
tympanic membrane via the malleus and act as conveyers of air-borne sound vibrations to the 
fluid-filled cochlea. The main function of this structure is to match the relatively low-impedance 
of the air outside the ear to the much higher impedance of cochlear fluids. This process is 
General introduction 
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essential to prevent the reflection of energy by cochlear perilymph and is achieved through the 
lever action of the ossicle chain and mainly through the difference in surface area between the 
tympanic membrane and the much smaller oval window, to which the flattened base of the stapes 
is connected.  The result is an increase in pressure by almost 200-fold when vibrations reach the 
inner ear (Purves et al., 2004). 
 
2.3 The inner ear 
The inner ear houses the sensory organs for balance and audition in a continuous bony shell 
termed the labyrinth, which is divided into three compartments. The vestibule and semicircular 
canals shelter the vestibular epithelia, which detect linear acceleration and rotation, respectively, 
contributing to the sense of balance and spatial orientation. The snail-shaped cochlea constitutes 
the third division of the labyrinth and harbors the auditory sensory epithelium—the organ of 
Corti. The cochlea is a tube-like structure wound around a conical bony core termed the 
modiolus. There are two basal openings in it: the oval window—covered by a membrane and 
the base of the stapes—and the round window—sealed solely by an elastic membrane. Inside, 
the cochlea is partitioned throughout by the flexible basilar membrane and the Reissner’s 
membrane into three fluid-filled compartments: the scala vestibuli, the scala media and the scala 
tympani (Figure 2.2B); except for a small region at the cochlear apex—the helicotrema—where 
scala tympani and scala vestibuli meet. This opening allows the Na+/Cl--rich perilymph that fill 
both scalae to mix, whereas the scala media contains the K+-rich medium endolymph 
(Fettiplace, 2017). 
Hence, the scala vestibuli is delimited by the Reissner’s membrane and extends from the oval 
window to the apical helicotrema, while the scala tympani runs from this point to the round 
window, being bordered by the basilar membrane. The scala media lies between the two and 
contains the organ of Corti (Figure 2.2B,C). 
Thus, sound waves reach the base of the stapes and force the perilymph in scala vestibuli to be 
displaced. This produces a travelling wave alongside that set the basilar membrane in vertical 




Figure 2.2: Anatomy of the cochlea and the organ of Corti 
A: Schematic of the bony labyrinth depicting the cochlea with its oval and round window, the 
vestibular organ and both the vestibular and auditory nerve. B: Cross section of the cochlea 
highlighting the area marked in A, showing its three compartments and the position of the organ 
of Corti between scala media and scala tympani. C: Detailed anatomical organization of the 
organ of Corti, showing its characteristic single row of inner hair cells (IHCs) and three parallel 
rows of outer hair cells (OHCs), the tectorial (purple) and basilar membrane (blue) as well as 
afferent and efferent innervation (modified from (Purves et al., 2004)). 
 
Due to the gradually varying mechanical properties of the basilar membrane along the cochlear 
axis—narrow and stiff at basal positions to wide and soft at the apex—sounds of different 
frequencies produce maximal motions at specific positions along the basilar membrane (Figure 
2.3B). Therefore, the travelling wave originates in the stiffer end and propagates toward the 
General introduction 
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apex with an increasing amplitude and reduction in velocity, until it reaches a spot of maximal 
vibration that is dependent on the sound frequency. Consequently, the basal, firmer end responds 
best to higher frequencies whereas the apical, more flexible region is responsive to lower 
frequencies. This gives rise to a topographical frequency gradient termed tonotopy, which is 
maintained at successive stations of the auditory pathway determining the organism’s frequency 
hearing range (reviewed in (Fettiplace, 2017)). This feature allows the basilar membrane to 
passively decompose complex sound signals into their fundamental spectral components, 
thereby acting as a Fourier analyzer (Dallos, 1996; Mann and Kelley, 2011). However, as 
suggested by the non-linear properties of the basilar membrane motion (Rhode, 1971), other 
factors contribute to maximizing this effect.  Among them, we could highlight the different 
properties and structural organization of the tectorial membrane depending on the tonotopic 
position (Gueta et al., 2006; Richter et al., 2007; Richardson et al., 2008) and the amplification 
provided by outer hair cells (OHC) (reviewed in (Ashmore, 2008; Dallos, 2008)). In any case, 
tonotopy along the cochlear spiral is a critical feature, which allows the radially arranged 
afferent fibers of spiral ganglion neurons (SGNs) to establish a position-based neural frequency 
code.  
 
Figure 2.3: Flow of energy in the cochlea and tonotopy 
A: Simplified schematic of an uncoiled cochlea showing the chain of events upon sound 
stimulation (arrows) B: Sound vibrations propagate along the basilar membrane as a travelling 
wave from the basal to the apical region (upper panel). The gradually changing mechanical 
properties of the basilar membrane give rise to its tonotopic distribution, meaning that maximal 
motion is elicited at specific positions of the basilar membrane in a frequency-dependent manner 
(lower panels) (modified from (Kandel et al., 2012)). 
 
2.4 The organ of Corti and ribbon synapses 
The organ of Corti harbors hearing receptor hair cells (HCs) and is responsible of 
mechanoelectrical transduction of sound. The HCs are organized in three rows of OHCs and a 
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single row of inner hair cells (IHCs), which are disposed in parallel to the basilar membrane 
along its length. Both OHCs and IHCs develop an apical bundle of stereocilia arranged in several 
rows of increasing height. OHCs express the “motor” protein prestin, which confers them 
electromotility (Zheng et al., 2000) for their function as amplifiers of the incoming sound signal. 
OHCs receive only ~5% of afferent innervation, while the bulk of the afferent fibers reach IHCs 
(~95%, type I fibers) and identify them as the genuine hearing receptors (Fettiplace, 2017).  
At each tonotopic position, the vibration of the basilar membrane deflects stereocilia against the 
tectorial membrane, resulting in the gating of mechanoelectrical transducer channels on top of 
IHCs hair bundles. Thus, cation influx (mainly K+) causes graded depolarization of IHCs, which 
in turn opens voltage-gated Ca2+ channels at their basolateral membrane (Fettiplace and 
Hackney, 2006). At the active zones (AZ) of the basolateral IHC membrane, the increase in Ca2+ 
triggers the release of glutamate-filled synaptic vesicles into the synaptic cleft (Brandt et al., 
2005). AMPA receptors at the afferent SGN postsynaptic bouton bind the released glutamate 
(Fuchs et al., 2003) triggering the depolarization of the SGN, which eventually fires action 
potentials (APs) that propagate via the VIII cranial nerve (vestibulocochlear nerve) to the 
cochlear nucleus (Figure 2.2A).  
The first auditory synapse is characterized by its high release rates and temporal precision 
(Fuchs, 2005; Köppl, 1997). SGN spike rates can well be above 1 kHz at sound onset and 
maintain an adapted discharge in the range of hundreds of Hz (reviewed in (Lagnado and 
Schmitz, 2015; Moser and Vogl, 2016; Wichmann and Moser, 2015)). Such exquisite ability 
seems to be mediated by an electron-dense structure at AZs—mainly composed of the scaffold 
protein RIBEYE (Magupalli et al., 2008; Schmitz, 2009)— termed the ribbon, which can also 
be found in photoreceptors, vestibular hair cells and bipolar cells in the retina among others 
(reviewed in (Matthews and Fuchs, 2010)). The molecular architecture of ribbon synapses 
seems to be very different than that of “conventional” neuronal synapses, apparently lacking 
many of the commonly found synaptic proteins (Moser and Vogl, 2016; Wichmann and Moser, 
2015) and having their own specific complement instead (Pangrsic et al., 2012). Functionally, 
ribbon synapses deviate from conventional synapses in their ability to respond to graded 
potentials, i.e. neurotransmitter release is regulated by stimulus intensity. Hence, IHCs allow to 
encode timing information and respond over large intensity ranges, since the rate of transmitter 
release translates into higher spike rates (Fuchs, 2005).  
General introduction 
9 
The ribbon tethers a pool of vesicles around it and thus, it is hypothesized to have a major role 
in replenishing vesicle release sites (Frank et al., 2010; von Gersdorff et al., 1996; Jean et al., 
2018; Maxeiner et al., 2016). Other plausible ribbon functions include: coordinating vesicle 
release sites with Ca2+ channels at the AZ (Frank et al., 2010; Khimich et al., 2005), regulating 
Ca2+ channels function (Jean et al., 2018), maintaining a population of vesicles close to release 
sites (Becker et al., 2018), limiting Ca2+ spread at areas close to the AZ (Graydon et al., 2011) 
or even limiting the speed of vesicle release (Jackman et al., 2009). 
 
2.5 Innervation patterns in the organ of Corti and spike generation in 
SGNs 
The innervation pattern in the organ of Corti is very structured and comprises different types of 
neural fibers. SGNs are the primary sensory neurons in the auditory pathway. Morphologically, 
they are bipolar neurons that pack their somata inside the bony modiolus, forming the spiral 
ganglion in Rosenthal’s canal (Figure 2.2B). Their peripheral neurites contact hair cells while 
their central processes run to the cochlear nucleus through the VIII cranial nerve. From there, 
successive synaptic relays ascend to the contralateral superior olive, the inferior colliculus, the 
thalamic medial geniculate body, and finally the auditory cortex. Structurally, SGNs are divided 
into two categories (Figure 2.4). Type I SGNs are wide, with myelinated and unbranched fibers. 
Their somata can be myelinated (as in the cat) or not (as in humans) (Rattay et al., 2013). Type 
I SGNs account for ~95% of all and contact IHCs. Each AZ is contacted by a single postsynaptic 
SGN bouton, so that information carried by each afferent fiber arises from individual AZs 
(Liberman, 1980). On the other hand, ~10-30 afferent fibers make synaptic contact with each 
IHC, and thus, several neurons encode information from each tonotopic location (Frank et al., 
2009; Liberman, 1982b) with a number of contacts that correlates with auditory sensitivity 
(Liberman et al., 1990). The remaining ~5% of the SGNs is constituted by type II afferents. 
They are unmyelinated along their length, have a narrower caliber and present a ramified pattern 
innervating 30-60 OHCs. The density of type II fibers is not evenly distributed in the cochlea, 
showing a gradient that decreases from the apical to the basal region (Liberman et al., 1990). 
Deciphering the function of type II SGNs has remained elusive, but recent studies suggest their 
role in suppressing cochlear amplification (Froud et al., 2015) and in auditory nociception 




Figure 2.4: Innervation in the organ of Corti 
Type I fibers (orange) transmit sensory information from individual IHCs and account for ~95% 
of the total afferent innervation in the cochlea. Type II fibers (blue) constitute the remaining 
~5% and show a branched pattern that innervate multiple OHCs. Most efferent axons from the 
superior olivary nuclei (green) directly innervate OHCs, but a number of them also regulates 
type I fiber activity (modified from (Kandel et al., 2012). 
 
The organ of Corti, also receives efferent innervation from the superior olivary nuclei that 
provides inhibitory input to OHCs and to the postsynaptic afferent boutons of SGNs, perhaps 
functioning as a feed-back mechanism (Brown, 1987). Efferent myelinated fibers innervating 
OHCs descend from the medial superior olive, whereas unmyelinated efferents originate in the 
lateral superior olive (Brown, 1987; Liberman et al., 1990). 
Among the diverse neuronal fibers innervating the organ of Corti, type I SGNs transmit the 
biggest share of the sound-coding information at high rates and with high temporal precision. 
Particularly, type I SGNs are unmyelinated at their postsynaptic segments just beneath the IHCs, 
and only after they pass through the slits of the habenulae perforata myelination starts. The first 
heminode—located at this point—is thought to be the first spike generator in type I fibers 
(Rutherford et al., 2012), likely due to its high densities of Nav1.6 channels (Hossain et al., 2005; 
Lysakowski et al., 2011), a common feature as well in the pre-terminal segment and successive 
nodes of Ranvier. High Nav1.6 densities could lower the AP threshold and reduce spike latency 
at recepto-neural segments, and also support transmission at nodes of Ranvier (Hossain et al., 
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2005). Due to the low synaptic threshold, almost every release event in the presynapse triggers 
a single AP in the postsynapse, if it is not refractory from previous firing (Rutherford et al., 
2012; Siegel, 1992). Further features supporting the high temporal precision of SGN spiking 
include their phasic excitability and the higher mean evoked EPSC amplitude (~300 pA) relative 
to their low rheobase (~50 pA) (Rutherford et al., 2012). 
 
2.6 Studying cochlear function through SGN responses   
Methods such as distortion-product optoacoustic emissions (DPOAE), auditory brainstem 
response (ABR) and compound action potential (CAPs) measurements provide a valuable gross 
assessment about the general status of cochlear function. As non-invasive procedures, they 
enable to maintain the auditory system in a native state while the experimenter collects insightful 
data rather quickly. However, those experiments lack the resolution required to provide 
information about the basic sound encoding apparatus: the single AZ-SGN synapses.  
Despite being more invasive, juxtacellular recordings from individual SGNs can pinpoint 
physiological aspects of hearing at the single neuron level. This way, collecting data from 
multiple SGNs compose a much more detailed description of sound encoding at the primary 
sensory neurons.  
Over the years, researchers have studied SGN activity in different mammal species. Pioneering 
work in guinea pig (Tasaki, 1954) and in the cat (Kiang et al., 1965; Liberman, 1978) have 
found continuity with other animal models as the gerbil (Ohlemiller and Echteler, 1990), the 
mouse (Taberner and Liberman, 2005) or the chinchilla (Temchin et al., 2008). While most of 
the field have focused on SGN responses to sound stimuli, some groups characterized auditory 
nerve responses to electrical stimulation (Dynes and Delgutte, 1992; Miller et al., 1999, 2001, 
2006, 2008).  
The study of SGN activity show heterogeneous patterns of SGN response properties, which 
however, depict common features across different mammal species.  
 
Frequency tuning 
SGNs are frequency-tuned. This means that the intensity threshold level of SGN firing is lowest 
for sounds of a given frequency, the so-called characteristic frequency (CF). Together, fibers of 
different CF cover the entire hearing range of the animal and define its frequency-selective 
sensitivity (Heil and Peterson, 2015; Meyer and Moser, 2010). This feature arises from the 
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tonotopic mapping of the cochlea described above, which is maintained in the auditory nerve 
(Greenwood, 1996). The relationship between threshold and sound frequency describes the 
tuning curve for each fiber, which generally shows a prominent minimum at CF and higher 
thresholds for the rest of the audible spectrum (Figure 2.5A) (Kiang et al., 1965; Liberman, 
1978; Taberner and Liberman, 2005). Low thresholds and narrow frequency tuning reflect the 
amplifier function of OHCs (Kiang et al., 1976).  
 
Spontaneous firing rate 
SGNs show a spontaneous, basal rate of AP firing termed the spontaneous rate (SR) that ranges 
from 0 to 120 spikes per second in the mouse (Taberner and Liberman, 2005). Species as the 
cat show a clear bimodal SR distribution across SGNs, where SR is negatively correlated with 
threshold (Liberman, 1978). This distribution is not as clear in the mouse, but rather continuous. 
However, an inverse correlation of SR and threshold is still present (Taberner and Liberman, 
2005). In the cat, despite the bimodal distribution of fibers either around low or high SR, 
Liberman established three SGN groups based on a correlation of SR with threshold (Liberman, 
1978). Thus, SR usually serve as a classifier of SGNs and it can be used to infer other SGN 
properties. Recently, it has been reported that high-SR fibers in gerbils use spike timing to 
encode sound in background noise, whereas low-SR fibers rely on rate for performing this task 
(Huet et al., 2018). Furthermore, in gerbils, the proportion of fibers with higher or lower SR 
seems dependent on CF (Bourien et al., 2014; Ohlemiller and Echteler, 1990). Differences in 
SR also correlate with the SGN contact location at the IHC. Fibers reaching the modiolar 
(neural) side of IHCs tend to have a lower SR than those projecting onto the pillar (abneural) 
side (Liberman, 1982a). This suggests that pre- and postsynaptic factors play a role in 
establishing the heterogeneity observed for SR (Heil and Peterson, 2015; Meyer and Moser, 
2010). Hence, ribbons, Ca2+ channel clusters and Ca2+ current amplitude are larger at the 
modiolar side (Frank et al., 2009; Ohn et al., 2016) while AMPA receptor patches have been 
suggested to follow an opposing gradient (Liberman et al., 2011), features that are likely 
influenced by olivocochlear efferents (Yin et al., 2014). In turn, different SR groups among 
SGNs arise from the differential protein expression patterns of broadly varied functions, ranging 
from Ca2+-channel regulators to transcription factors. Additionally, IHC-driven activity is 
crucial for the development of SGN identities (Shrestha et al., 2018). Moreover, a recent study 
reported a more depolarized operating range of presynaptic Ca2+ channels at the modiolar side 
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when compared to the pillar side (Ohn et al., 2016). This could contribute to the observed 
reduction in SR for fibers reaching the modiolar side, but also predict a lower sound evoked 
vesicle release for the same stimulus intensity (Ohn et al., 2016). Further comparison of these 
SGNs subtypes show that low-SR and high-SR fibers have, respectively, small and large fiber 
diameter and mitochondrial content (Gleich and Wilson, 1993; Liberman, 1982a; Liberman and 
Oliver, 1984), which could help to explain the correlation of SR with threshold (Geisler et al., 




A third important feature in SGN responses is the correlation of spiking rate with stimulus 
intensity, giving rise to the rate-level function (RLF). As described above, there is a direct 
correlation between the SR of an SGN and its sensitivity to stimulation. Low-SR fibers require 
a higher stimulus intensity to increase their firing rate, but their firing rate monotonically 
increases for wide intensity ranges. In contrast, spiking rate in high-SR fibers reaches saturation 
within milder increments of stimulus strength (Ohlemiller et al., 1991; Sachs et al., 1989; 
Taberner and Liberman, 2005; Winter et al., 1990). This is quantified by the dynamic range 
(DR) of SGNs, i.e. the range of stimulus intensity for which the firing rate increases from 10 to 
90% of the difference between spontaneous and maximal rates (Figure 2.5B). Thus, DR 
correlates directly with SGN threshold and inversely with SR (Yates et al., 1990). Therefore, 
each IHC steers spiking of a repertoire of SGNs with diverse response properties. Together, 
these correlations suggest that the intensity range discernible by an organism results from the 
cooperation of fibers with varied characteristics, arising from each tonotopic region (Meyer and 
Moser, 2010). In the mouse, most RLFs have DRs < 20 dB SPL in response to pure tones at CF, 
show hard saturation and can be approximated using sigmoid functions (Taberner and Liberman, 
2005). There, narrower DRs and steeper RLFs might be related to the specialization of this 
animal for high frequencies. Most of the mouse hearing range falls above sound frequencies for 
which spike synchronization to the stimulus waveform carries significant information (see 
below); therefore, the rise of spiking rate with sound intensity is more pronounced than in other 






Figure 2.5: Response properties of SGNs 
A: Exemplary tuning curves of several SGNs from the cat show minimum intensity thresholds 
for preferred sound frequencies (CF) (top panel). This feature arises from the tonotopic 
distribution of the basilar membrane. Approximate points of innervation along the basilar 
membrane are shown in the bottom panel (modified from (Purves et al., 2004), as C). B: Rate-
level functions represent SGN response rates as stimulus intensity increases. The calculation of 
the dynamic range of the fiber is defined by the sound intensities required to elicit 10% and 90% 
of the difference between spontaneous and maximal rates. C: Response histograms of a low 
frequency SGN to a 50-ms pure tone (260 Hz, 56 dB SPL) show prominent, phase-locked 
responses to a specific phase of the stimulus waveform (bottom). 
 
Phase-locking 
When SGNs are stimulated with periodic stimuli, they tend to fire APs at the same phases of the 
stimulus period, a phenomenon termed phase-locking (Figure 2.5C). While the notion of 
entrainment (the ability of a fiber to fire APs in each stimulus period (Avissar et al., 2013)) 
quantifies spike fidelity, phase-locking assesses the temporal precision of firing relative to the 
stimulus period (Heil and Peterson, 2015). Phase-locked spikes are important for sound 
localization (reviewed in (Grothe et al., 2010)) and for pitch recognition (Cariani and Delgutte, 
1996). The measure used to evaluate the extent of phase-locking is the vector strength (or 
synchronization index) (Goldberg and Brown, 1969) a scalar that ranges from 0 (indicating a 
random relationship of APs with the stimulus period) to 1 (indicating perfect phase-locking). 
Usually, the Rayleigh test of circular data is used to estimate the significance of the obtained 
General introduction 
15 
vector strength (Hillery and Narins, 1987). The quality of phase-locking depends on stimulus 
intensity and frequency (Heil and Peterson, 2015), and is inversely correlated with SR (Johnson, 
1980). As sound intensity increases, vector strength grows over 20-30 dB until reaching 
saturation (Johnson, 1980). In terms of sound frequency, phase-locking falls off dramatically 
when pure tones approach 4 kHz, but variance among species exists (Heil and Peterson, 2015) 
(see (Temchin and Ruggero, 2010) for the chinchilla, (Versteegh et al., 2011) for the gerbil, 
(Taberner and Liberman, 2005) for the mouse and (Köppl, 1997) for the barn owl). The cause 
of this decay relates to the IHC membrane capacitance acting as a low-pass filter that attenuates 
the AC component of the receptor potential as the frequency increases. At sufficiently high 
frequencies, only the DC component remains (Palmer and Russell, 1986). For the cat, the 
maximum sound frequency that elicits significant phase-locking is higher than the average at ~6 
kHz, (Johnson, 1980); whereas for the barn owl this maximum increases up to ~10 kHz tones 
(Köppl, 1997). The mouse is specialized for high frequencies, i.e. there is a low proportion of 
SGNs with CFs at < 4 kHz. For these few low frequency fibers, the synchrony of the response 
is similar than in other animals. In contrast, for the rest of the fibers, phase-locking seems to be 
absent. Therefore, synchronization of SGN responses to pure tones does not seem to be 
particularly relevant in this animal (Taberner and Liberman, 2005). However, phase-locked 
spikes also occur in response to the envelope of higher frequency sounds (Dreyer and Delgutte, 
2006), to amplitude-modulated tones (reviewed in (Joris et al., 2004)) and to clicks (Kiang et 
al., 1965; Lin and Guinan Jr, 2000; Pfeiffer and Kim, 1972). 
 
2.7 Sensorineural hearing loss 
Over 430 million adults and 34 million children worldwide (> 5% of the world’s population) 
suffer from disabling hearing loss, the most common human sensory impairment. Far from being 
a minor concern at present, projections estimate that these figures will double by 2050. Hence, 
disabling hearing loss is a major public health issue that directly impacts communication and 
often results in feelings of isolation, depression and lessening of job prospects (WHO, 2018). In 
sensorineural hearing loss (SNHL) dysfunction originates in the inner ear and it represents the 
most common type of hearing impairment (Smith et al., 2005).  
SNHL involves deficient transduction or transmission of signals to the brain and usually 
proceeds with loss of HCs or their synapses (Moser and Starr, 2016; Youm and Li, 2018; Zhang 
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et al., 2018). Among the multiple underlying causes, genetic factors account for around 50% of 
the cases of congenital hearing loss (Smith et al., 2005; Zhang et al., 2018) while one-third of 
acquired SNHL cases is attributable to noise-induced damage (Duan et al., 2004). In addition, 
age-related hearing loss (presbycusis) is the most typical form of hearing impairment in the 
elderly, affecting one in three adults over age 60 (Fioretti et al., 2014).  
 
Genetic forms of SNHL 
Genetic disorders leading to SNHL target proteins of very varied function, with more than 100 
loci associated with human monogenic hearing loss (Richardson et al., 2011; Wichmann, 2015). 
Defects downstream mechanoelectrical transduction affect, for instance, OHCs. There, 
mutations in the Slc26a5 gene coding for prestin lead to aberrant splicing and hamper cochlear 
amplification (Toth et al., 2007). In IHCs, auditory synaptopathies cause ribbon synapse 
dysfunction and affect critical proteins for hearing function such as otoferlin or VGluT3. Around 
90 pathogenic otoferlin mutations have been described (Santarelli et al., 2015), leading to 
defective IHC ribbon synapse exocytosis and underlying prelingual hearing impairment 
(DFNB9) (Yasunaga et al., 1999) or temperature-dependent deafness (Varga et al., 2006). On 
the other hand, postlingual hearing loss (DFNA25) arises from abnormal glutamate release due 
to mutations in VGluT3 (Ruel et al., 2008; Seal et al., 2008). Additionally, disorders of the Ca2+ 
channel complex (channelopathies) can alter synaptic function. Mutations in the pore-forming 
Cav1.3α1 subunit (Baig et al., 2011) lead to impaired Ca
2+ current (Platzer et al., 2000) and 
stimulus-coupled exocytosis (Brandt et al., 2003) causing syndromic hearing loss (Baig et al., 
2011). Alternatively, alterations in the Ca2+-binding protein 2 (CABP2) underlie non-syndromic 
hearing deficits (DFNB93) (Schrauwen et al., 2012) by disturbing the inhibition of Cav1.3 
channel inactivation (Picher et al., 2017). Finally, SNHL can also arise from SGNs dysfunction. 
For instance, missense mutations in the OPA1 gene, important for mitochondrial shaping, result 
in failed SGN activation leading to syndromic autosomal dominant optic atrophy (Yu-Wai-Man 
et al., 2010) likely due to peripheral neurite degeneration (Moser and Starr, 2016).  
 
Acquired forms of SNHL 
The most common forms of acquired SNHL are caused by exposure to loud noise and ageing. 
In both cases, dysfunction or loss of OHCs and IHCs is typical, being common that OHCs loss 
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occurs first through ageing, according to data obtained in mice and rats (Yang et al., 2015). In 
contrast, noise trauma seems to primarily cause fibrocytes loss in the spiral ligament (Hirose 
and Liberman, 2003) and would affect HCs in a frequency-dependent manner only after 
prolonged exposure or higher intensities (Wang et al., 2002). In addition, loss of IHC ribbon 
synapses contributes to noise-induced hearing loss (Henry and Mulroy, 1995; Kujawa and 
Liberman, 2009) and to presbycusis (Sergeyenko et al., 2013; Stamataki et al., 2006) possibly 
due to glutamate excitotoxicity (Kujawa and Liberman, 2015; Puel et al., 1991). Interestingly, 
this seems to affect high threshold fibers (critical for hearing in noisy environments) to a greater 
extent (Furman et al., 2013). Experiments employing noise exposures leading to only temporary 
ABR or DPOAE threshold shifts, but to a permanent attenuation of CAP and ABR wave I 
amplitude, showed that a vast loss of functional synapses underlies these changes (Kujawa and 
Liberman, 2009). It is possible that in humans, excitotoxic synaptic loss would hinder hearing 
when background noise is present; but evidence is only emerging (Moser and Starr, 2016). 
Finally, degeneration of SGNs can also occur after noise insult and in ageing, occurring either 
after HC loss (Sha et al., 2008) or independently of this (Kujawa and Liberman, 2006). After 
noise trauma, SGN death seems to proceed slowly, over months or years, and is preceded by the 
loss of their afferent neurites. Due to the selective loss of high threshold fibers, this might not 
affect performance at threshold detection tests (Liberman, 2017) and thus, it is termed hidden 
hearing loss (Schaette and McAlpine, 2011). 
 
2.8 Current strategies to confront SNHL 
When hearing fails, auditory prostheses can be used to partially overcome the dysfunction. 
Current strategies are fundamentally based on three types of auditory prostheses. 
Hearing aids amplify the sound signal and are primarily indicated in mild to moderate forms of 
SNHL, as well as in conductive hearing loss (Johnson et al., 2018). In more severe cases, but 
when spike generation and conduction in the auditory nerve remain, the cochlear implant (CI) 
is the option of choice. CIs typically enable open speech understanding (Wilson and Dorman, 
2008; Zeng et al., 2008) and thus, they are considered the most successful neural prostheses in 
terms of function restoration and in number of recipients, with around 500,000 users (Wrobel et 
al., 2018). CIs are electrical devices that bypass the dysfunctional sensory epithelia by directly 
stimulating SGNs. Sounds are first captured by an external microphone and digitally processed, 
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then, a transmitter sends acoustic information to internal additional electronics that control the 
activation of an electrode array placed in scala tympani. Several independent channels in the 
electrode array allow to stimulate SGNs along the tonotopic map (Lenarz, 2018). However, CIs 
cannot cover the whole frequency range used in normal hearing due to several reasons. The 
decreasing volume available in scala tympani and its coiled shape limits the depth of insertion, 
thus reducing the extent of stimulation (Wilson and Dorman, 2008). Moreover, due to the high 
conductivity of perilymph and the relative long distance between the electrodes and the spiral 
ganglion (Wilson and Dorman, 2008) the large current spread around each electrode contact 
stimulates neighboring off-target neurons (Fu and Nogaki, 2005; Kral et al., 1998), impedes 
more than 10 non-overlapping channels (Friesen et al., 2001) and limits the output dynamic 
range (<10 dB) (Zeng et al., 2008). This results in poor understanding of speech in background 
noise and hampers music appreciation (Moser, 2015a). However, despite these shortcomings, 
the strong electrical stimulation provided by the CI is even able to activate the auditory pathway 
in some cases that involve SGN disorders (Giraudet and Avan, 2012). 
In cases where the auditory nerve is lost (mostly after acoustic neuroma surgery in patients with 
neurofibromatosis type 2), the auditory brainstem implant (ABI) restores some hearing percepts 
by providing electrical stimulation to the cochlear nucleus (Colletti et al., 2012). However, the 
fact that only a small fraction of the < 2,000 implanted patients worldwide have reported 
significant speech understanding and the increased risks of craniotomy have limited its use 
(Schwartz and Wilkinson, 2017). 
 
2.9 Optogenetics as a tool to confront SNHL 
The discovery of channelrhodopsins (ChRs), first identified in the green alga Chamydomonas 
reinhardtii (ChR1, (Nagel et al., 2002); ChR2, (Nagel et al., 2003)), marked a milestone in the 
history of neuroscience. These light-gated cation channels naturally function as photoreceptors 
to control phototaxis in green algae (Sineshchekov et al., 2002), but were essential to fulfill a 
long-sought achievement: the ability to precisely control the activity of well-defined populations 
of excitable cells. The functional possibilities of ChR2 were demonstrated first in vitro in 
cultured neurons (Boyden et al., 2005) and then in vivo via lentiviral ChR2 delivery to the 
vibrissal motor cortex in rats to control whisker movement (Aravanis et al., 2007) and to 
modulate behavior in freely moving mice (Adamantidis et al., 2007). These studies paved the 
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way for the expansion of optogenetics (first coined in (Deisseroth et al., 2006)). Broadly, 
optogenetics results from combined optical and genetic methods that allow reliable control of 
defined biological events, leading to gain/loss of function of those in living entities, ranging 
from cells to entire organisms (Deisseroth, 2010).  
 
Channelrhodopsins: structure, pore-gating kinetics, selectivity and spectral properties 
ChRs belong to the type I opsins family (also termed microbial opsins). Unlike type II opsins 
(animal opsins), they operate both as light sensors and ion channels. According to Yizhar et al. 
(2011), two more opsin classes belong to the same family: bacteriorhodopsins, light-gated 
outwardly-directed H+ pumps (Oesterhelt and Stoeckenius, 1971) and halorhodopsins, light-
driven chloride pumps (Matsuno-Yagi and Mukohata, 1977). However, structural and functional 
analyses propose xenorhodopsins, light-gated inwardly-directed H+ pumps, as yet another class 
(Shevchenko et al., 2017; Ugalde et al., 2011). 
Structurally, ChRs contain seven-transmembrane domains (helices A-G) forming a pore that 
opens upon photoisomerization of the chromophore retinal (Yizhar et al., 2011). Retinal is 
covalently bound to helix G via a conserved lysine, forming a protonated Schiff base (Nagel et 
al., 2002, 2003). In the ChR1/ChR2 chimaera C1C2, the pore is formed from helices A, B, C 
and G and harbors two gates that are key for H+/cation selectivity. The internal gate is formed 
by glutamate residues E82 and E83 interacting with H134, while the central gate is flanked by 
N258, S63 and E90 (Kato et al., 2012). 
The central gate opens within nanoseconds upon retinal photoisomerization, followed by a series 
of rearrangements that open the internal gate and render the channel conductive in the sub-
millisecond scale (τon) (Kuhne et al., 2015; Lórenz-Fonfría et al., 2015). Spectroscopy studies 
suggest the coexistence of light- and dark-adapted photocycles based on the syn-/anti- 
isomerization of the chromophore, respectively. The light-adapted cycle open state (O2) is less 
permeable to H+ and cations than its dark-adapted counterpart (O1) (Bruun et al., 2015). As O2 
is gradually occupied under prolonged illumination, photocurrent adapts from the initial (I0) to 
a stationary amplitude (Is). (Schneider et al., 2013). The O1/O2 ratio (as the opening and closing 
kinetics) is pH- and voltage-dependent and also very heterogeneous among ChRs (Mattis et al., 
2011). After light-off, photocurrents outlast illumination, due to ChRs still completing their 
photocycle, for a time interval that varies greatly among ChRs (τoff). In ChR2, τoff ~10 ms 
(Gunaydin et al., 2010), what hampers temporal fidelity at high stimulation rates in fast-spiking 
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neurons, as SGNs. Shorter τoff values are achievable by mutations in critical residues that 
stabilize the positive charge of the Schiff base (Schneider et al., 2015) as E123T, reducing τoff 
to ~4 ms (ChETA variant) and allowing spiking up to 200 Hz (Gunaydin et al., 2010). However, 
speed in ChETA comes at the cost of reduced light sensitivity, due to the effect of the shorter 
channel open time on the photocurrent (Yizhar et al., 2011). Mutations H132R (Nagel et al., 
2005a), T159C (Berndt et al., 2011) and the ChEF ChR1/ChR2 chimera offer lower inactivation 
and therefore enhanced light sensitivity than ChR2, but also slower kinetics (Lin et al., 2009). 
By adding the I170V mutation (ChIEF), τoff returned to ChR2 levels while maintaining a higher 
sensitivity (Lin et al., 2009). Combinations of mutations are possible and usually yield additive 
effects, e.g. the T159C/E123T double mutant offers larger photocurrents and faster off-kinetics 
(Berndt et al., 2011). In contrast, mutations at C128 and D156 slow off-kinetics up to 30 min 
and provide bistability by using blue light for activation and red-shifted light for deactivation 
(step-function opsins) (Berndt et al., 2008). This enhances light sensitivity by 300-fold and is 
useful for applications as two-photon optogenetics (Prakash et al., 2012).  
The single-channel conductance of ChR2 was estimated to ~40 fS (Feldbauer et al., 2009), 
which is orders of magnitude lower than native channels in neurons. Therefore, ChR expression 
levels need to be high in order to elicit physiologically-relevant currents. Chronos, isolated from 
Stigeoclonium helveticum, is the fastest ChR to date and was said not to trade speed off for light 
sensitivity, probably due to higher expression levels than other ChRs (Klapoetke et al., 2014).  
In terms of ion selectivity, ChRs are most permeable to H+ (PH+/PNa+ ~ 10
6 (Berndt et al., 2011; 
Nagel et al., 2003)) while their relative conductance varies with pH and voltage and among 
cation species: Na+ > K+ >> Ca2+ > Mg2+ (Nagel et al., 2003; Schneider et al., 2013). This means 
that under physiological conditions Na+ is the main contributor to the photocurrent (in 
perilymph: [Na+] ~140 mM at pH 7.3 (Wangemann and Schacht, 1996)). The pore of ChRs 
seems to lack high-affinity ion-binding sites (Nagel et al., 2003). Its selectivity mechanism 
rather relies on the electronegative surface of the pore, as suggested by mutations resulting in 
pore surface electropositivity that yielded C1C2 Cl- selective (Berndt et al., 2014). This 
mechanism also occurs in natural Cl--selective ChRs as GtARC2 (Berndt and Deisseroth, 2015; 
Govorunova et al., 2015).  
Moreover, the L132C mutation of ChR2 gave rise to CatCh, with enhanced light sensitivity and 




speeds up hyperpolarization by opening Ca2+-dependent BK channels, thus allowing higher 
stimulation rates (Kleinlogel et al., 2011; Mattis et al., 2011). 
Finally, the spectral properties of ChRs also differ. Red-shifted sensitivity seems to result from 
the G181S replacement in natural and artificial ChRs, leading to a biased polarity in the retinal 
binding pocket around the β-ionone ring of retinal (Deisseroth and Hegemann, 2017; Zhang et 
al., 2008). Other factors influencing red-shifted spectral properties of ChRs are retinal planarity, 
structural rigidity of the retinal binding pocket and protonation state of counterion residues, 
leading to a weaker stabilization of retinal charge (Deisseroth and Hegemann, 2017; Oda et al., 
2018). Volvox ChR (VChR1) was the first natural red-shifted ChR found with a spectral peak 
at ~550 nm (Zhang et al., 2008). To improve its low expression levels, membrane-trafficking/ER 
export signals, which were successfully used before for Natronomonas pharaonis 
halorhodopsin, were added (Gradinaru et al., 2010). Further chimaerization with ChR1 and 
ChETA mutations improved its photocurrents, resulting in C1V1, which allowed for the first 
red light-driven spikes (Yizhar et al., 2011). ReaChR (Lin et al., 2013), MChR1 (Govorunova 
et al., 2011) and bReaCHES (Rajasethupathy et al., 2015) together with Chrimson (Klapoetke 
et al., 2014) expanded the optogenetic toolbox. All red-shifted opsins described to date retain 
responsivity in blue light. Chrimson, from Chlamydomonas noctigama shows the most red-
shifted spectral peak at 590 nm, ~45 nm longer than other ChRs (Klapoetke et al., 2014). The 
same study presented the faster variant ChrimsonR (K176R), with τoff ~16 ms. The crystal 
structure of Chrimson revealed that its retinal binding pocket resembles light-driven ionic 
pumps as bacteriorhodopsin, while its ion-conduction pathway is more similar to other ChRs 
(Oda et al., 2018). Due to its red-shifted activation spectrum, Chrimson enables to trigger 
photocurrents even with high intensities of far-red light up to a maximum of 720 nm, far beyond 
the limits of other opsins. Hence, a number of researchers have used Chrimson in combination 
with other blue light-gated ChRs to perform dual color optogenetics in model organisms as C. 
elegans (Schild and Glauser, 2015) and mouse (Kampasi et al., 2018). 
 
Cochlear optogenetics 
As described above, current CI strategies have major shortcomings that result in a poor quality 
of sound percepts in CI users. In contrast, cochlear optogenetics bears the potential to overcome 
these weaknesses. Light can be directed and focused, allowing for a better spatial confinement 
onto targeted SGN populations, thereby reducing the spread of excitation as compared to 
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electrical stimulation (Hernandez et al., 2014a; Jeschke and Moser, 2015; Weiss et al., 2016). 
In the future optical CI (oCI), this would reduce channel cross-talk and promises a much higher 
number of independent stimulation channels to effectively increase frequency resolution 
(Hernandez et al., 2014a). Similarly, the oCI is also expected to expand the dynamic range of 
coding due to i) the smaller spread of excitation, ii) the heterogeneous opsin expression levels 
and iii) the differences in position relative to the emitter among SGNs, which could mimic the 
different thresholds observed for acoustical stimulation (Jeschke and Moser, 2015; 
Schoenenberger et al., 2008). However, cochlear optogenetics needs to make use of ChRs that 
are fast enough to maintain a high temporal precision of auditory coding (Weiss et al., 2016).  
To render the auditory pathway sensitive to light, ChRs need to be heterologously expressed in 
SGNs—cochlear optogenetics—or alternatively in other neurons from the ascending auditory 
pathway as in cochlear nucleus neurons (Hight et al., 2015; Shimano et al., 2013). The non-
integrating, low immunogenic adeno-associated virus (AAV) seems to be the best suited option 
for ChR transgene delivery and for translation of cochlear optogenetics to the clinical level, as 
they were in the case of the retina (Dalkara et al., 2016). Indeed, there are two ongoing clinical 
trials on AAV-mediated optogenetics for vision restoration in patients with retinitis pigmentosa 
(Simunovic et al., 2018). One of them employs AAV2-ChR2 for advanced retinitis pigmentosa 
and is currently in phase I/II (ClinicalTrials.gov, 2015; identifier: NCT02556736). A second 
one was registered in 2017 and has not yet undertaken. This study aims to use AAV2.7m8-
CAG-ChrimsonR-tdTomato and biomimetic Visual Interface Stimulating Glasses for non-
syndromic retinitis pigmentosa (ClinicalTrials.gov, 2017; identifier: NCT03326336). 
In order to be applied in auditory system prosthetics, ChRs ideally require (1) fast kinetics to 
mimic the fast physiological firing of SGNs, (2) high light sensitivity to trigger large 
photocurrents and (3) a red-shifted action spectrum to minimize the risks of phototoxicity and 
reduce light scattering (Moser, 2015a).  
The proof-of-concept study, carried out in our laboratory (Hernandez et al., 2014a), employed 
transgenic mice expressing ChR2 under the Thy1.2 promoter and trans-uterine otocyst 
injections of AAV2/6 for expression of CatCh under the human synapsin (hSyn) promoter. Both 
strategies provided enough expression levels to drive auditory activity with low irradiances in 
the range of few mW/mm2. Optogenetic activation of the auditory pathway was demonstrated 
using single-channel micro light-emitting diodes (µLEDs) and blue laser-coupled optical fibers.  
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By recording optically-driven ABRs (oABR), the population response was measured, remaining 
after deafening and growing with stimulus intensity, while maximal stimulation rates were 
modest (< 80 Hz). Activity in the inferior colliculus reflected a lower spread of excitation than 
that of monopolar electrical stimulation and recordings of single auditory nerve fibers showed 
a lower spike jitter than that of acoustical clicks, but larger than in response to electrical 
stimulation. This work further showed that optogenetic stimulation partially restored auditory 
activity in a mouse model lacking functional otoferlin. Next steps after this study included 
developing a postnatal injection protocol for cochlear optogenetics (Akil et al., 2012) and using 
faster ChRs.  
The first report on cochlear optogenetics in adult animals was published recently and used 
AAV2/6-CatCh-YFP (Wrobel et al., 2018). This work further provided the first behavioral 
evidence of hearing restoration using cochlear optogenetics. Challenges prior to clinical 
translation are, however, still manifold. Energy requirements need to be reduced, biosafety 
assessments in the long term need to be performed, as well as scaling up to larger animal models 
and non-human primates. On the technical side, suitable and miniaturized light sources need to 
be developed, and finally and most importantly, a higher performance of the oCI compared to 
eCIs needs to be proven (Weiss et al., 2016). Nevertheless, results are promising and the road 
for cochlear optogenetics has only begun. Further insight will be discussed in the next chapters.  
 
2.10 Aim of this work 
This work primarily aims at characterizing optogenetic stimulation of the auditory nerve using 
the fast-gating opsins Chronos-ES/TS and f-Chrimson expressed in SGNs. Given the low 
temporal bandwidth of optogenetic coding using ChR2 in the auditory system, with responses 
vanishing below 100 Hz, I evaluated the ability of these two ChRs to improve spike fidelity and 
temporal precision of spiking in SGNs, thereby bringing them closer to physiological levels. 
Hence, I used electrophysiological approaches in vivo to estimate the performance of the 
auditory system in response to optogenetic stimulation. I used oABR recordings with varying 
stimulus parameters (laser power, pulse duration and stimulation rate) to characterize the 
population response and define the limits of the system’s performance. Moreover, optically-
evoked single-unit recordings provided a higher definition and enabled me to estimate the extent 
of spike probability and temporal precision at increasing pulse rates. Additionally, recordings at 
the single neuron level allowed me to investigate SGN responses at varying light intensities and 
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Optogenetic tools, providing non-invasive control over selected cells, have the potential to 
revolutionize sensory prostheses for humans. Optogenetic stimulation of spiral ganglion neurons 
(SGNs) in the ear provides a future alternative to electrical stimulation used in cochlear 
implants. However, most channelrhodopsins do not support the high temporal fidelity pertinent 
to auditory coding because they require milliseconds to close after light-off. Here, we 
biophysically characterized the fast channelrhodopsin Chronos and revealed a deactivation time 
constant of less than a millisecond at body temperature. In order to enhance neural expression, 
we improved its trafficking to the plasma membrane (Chronos-ES/TS). Following efficient 
transduction of SGNs using early postnatal injection of the adeno-associated virus AAV-PHP.B 
into the mouse cochlea, fiber-based optical stimulation elicited optical auditory brainstem 
responses (oABR) with minimal latencies of 1 ms, thresholds of 5 µJ and 100 µs per pulse, and 
sizable amplitudes even at 1000 Hz of stimulation. Recordings from single SGNs demonstrated 
good temporal precision of light-evoked spiking. In conclusion, efficient virus-mediated 




Since the discovery of channelrhodopsins (ChRs, (Nagel et al., 2002, 2003) and the application 
of these light-gated ion channels for controlling excitable cells (Boyden et al., 2005), the concept 
of optogenetics has revolutionized the life sciences (Adamantidis et al., 2015; Kim et al., 2017). 
Application of optogenetics to restore sensory function in the immune-privileged eye and the 
ear are thought to have a fair chance of clinical translation (Jeschke and Moser, 2015; Sahel and 
Roska, 2013). Indeed, AAV-mediated optogenetics for vision restoration has recently entered a 
first clinical trial in a dose-finding effort (ClinicalTrials.gov, 2015; Identifier: NCT02556736) 
while neural coding of visual information can likely be achieved with ChRs that deactivate 
within several milliseconds (Busskamp et al., 2012), faster ChRs are required for sound coding 
in spiral ganglion neurons of the ear (SGNs) that spike at hundreds of Hz with sub-millisecond 
precision (Jeschke and Moser, 2015).  
If such ultrafast optogenetic control of neural activity was available, it would serve auditory 
research and could fuel the development of future optical cochlear implants (oCIs). Clinically, 
 
28 
this is highly relevant as approximately 466 million people—over 5% of the world's 
population—suffer from a disabling hearing impairment (WHO, 2018) and we are still lacking 
causal therapies for the most common form; sensorineural hearing impairment. Consequences 
are impaired communication, often social isolation, depression, and reduction in professional 
capabilities. As of today, partial restoration of auditory function by hearing aids and electrical 
CIs (eCI) represent the options of choice for rehabilitation in sensorineural hearing impairment, 
which results from cochlear dysfunction or degeneration. The eCI bypasses dysfunctional or 
lost cochlear hair cells via direct electric stimulation of SGNs and, with most of the 
approximately 500.000 users achieving open speech comprehension, is considered the most 
successful neuroprosthesis (Lenarz, 2018; Zeng, 2017). Nonetheless, there is an urgent need for 
further improvement of the CI. The biggest bottleneck of the eCI is the poor spectral resolution 
of coding that arises from the wide spread of current around each electrode contact (Kral et al., 
1998). Using light for stimulation in oCI is one of the present developments to improve spectral 
coding by CIs, as light can be better spatially confined than electric current (e.g. Richter et al, 
2011; Hernandez et al, 2014). One of the implementations used optogenetic stimulation of SGNs 
for a first proof-of-principle study on activation of the auditory pathway up to the midbrain 
(inferior colliculus, IC), demonstrating a lower spread of cochlear excitation for fiber-based oCI 
than for monopolar eCI (Hernandez et al., 2014a). However, the temporal fidelity of ChR2-
mediated optogenetic control of SGN firing seemed limited; auditory brainstem responses broke 
down even below 100 Hz of stimulation. Higher temporal fidelity of optogenetic SGN 
stimulation might be achieved when using faster ChRs such as Chronos (Klapoetke et al., 2014), 
the newly engineered Chronos mutant ChroME (Mardinly et al., 2018) or fast Chrimson mutants 
(Mager et al., 2018).  
Therefore, characterizing and optimizing fast ChRs is of great importance for fast spiking 
neurons in the auditory system, but also in the somatosensory system, cerebellum, and a wide 
range of inhibitory circuits. Here, we targeted Chronos, the fastest ChR reported so far, and first 
dissected its gating by patch-clamp recordings of photocurrents. Towards its application for 
optogenetic stimulation of mouse SGNs we optimized Chronos, the viral vector and virus 
injection approach for achieving high plasma membrane expression. As described for another 
opsin (Gradinaru et al., 2010) we appended sequences for improved exit from the endoplasmic 
reticulum (ES) (Ma et al., 2001; Stockklausner et al., 2001) and trafficking to the plasma 
membrane (TS) (Hofherr, 2005) to Chronos (Chronos-ES/TS) and performed postnatal 
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injections of AAV-PHP.B serotype (Deverman et al., 2016), which drove highly efficient 
Chronos-ES/TS expression. We demonstrate by recordings of oABR and single SGN firing that 
Chronos-ES/TS enables ultrafast stimulation of the auditory pathway.  
 
3.3 Results  
3.3.1 Chronos undergoes sub-millisecond on/off transitions at 36°C 
The kinetic properties of ChRs are best studied in cells with little background conductance to 
characterize the light-induced conductance in isolation. To this end, we used human embryonic 
kidney cells 293T (HEK-293T cells) expressing Chronos or ChR2 (Methods). We clamped the 
membrane voltage to -60 mV where any light-induced change in the conductance is then linearly 
reflected in a change of the pipette current. First, we compared gating kinetics of ChR2 and 
Chronos at a low light intensity of 0.27 mW mm-², far below the half maximal activation. At 
22°C, we found activation and de-activation time constants (mean ± s.e.m.) of 
τact = 4.9 ± 0.3 ms, τdeact = 9.4 ± 1.0 ms (n = 6) for ChR2 and τact = 1.5 ± 0.1 ms, 
τdeact = 3.0 ± 0.2 ms (n = 21) for Chronos (Figure 3.1A). When increasing the temperature to 
36°C, activation and deactivation accelerated, with τact = 0.58 ± 0.02 ms and 
τdeact = 0.76 ± 0.05 ms (n = 6), Chronos reached the sub-millisecond range, while ChR2 gating 
kinetics, τact = 2.3 ± 0.1 ms, τdeact = 3.0 ± 0.3 ms (n = 6 and 5 respectively), at 36°C were 
comparable to the values achieved by Chronos at 22°C. Hence, already at such low light 
intensity, Chronos, but not ChR2, activation and deactivation should permit signal transmission 
with a bandwidth of several hundred Hertz. Probing the frequency bandwidth directly by 
applying light chirps, Chronos confers a much higher bandwidth compared to ChR2 (Figure 
3.1B). The gain of chirp responses could be very well characterized by a single cut-off frequency 
of 24 Hz and 86 Hz for ChR2 and Chronos, respectively, at 22°C and 63 Hz and 150 Hz at 36°C 
(Figure 3.1C). 
 
3.3.2 Improving the plasma membrane expression of Chronos  
The above biophysical characterization had indicated Chronos as a strong candidate for 
optogenetic stimulation of SGNs with the required high temporal fidelity, provided sufficient 
plasma membrane expression can be achieved. Recent studies have shown that adding ER 




Figure 3.1: Chronos mediates fast light-driven currents  
A: One second long light pulses (LED centered 480 nm, 0.27 mW mm-²) elicit current responses 
in HEK-293T cells expressing ChR2 and Chronos, tested at 22°C and 36°C. Right panels show 
activation and deactivation at higher time resolution. B: A quasi-periodic chirp stimulus is used 
to directly probe the bandwidth of Chronos- and ChR2-mediated photocurrents in HEK-293T 
cells. Top: stimulus, middle: full response, bottom: sections from the beginning, middle and end 
of the response. Note the substantially larger frequency range over which Chronos currents 
follow the light stimulus. At 36°C this range is extended even further. C: Analysis of the chirp 
responses of HEK-293T cells as in Figure 3.1B. The current amplitude modulation is plotted 
against the stimulus frequency. The smooth lines represent fits to the magnitude of the transfer 
function of a single pole filter 𝑎𝑏𝑠((1 + 𝑖𝑓/𝑓𝑐𝑢𝑡)
−1 ). 
 
the cytoplasmic C-terminus of opsins promote their plasma membrane expression (Gradinaru et 
al., 2010). Hence, we added these sequences, here nick-named ES (Export Signal) and TS 
(Trafficking Signal), sandwiching EYFP, to Chronos (Chronos-ES/TS, Figure 3.2A). We first 
compared expression of Chronos-ES/TS and Chronos in HEK-293T cells transfected with the 
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respective pAAV plasmid by immunocytochemistry. Using confocal and stimulated emission 
depletion (STED) microscopy we found a preferentially peripheral, likely plasmalemmal, 
localization of Chronos-ES/TS with some intracellular signal most likely arising from the Golgi, 
while the original Chronos construct was more diffusely distributed throughout the extra-nuclear 
intracellular space (Figure 3.2B-D). We quantified the cellular distribution of the opsin by line 
profile analysis (Figure 3.2C) and found a significantly greater peripheral than central 
immunofluorescence for Chronos-ES/TS when compared to the original Chronos construct 
(Figure 3.2C, D). The larger variance of the ratio of membrane and intracellular fluorescence 
for Chronos-ES/TS (Figure 3.2D) is likely explained by dividing by the relatively low, yet 
varying intracellular abundance of the opsin. In summary, the data suggests improved 
trafficking to the plasma membrane of Chronos-ES/TS.  
Similar findings were also obtained in hippocampal neurons in culture transduced by AAV2/6 
or AAV-PHP.B (Figure 3.3). This indicates that neurons, too, struggle to traffic Chronos to the 
plasma membrane and that this can be alleviated when adding the ES- and TS-signals, at least 
when tested in culture.  
 
3.3.3 AAV-mediated expression of Chronos and Chronos-ES/TS in mouse SGNs 
Next, we turned to expression of Chronos in mouse SGNs in vivo and, once more, compared the 
original Chronos and Chronos-ES/TS. We aimed to establish efficient AAV-mediated 
transduction of SGNs and employed the human synapsin promoter (hSyn, Figure 3.2A) that had 
turned out to drive efficient and specific SGN expression (Hernandez et al., 2014a). We first 
followed our previous protocol using transuterine injections of AAV2/6 into the otocyst of 
mouse embryos at embryonic day 11.5 (Figure 3.4A, upper). In most of the cases the expression 
of Chronos-EGFP was absent or sparse (Figure 3.4B, left and middle). Exceptionally we saw 
high expression levels (Figure 3.4B right). As before (Hernandez et al., 2014a), the expression, 
if any, was largely limited to the SGNs of the basal cochlear turn and was never seen in inner 
hair cells (Figure 3.4B right, inset).  
Next, we moved on to early postnatal injections (Figure 3.4A, middle and lower, postnatal day 
(P) 5-7) into the cochlea via the round window, which had proven highly successful for 
transduction of hair cells (e.g. (Akil et al., 2012; Jung et al., 2015). We employed AAV-PHP.B, 
a novel AAV-serotype (Deverman et al., 2016) with improved efficiency of neural transduction, 




Figure 3.2: Optimizing membrane expression of Chronos by adding ER-exit and 
trafficking signals: HEK-293T cells 
A: pAAV vector used in the study Chronos with a trafficking signal (TS), EYFP and ER export 
signal (ES) Chronos-ES/TS (upper) or containing the original Chronos-EGFP (Klapoetke et al., 
2014), lower). In each, expression was driven by the human synapsin promoter (hSyn) and 
enhanced by the Woodchuck hepatitis virus posttranslational regulatory element (WPRE) and 
bovine Growth Hormone (bGH) polyadenylation signal (bGH poly A) sequences. ITR: inverted 
terminal repeats. B: Confocal and STED section of representative HEK-293T cells transfected 
with ChronosES/TS (upper) and Chronos (lower) and immunolabeled for FP: membranous 
labeling is more obvious for Chronos-ES/TS. Scale bars: 10, 5 and 2 µm for left, middle and 
right panels. C: Peak-normalized line profiles (7.5 µm) centered on the estimated membrane of 
HEK-293T cells expressing Chronos-ES/TS (blue) or Chronos (green) as in B: mean ± s.e.m. 
Chronos-ES/TS-expressing cells showed a clear peripheral, likely membrane peak, which is 
missing in Chronos-expressing cells. Inset shows box and whisker plot of the maximum peak at 
membrane. Right panels show exemplary line profile placements. One line per cell was placed 
perpendicular and centered to cell edge, aiming at sufficient intracellular coverage and avoiding 
fluorescent aggregates (arrowheads). N corresponds to analyzed cells (1 sample/cell). D: Box 
and whisker plot of the ratio of membrane and cytoplasmic fluorescence of immunolabeled 
HEK-293T cells expressing Chronos-ES/TS or Chronos: Mann-Whitney U test showed 
significantly higher ratio in Chronos-ES/TS cells demonstrating an improved membrane 
expression of Chronos-ES/TS (p = 4.4e-4). The horizontal line within the box indicates the 
median, boundaries of the box indicate the 0.25- and 0.75-percentile, and the whiskers indicate 
the highest and lowest values of the results. Squares: individual data points. For details on 





Figure 3.3: Improved membrane expression of optimized Chronos-ES/TS in hippocampal 
neurons 
A: Hippocampal neurons infected at DIV 10 with two different versions of Chronos show very 
distinct expression patterns. Neurons infected with Chronos-ES/TS (upper panels) either using 
AAV2/6 (left) or PHP.B virus (middle) show very specific plasma membrane expression in 
somatic regions and proximal dendrites. Infection of neurons with Chronos (lower panels) either 
using AAV2/6 (left) or AAV-PHP.B (middle) showed more intracellular opsin abundance. 
Right panels show exemplary line profile placement (yellow). Scale bar: 50 µm applies to all 
panels. B: Peak-normalized line profiles (1.5 µm) centered on the outer cell edge of AAV-
PHP.B transduced hippocampal proximal dendrites expressing Chronos-ES/TS (blue) or 
Chronos (green) as in A: mean ± s.e.m. Chronos-ES/TS-expressing cells showed a clear 
peripheral, likely plasmalemmal peak, which is missing in Chronos-expressing cells. C: Box 
and whisker plot of the ratio of membrane and intracellular fluorescence of immunolabeled 
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hippocampal neurons expressing Chronos-ES/TS or Chronos: Mann-Whitney U-test showed 
significantly higher ratio in Chronos-ES/TS cells demonstrating an improved membrane 
expression of Chronos-ES/TS (p = 4.2e-8). The horizontal line within the box indicates the 
median, boundaries of the box indicate the 0.25- and 0.75-percentile, and the whiskers indicate 
the highest and lowest values of the results. Squares: individual data points. For details on 
membranous and cytoplasmic area, see Materials and Methods section. 
 
1012 GC ml-1) in SGNs. Twelve out 12 AAV-PHP.B-injected mice showed substantial SGN 
transduction in immunohistochemistry for Chronos-ES/TS and 9 out 9 for Chronos. Postnatal 
injection of AAV-PHP.B drove strong expression of Chronos-ES/TS across all cochlear turns 
(Figure 3.4C). Similar to HEK-293T cells and hippocampal neurons in vitro, Chronos-ES/TS 
localized preferentially peripheral, likely plasmalemmal in SGNs in vivo, while the original 
Chronos construct was more diffusely distributed throughout the cell (Figure 3.4D). Once again, 
we quantified the cellular distribution of the opsin by line profile analysis (Figure 3.4E) and 
found a significantly greater peripheral than central immunofluorescence for Chronos-ES/TS 
when compared to the original Chronos construct (Figure 3.4E, p = 4.1e-5). The difference can 
be appreciated by the 0.56 µm more intracellular 50 % FP-immunofluorescence for Chronos. 
We note that the cytosolic parvalbumin immunofluorescence allowed a better estimation of the 
cell border which was independent of the opsin expression, both advantageous when compared 
to HEK-293T cell analysis (Figure 3.2). Despite some differences in absolute numbers between 
both analyses, which are not unexpected given the different cell types, means of transfection 
and analysis method, both support the main observation: improved relative plasma membrane 
abundance of Chronos-ES/TS. 
When analyzing the transduction rates in the injected (left) and non-injected (right) cochleae, 
we confirmed robust SGN transduction across all turns of the injected cochlea for both Chronos-
ES/TS and Chronos (Figure 3.4F). We note that the counterstain for parvalbumin-α, used for 
AAV-PHP.B injected ears, is a more general marker of SGNs than calretinin, used for AAV2/6 
injected ears, which is present only in a subset of SGNs. Therefore, if anything, we would have 
been prone to overestimate the transduction rate for AAV2/6 injected ears, which, however, was 
very low. Interestingly, for both cases of AAV-PHP.B injection we also found substantial 
expression in the contralateral, non-injected cochleae, indicating spread of virus in the specific 
conditions of pressure injection into the scala tympani of the early postnatal cochlea. This spread 
likely occurred via the cochlear aqueduct and/or the endolymphatic ducts and the cerebrospinal 
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fluid space (Lalwani et al., 1996). The density of SGNs in the injected as well as in non-injected 
ears were comparable (Figure 3.4G). The injected mice behaved normal as concluded from 
routine animal observation.  
 
Figure 3.4: Establishing efficient expression of Chronos in SGNs: use of Chronos-ES/TS, 
potent AAV-PHP.B, and postnatal mode of AAV-injection 
A: Upper panel: schematic representation of the viral injection into the embryonic otocyst (left: 
black cylinder marks the light guide used to trans-illuminate the embryo in the uterus after 
mobilization from the abdominal cavity, green: micropipette filled with fast green-colored AAV 
suspension). Middle panel: schematic representation of AAV-injection into the postnatal 
cochlea via the round window (RW). Lower panel: surgical situs of a P7 mouse with 
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retroauricular incision, graphical aid encircles the injection site). Inset shows ex-vivo cochlea 
just after AAV injection via RW. Scale bar: 2 mm. B: Maximum projection of confocal images 
of immunolabeled mid-modiolar cochlear cryosections (exemplary sections of basal turn) of 
embryonically AAV2/6-Chronos-injected mice collected at 4-weeks of age. EYFP (green) 
marks transduced SGNs, calretinin (magenta) was used as generic marker of SGNs, scale bar: 
50 µm. In the inset, color code for EYFP channel was changed to fire (EYFP). Left panel: most 
common, non-expressing example, inset shows zoom of negative SGNs. Middle panel: 
occasional, sparsely expressing example, inset: one out of two positive SGNs. Right panel: rare, 
highly expressing example, inset: negative inner hair cell (calretinin in gray), exclusive 
localization of EYFP in the SGN boutons and fibers. C: Postnatally AAV-PHP.B-Chronos-
ES/TS-injected mouse (see B except where stated differently). EYFP (green) marks transduced 
SGNs, parvalbumin (magenta) was used as generic marker of SGNs, scale bar: 50 µm. High 
transduction rate, good membrane expression. In inset, color code for the green channel was 
changed to fire for better visualization. Similar to B. D: Postnatally AAV-PHP.B-Chronos-
injected mouse (see C except where stated differently). Substantial SGN transduction, poor 
membrane expression. E: Line profile analysis of FP-immunofluorescence across the membrane 
of SGN somata. Traces were centered at the transition from high to low parvalbumin 
immunofluorescence as a proxy of plasma membrane location. Left panel: clear membrane 
abundance in Chronos-ES/TS (blue, mean ± s.e.m.), but mostly intracellular localization in 
Chronos (green, mean ± s.e.m.). Inset shows box and whisker plot of the maximum fluorescence 
at the membrane. Right panel: Box and whisker plot of the ratio of membrane and intracellular 
FP fluorescence for Chronos-ES/TS (left) and Chronos (right): stronger relative membrane 
expression in Chronos-ES/TS (Mann–Whitney U test, p = 4.1e-5). Squares: individual data 
points. For details on membranous and cytoplasmic area, see Materials and Methods section. F: 
Box and whisker plot of the fraction of FP-positive SGNs (transduced out of all parvalbumin-
positive SGNs) for the apical, middle and basal cochlear turn of the injected ear (colored) and 
contralateral, non-injected (grey) ear of Chronos-ES/TS-AAV-PHP.B and Chronos-AAV-
PHP.B mice. Points: individual animals plotted on top; n refers to number of cochleae studied. 
The horizontal line within the box indicates the median, boundaries of the box indicate the 0.25- 
and 0.75-percentile, and the whiskers indicate the highest and lowest values of the results. G: 
Box and whisker of the SGN density for the apical, middle and basal cochlear turn of the injected 
(colored) ear and the contralateral, non-injected (grey) ear (as in F). No significant differences 
between Chronos and Chronos-ES/TS nor between injected and non-injected ear. Points: 
individual cells plotted on top, n as stated in F. 
 
3.3.4 Chronos-mediated optogenetic neural stimulation of the auditory pathway: 
transuterine injections of AAV2/6 
We performed acute recordings of oABRs using fiber-coupled laser stimulation 4-12 weeks 
after AAV-injection. Following posterior tympanotomy, we inserted a 50 µm optical fiber 
through the round window (RW) to project the light of a blue laser (λ = 473 nm) onto the SGNs. 
When oABRs were present (Figure EV1), we typically found three to five oABR peaks, which 
likely reflected the synchronous activation of Chronos-expressing SGNs (first peak) and 
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downstream auditory pathway (subsequent peaks). Transuterine injections of AAV2/6-Chronos 
did not generally support oABRs; only 3 out of dozens of injected mice (including 2 different 
AAV2/6 produces) showed oABRs. In these positive mice, oABR grew in amplitude and 
showed shorter latencies when increasing radiant flux (see inset of Figure EV1).  
 
3.3.5 Chronos-ES/TS enables ultrafast optogenetic stimulation of the auditory 
pathway: oABRs 
Postnatal injection of AAV-PHP.B reliably achieved high transduction rates (Figure 3.4), which 
enabled oABRs in 19 out of 20 AAV-PHP.B-Chronos-ES/TS-injected mice and 8 out of 17 
AAV-PHP.B-Chronos-injected mice. Next, we performed a detailed characterization of 
Chronos-ES/TS-mediated optogenetic activation using oABRs and compared the results to 
those obtained with Chronos. oABR amplitude grew with increasing stimulus intensity (Figure 
3.5A,B, 1 ms light pulses delivered at 10 Hz – averaged across 1000 repetitions), while oABR 
latency (i.e. the time interval between the stimulus onset and the oABR P1 wave) got shorter for 
Chronos-ES/TS (sign test between the threshold and highest radiant flux tested, p = 0.009), 
which did not reach statistical significance for Chronos (Figure 3.5A,C; p = 0.11). oABR 
thresholds and amplitudes differed between animals (shown for the first peak, P1-N1, Figure 
3.5B). Stimuli as weak as 1.08 mW (duration: 1 ms, rate: 10 Hz – averaged across 1000 
repetitions) were sufficient to drive oABRs in one Chronos ES/TS injected mouse and 4.56 mW 
in a Chronos injected mouse. For 1 ms light pulses delivered at 10 Hz, the average oABR 
threshold amounted to 6.58 ± 1.08 mW and 13.95 ± 3.52 mW for Chronos-ES/TS and Chronos, 
respectively (p = 0.0367, Mann–Whitney U test; n = 13 and n = 8). In most animals oABR 
amplitudes grew with radiant flux increasing over more than one order of magnitude (Figure 
3.5B). The minimal latency of the first oABR peak (P1, Figure 3.5C) amounted to 
0.95 ± 0.07 ms (n = 13) for Chronos-ES/TS and 1.26 ± 0.07 ms for Chronos (n = 8, p = 0.014, 
Mann-Whitney U test). 
oABRs could be elicited by light pulses as short as 20 µs with Chronos-ES/TS and 400 µs with 
Chronos (irradiance: 38 mW, rate: 10 Hz – averaged across 1000 repetitions, Figure 3.5D,E). 
oABR amplitudes grew with pulse duration up to approximately 0.6 ms and tended to become 
smaller for longer pulses, possibly due to accumulating channel inactivation and/or increasing 





Figure 3.5: Characterizing optogenetic stimulation by recordings of oABRs  
A: oABRs driven with varying radiant flux (1 ms at 10 Hz, colors code the radiant flux in mW) 
for exemplary mice injected with AAV-PHP.B-Chronos (left) or AAV-PHP.B-Chronos-ES/TS 
(right). B: Normalized P1 – N1 amplitude of oABR as a function of light intensity for Chronos 
as in A (green, throughout figure) and Chronos-ES/TS (blue). Radiant flux was binned per 5 
mW steps (horizontal error: ± s.e.m.). Inset: maximal absolute P1–N1 amplitude of oABR 
(mean ± s.e.m.) was greater for Chronos-ES/TS than for Chronos (p- ≤ 0.001; Mann-Whitney-
U test). C: Latency of oABR P1 as a function of radiant flux as in B. Radiant flux was binned 
per 5 mW steps (horizontal error: ± s.e.m.). D: oABRs driven with varying stimulus duration 
(10 Hz, 38 mW, colors code the duration) for exemplary mice injected with AAV-PHP.B-
Chronos (left) or AAV-PHP.B-Chronos-ES/TS (right). E: P1-N1 amplitude as a function of 
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stimulus duration as in D (normalized against P1-N1 oABR amplitude. F: Latency of oABR P1 
as a function of stimulus duration as in E. G: oABRs driven with varying stimulus rate (1 ms 
and 0.5 ms for 10-500 Hz and 500-1000 Hz, respectively, 38 mW, colors code the stimulus rate) 
for exemplary mice injected with AAV-PHP.B-Chronos (left) or AAV-PHP.B-Chronos-ES/TS 
(right). H: P1-N1 amplitude as a function of stimulus rate as in G (normalized against P1-N1 
oABR amplitude at 20 Hz). I: Latency of oABR P1 as a function of stimulus rate as in H: 
Chronos-ES/TS enables responses up to at least 1000 Hz. Dashed line indicates latency data 
points obtained with a pulse duration of 0.5 ms. 
Data information: The P1-N1 amplitude and P1 latency were measured on the same animals. 
Animal count (n) is stated on bottom right of panel B, E, and H. Data are expressed as 
mean ± s.e.m. 
 
Next, we tested the dependence of oABRs on the stimulus rate [duration: 1 ms up 500 Hz and 
0.5 ms from 500 Hz, intensity: maximum (38-43mW)]. When increasing stimulus rate, oABR 
amplitudes declined (Figure 3.5G) and latencies prolonged (Figure 3.5G,I). However, in 
contrast to our previous reports on: i) ChR2: where potentials were found only up to 70 Hz 
(Hernandez et al., 2014a); ii) CatCh: up to 200 Hz, and f-Chrimson: up to 250 Hz (respectively 
(Wrobel et al., 2018; Mager et al., 2018), we could detect sizable P1-N1 up to stimulus rates of 
500 Hz for Chronos (Figure 3.5G,H) and 1000 Hz for Chronos-ES/TS (the highest tested in our 
experiments, Figure 3.5G-H). P1-latency increased with higher stimulus rates in both cases.  
 
3.3.6 Chronos-ES/TS enables ultrafast optogenetic stimulation of the auditory 
pathway: recordings from single putative SGNs 
To further validate the Chronos-ES/TS-mediated SGN stimulation and evaluate the temporal 
fidelity of stimulation, we performed juxtacellular recordings from auditory nerve fibers (central 
axon of SGN) as described in (Hernandez et al., 2014a; Mager et al., 2018). In brief, we targeted 
glass micropipettes to where the auditory nerve enters the anteroventral cochlear nucleus 
(AVCN) and searched for responses while stimulating the SGNs through the round window via 
an optical fiber coupled to a blue laser. We favored recordings of SGNs by deep positioning 
(>1000 µm relative to the surface of the cochlear nucleus) of the pipette tip, but, given that 
responses to acoustic stimuli were lost upon the ear surgery, we could not safely discriminate 
SGNs from AVCN neurons, hence, we termed the light-responsive neurons “putative SGN”. 
We found that the putative SGNs fired upon optogenetic stimulation with high temporal 
precision for stimulus rates of up to hundreds of Hz (Figure 3.6A, B); some neurons followed 
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stimulation to some extent even up to 1000 Hz (Figure 3.6B). Temporal precision of firing, 
evaluated based on vector strength (Goldberg and Brown, 1969), see Materials and Methods, 
Figure 3.6C) and spike jitter (i.e., standard deviation of spike latency across trials, Figure 3.6D), 
was generally high, but varied across the recorded neurons. 
Temporal precision and spike probability (Figure 3.6E) diminished with increasing stimulation 
rates, indicating that single SGNs code optogenetic information in a less reliable manner at very 
high stimulation rates. Spike jitter, calculated for spikes occurring in a time window comprised 
between two pulse onsets, increased with rate but it was typically below a millisecond for 
stimulus rates lower than 300 Hz (Figure 3.6D). At higher stimulus rates, spike jitter increased 
beyond the values obtained for simulated Poisson spike trains (see Materials and Methods, red-
shaded area, Figure 3.6D), indicating that spike synchronization with the light pulses became 
less reliable. The lower spike precision and limited spike probability at stimulus rates beyond 
100 Hz observed are likely compensated by the population response, as several SGNs jointly 
encode information from each place of the tonotopic map (Liberman, 1978).  
Light-evoked firing rate patterns differed among the putative SGNs as stimulation rates 
increased (Figure 3.6F). There was, in general, a linear rise of discharge rates up to 100 Hz, 
followed by a constant decrease as a response to mid and high stimulation rates. Nevertheless, 
some putative SGNs were able to maintain moderate (and to some extent synchronized) spike 
rates even at pulse rates of 1000 Hz (fibers showing computable spike probability —see 
Materials and Methods— at 500 Hz: 7/21, 33.3%; at 600 Hz: 3/18, 16.7%; at 700 Hz: 3/18, 
16.7%; at 800 Hz: 1/19, 5.26%; at 900 Hz: 2/21, 9.52%; and at 1000 Hz 2/19, 10.53%). 
Interestingly, the response patterns of the putative SGNs that we recorded varied across units at 
increasing stimulation rates (Figure EV2). We found two main types of responses; putative 
SGNs that rapidly adapted their spiking as stimulation rates rose (Figure EV2A), and neurons 
that continued spiking even at very high pulse rates (albeit with a lower frequency as compared 







Figure 3.6: Characterizing optogenetic stimulation by juxtacellular recordings from single 
putative SGNs  
A: Raster plots showing spiking activity from a representative putative SGN (“unit”) in response 
to 400 ms-long trains of laser pulses (at 30 mW, 1 ms for 20-600 Hz, 500 µs for ≥700 Hz) 
recorded at five different stimulation rates over 20 repetitions. Polar plots to the right side of 
raster plots show synchronicity of firing relative to the cycle between two pulse onsets. B: Same 
protocol and analysis of the “fastest unit” recorded, showing lower adaptation and firing even 
at very high stimulation rates. C-F: Quantification of the vector strength (C), spike jitter (D), 
spike probability (E) and discharge rate (F) as a function of repetition rate of 40 putative SGNs 
(obtained from 6 mice). In panel D, the red-shaded area represents the hazard function obtained 
in response to simulated Poisson spike trains.  
Data information: Black data points and lines show mean ± s.e.m.; individual units are shown 
in gray. The units shown on A-B are shown in green and blue, respectively. Number of units 
tested for each repetition rate: 20 Hz: 40, 50 Hz: 25, 100 Hz: 24, 200 Hz: 26, 300 Hz: 21, 400 
Hz: 20, 500 Hz: 21, 600 Hz: 18, 700 Hz: 18, 800 Hz: 19, 900 Hz: 21, 1000 Hz: 19. 
 
3.4 Discussion 
Here, we characterized and optimized Chronos for its utility in fast optogenetic control of 
excitable cells. We demonstrate sub-millisecond off-kinetics at physiological temperature of 
Chronos. Using the auditory system as a fast spiking neural model circuitry, we show that 
Chronos supports ultrafast control of neuronal spiking. In doing so, we solved a major 
shortcoming that plagued optogenetics as a stimulus modality for the cochlea; the low temporal 
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fidelity of light-driven SGN-firing, caused by the slow deactivation kinetics of the ChR2 
employed so far. We found that adding sequences promoting ER-exit and plasma membrane 
trafficking to Chronos (Chronos-ES/TS) and using postnatal injection of the powerful AAV-
PHP.B vector critically improved the in vivo utility. In conclusion, Chronos-ES/TS in 
combination with potent viral vectors such as AAV-PHP.B is a promising tool for auditory 
neuroscience and a candidate ChR for use in future optical CIs. 
 
3.4.1 Biophysical characterization of Chronos and improving plasma membrane 
expression 
Here, we compared activation and deactivation for ChR2 and Chronos and also studied the 
temperature dependence of gating for Chronos. In our hands Chronos deactivates about 3 times 
faster than ChR2 and has sub-milliseconds off-kinetics at physiological temperature with a Q10 
of 2.7. This reflects short-lived open states for Chronos resulting in lower open probability, 
which together with the relatively poor membrane expression likely explains the challenges we 
faced with using the original Chronos construct for driving SGN spiking, when using the 
transuterine injection in the AAV2/6-hSyn vector that we previously used successfully for the 
ChR2 mutant CatCh (Hernandez et al., 2014a). No problems were reported in two other studies 
of Chronos in the auditory system using different viruses and stages of the pathway; cochlear 
nucleus (Hight et al., 2015) and inferior colliculus (Guo et al., 2015). A recent study using the 
in silico predicted ancient AAV Anc80 also achieve functional expression in the cochlea, but 
did not differentiate between expression in SGNs and hair cells (Duarte et al., 2018). Inspecting 
the Chronos-GFP expression in the cochlear nucleus (Figure 2 of (Hight et al., 2015)) and SGNs 
(Duarte et al., 2018) suggest a similar diffuse intracellular distribution as we observed in HEK-
293T cells (Figure 3.2) and hippocampal neurons (Figure 3.3) in culture as well as in SGNs in 
our study (Figure 3.4). Using these 3 cell types and vastly different conditions, we show a robust 
improvement of the plasma membrane expression of Chronos upon adding ER-export (Ma et 
al., 2001; Stockklausner et al., 2001) and trafficking signals (Hofherr et al., 2005) of inward 
rectifying K+ channels. Introduction of the powerful AAV-variant AAV-PHP.B (Deverman et 
al., 2016) was an additional factor changing the game: even the unmodified Chronos (Klapoetke 
et al., 2014) enabled oABRs on a regular basis. However, when comparing the functionality of 
Chronos-ES/TS with enhanced membrane trafficking to Chronos, transduced by the same AAV-
PHP.B vector, titer, injection method and incubation time, we found increased oABR amplitudes 
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and improved temporal fidelity of the Chronos-ES/TS-mediated responses, when increasing the 
rate of stimulation. Disentangling the contributions of the improved membrane expression and 
the slightly higher fraction of Chronos-positive SGNs with Chronos-ES/TS is challenging. 
Regardless of the precise contributions, these experiments suggest that Chronos-ES/TS will be 
a valuable tool for optogenetic applications requiring good temporal fidelity. Moreover, 
avoiding the largely intracellular localization of Chronos lowers the proteostatic stress to the 
cell. 
  
3.4.2 Ultrafast Chronos-mediated stimulation of the auditory pathway 
Stimulation of the auditory pathway is a prime example for an application of optogenetics 
requiring both high speed and light sensitivity. Upon sound stimulation, SGNs fire at hundreds 
of Hz and show sub-millisecond temporal precision of spiking relative to the stimulus. When 
considering optogenetics for improved cochlear prosthetics, each stimulus should not exceed 
the energy requirements of electrical cochlear implants which are in the range of 0.2 µJ per pulse 
(Zierhofer et al., 1995). However, so far, the threshold for optogenetic activation of SGNs 
reported for ChR2 and ChR2 variant CatCh amounted to approximately 2 µJ, and the responses 
broke down for stimulation rates exceeding 20 Hz (Hernandez et al., 2014a).  
Chronos, featuring a sub-millisecond deactivation time constant at physiological temperature 
(Figure 3.1) is an obvious candidate for cochlear optogenetics. So far, we had employed 
transuterine AAV2/6-injections into the embryonic otocyst and observed a strong basoapical 
gradient of expression in the cochlea (Hernandez et al., 2014a). Using AAV-PHP.B, a novel 
AAV vector (Deverman et al., 2016) at high titers (1–2.5 1012 GC/ml) for injections into the 
cochlea of P5-P7 mice, we found highly efficient transduction of SGNs across all cochlear turns 
(Figure 3.5). The light thresholds estimated for oABRs mediated by postnatal AAV-PHP.B 
injections of Chronos-ES/TS in SGNs amounted to 7µJ (14 µJ for Chronos), which is 
substantially higher than the energy per pulse for suprathreshold stumulation in eCIs. Therefore, 
further improvements of membrane expression of Chronos or the design of fast channels with 
larger pore remain an important objective. At present, we can only speculate how much light 
will be required for an auditory percept mediated by Chronos-based cochlear optogenetics. 
Future studies using behavioral experiments will be required to address this point. Nonetheless, 
we argue that future optogenetic CIs might not need the high stimulation rates employed in eCIs 
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(800 Hz or higher) which might help balancing a greater energy requirement per pulse of an 
oCI. In most animals, oABR increased in amplitude when increasing light intensity over more 
than one order of magnitude (Figure 3.6). Hence, the output dynamic range of optical 
stimulation assessed as P1-N1 amplitude, on average, was > 10 dB (mW) compared to typically 
< 10 dB for coding with eCI (Zeng et al., 2008). This likely reflects the lower spread of 
excitation with optical stimulation as well as differences in the levels of Chronos-ES/TS 
expression among SGNs at the same tonotopic place of stimulation. 
The temporal fidelity of Chronos-ES/TS-mediated optogenetic stimulation was estimated at the 
single SGN and the SGN population levels. The minimal oABR latency was considerably 
shorter (1.01 ± 0.09 ms) than that of the first light-evoked potential, typically a trough, that we 
had previously reported for transgenic ChR2 mice (3.14 ± 0.26 ms (Hernandez et al., 2014a)). 
Moreover, the minimal duration of the light pulse required for eliciting an oABR at high light 
intensity was shorter (<100 µs) than that found before with ChR2 or CatCh (≥ 200 µs; 
(Hernandez et al., 2014a)). Most importantly, population responses mediated by Chronos-ES/TS 
followed pulse rates up to at least 1000 Hz unlike for ChR2, where oABRs were lost below 
100 Hz. Obviously, the analysis had to be restricted to a very short measurement time window 
in order to track the response to such high rates and hence signal propagation along the pathway 
cannot be demonstrated. This ABR analysis suggests that the Chronos-ES/TS mediated 
optogenetic stimulation achieves a temporal fidelity similar to that of acoustic coding. Using 
juxtacellular recordings we could demonstrate firing of single SGNs in response to trains of 
light pulses at hundreds of Hz with sub-millisecond temporal precision. Such temporal fidelity 
of optogenetic control of SGN firing marks a major breakthrough on the way towards using 
optogenetic stimulation for auditory research and for the future development of the clinical 
optical cochlear implant. 
 
3.5 Materials and Methods 
Cloning 
For the cloning of pAAV_hSyn_Chronos-ES/TS as a starting material we have used pAAV-
Ef1a-DIO-eNpHR 3.0-EYFP (Addgene, plasmid nr. #26966). In order to obtain flanked EYFP 
with ES/TS sequences we performed a classical PCR reaction. The primers that we used for this 
cloning were 5’-GAGAACCGGTCAAGAGCAGGATCAC-3’ and 5’-
GTGGGGTACCCCTTACACCTCGTTCTC-3’. In the second step, the  obtained PCR 
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fragment was digested with AgeI/Acc65I (Thermo Scientific, MA, USA) (Acc65I produces 
compatible cohesive ends as BsrGI) gel extracted (GeneJET Gel Extraction Kit, Thermo 
Scientific, MA, USA) and further used for ligation. At the same time, the plasmid 
pAAV_hSyn_Chronos-GFP (Addgene, plasmid no. 59170) was also digested using restriction 
enzymes AgeI/BsrGI and used as a backbone plasmid. All obtained ligation products were 
further tested by the means of colony PCR and finally sequenced by an external company. 
 
Cell Culture and HEK-293T transfection 
HEK-293T cells (ATCC, USA) were cultured at 37°C and 5 % CO2 in DMEM (Gibco, USA) 
supplemented with 10 % fetal calf serum (Gibco, Germany), and 1 % penicillin/streptomycin 
(Sigma, Germany). One day prior to transient transfections the HEK293T cells were seeded on 
24-well plates. The day after seeding, cells were transiently transfected with 
pAAV_hSyn_Chronos-ES/TS or pAAV_hSyn_Chronos using PEI 25.000MW (Polysciences 
Inc. USA). Two days after transfection cells were briefly washed and then fixed with 4 % PFA 
for 10 min. After fixation cells were mounted with Mowiol (Sigma, Germany) and processed to 
confocal/STED imaging. Cells were regularly tested for mycoplasma contamination. No method 
of cell line authentication was used. 
For characterization of gating kinetics, HEK-293T cells were transfected with 3-5 µg of plasmid 
DNA encoding a ChR2-YFP or a Chronos-GFP fusion protein via nucleofection using a Lonza 
nucleofector device and the Amaxa Cell Line Nucleofection Kit V (Lonza, Switzerland; 
program Q-01), following the manufacturer’s instructions. The pcDNA 3.1-ChR2-YFP 
construct was kindly provided by Ernst Bamberg (MPI for Biophysics, Frankfurt, Germany), 
and Chronos-GFP was kindly provided by Edward Boyden (MIT, Cambridge, MA). After 
transfection, the cells were plated on poly-L-lysine coated 10 mm glass cover slips. 
Electrophysiological characterization was performed 20 to 30 h after transfection. 
 
Electrophysiology 
Transfection success was accessed via fluorescence in an inverted Axiovert 135 TV 
fluorescence microscope (ZEISS, Germany), equipped with a 40X/0.65 N.A. Achroplan 
objective. Only cells isolated from others and exhibiting clear membrane fluorescence signal 
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were recorded. Whole-cell patch-clamp recordings were made in voltage-clamp mode (-60 mV 
holding potential) using an EPC 10 USB amplifier (HEKA Elektronik, Germany). Current 
signals were low-pass filtered at 3 kHz and digitized at 20 kHz. Patch-pipettes were prepared 
from PG10165-4 glass capillaries (World Precision Instruments, USA) in a PIP 6 vertical puller 
(HEKA Elektronik, Germany), and had resistances between 3-5 MΩ when filled with the 
following pipette solution (in mM): 110 NaCl, 10 Na4-EGTA, 4 MgCl2, 10 HEPES, and 
10 Glucose (pH 7.4 and osmolarity between 285-290 mOsm). The bath solution contained (in 
mM): 145 NaCl, 3 KCl, 1 MgCl2, 2 CaCl2, 10 HEPES, and 15 Glucose (osmolarity between 
310-315 mOsm and pH 7.35). Series resistance (always < 20 MΩ before compensation) was 
electronically compensated 60 to 90 %. For recordings at physiological temperature, warm 
solution was perfused by gravitation in the recording chamber via an HPT-2 in-line heater (ALA 
Scientific Instruments, USA) controlled by a TC-10 temperature controller (NPI Electronic, 
Germany). Temperature at the recording chamber was monitored via a thermistor placed in the 
chamber and it was maintained at 36  1 °C. Light-stimulation was achieved using a 480 nm 
diode (5 W Luxeon rebel color with Lambertian dome; Philips Lumileds) controlled by a 
custom-built controller. Stimulation protocols consisted of 1 s-long light steps at different 
intensities (0.08, 0.14, 0.19, 0.23, 0.27 mW mm-2), with a 11 s-long dark period in between, or 
a 10 s-long light chirp linearly-increasing from 0.1 to 100 (or 500) Hz and maximum amplitude 
of 0.27 mW mm-2 (following a 1 s-long pre-pulse at half maximum intensity). The LED output 
faithfully followed the voltage command up to at least 5 kHz. Light-elicited currents were 
analyzed offline in Matlab 2011b/2014b (Mathworks, USA), Igor Pro 6/7 (Wavemetrics, USA) 
and OriginPro 7 (OriginLab, USA), and this included the correction of baseline drifts during the 
10 s-long chirp recordings. For recordings at 36°C occasionally spike-like artifacts occurred due 
to the in-line heater. Those spikes were removed for display purposes in Figure 3.1. 
 
Dissociation and culture of hippocampal neurons, AAV infection and 
immunocytochemistry 
E18 pregnant Wistar rats were sacrificed using CO2, embryos were removed and heads of 
embryos were placed in a 10 cm petri dish containing ice-cold dissection media (HBSS (Gibco) 
+ 10 mM Hepes (Gibco)). Brains were removed and collected in fresh dissection medium. 
Hippocampi were separated from the brain and meninges were removed. Hippocampi were 
digested with 2 ml pre-warmed 37°C 0.05 % trypsin-EDTA (Gibco, Germany) for 20 min at 
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37°C. Trypsin was removed and the tissue was washed three times with 4°C dissection medium. 
Dissection medium was replaced with 1 ml pre-warmed NB+ (Neurobasal with 1X B-27 
supplement, 1X Glutamax and penicillin (5000 U ml-1)/streptomycin (5000 µg ml-1); all from 
Gibco) and tissue was triturated by gentle pipetting. The tissue suspension was filtered through 
a 100 mm cell strainer (BD Biosciences). Cells were counted using the trypan blue exclusion 
method and cultured on 12 mm glass coverslips (Thermo Scientific) coated with poly-D-lysine 
(PDL, Sigma) dissolved in 0.1 M borate buffer, in 24-well plates (CytoOne) at a density of 
80000 hippocampal neurons per cm2 in NB+ medium in a HeraCell 240i cell culture incubator 
(Thermo Scientific) at 37°C and 5 % CO2. On DIV 10, neurons were infected with 1 µl AAV2/6 
Chronos, AAV2/6 Chronos-ES/TS or the same constructs packed in PHP.B virus capsid. 72 h 
after infection, neurons were briefly washed with pre-warmed PBS and then fixed with 4 % PFA 
at RT for 10 min. After fixation and several steps of washing, neurons were subjected to 
immunocytochemistry (rabbit anti-Map2 primary antibody, 1:1000, Abcam and goat anti-rabbit 




AAVs were generated in HEK-293T cells (ATCC) using polyethylenimine transfection 
(25.000 MW, Polysciences, USA) (Gray et al., 2011; Deverman et al., 2016). In brief, triple 
transfection of HEK-293T cells was performed using pHelper plasmid (TaKaRa/Clontech), 
trans-plasmid providing viral capsid PHP.B (generous gift from Ben Deverman and Viviana 
Gradinaru, Caltech, USA) and cis-plasmid providing Chronos or Chronos-ES/TS (Figure 3.2A). 
The cell line was regularly tested for mycoplasma. We harvested viral particles 72 h after 
transfection from the medium and 120 h after transfection from cells and the medium. Viral 
particles from the medium were precipitated with 40 % polyethylene glycol 8000 (Acros 
Organics, Germany) in 500 mM NaCl for 2 h at 4°C and then after centrifugation at 4000 g for 
30 min combined with cell pellets for processing. The cell pellets were suspended in 500 mM 
NaCl, 40 mM Tris, 2.5 mM MgCl2, pH 8, and 100 U mL-1 of salt-activated nuclease 
(Arcticzymes, USA) at 37°C for 30 min. Afterwards, the cell lysates were clarified by 
centrifugation at 2000 g for 10 min and then purified over iodixanol (Optiprep, Axis Shield, 
Norway) step gradients (15 %, 25 %, 40 % and 60 %) (Zolotukhin et al., 1999; Grieger et al., 
2006) at 320,006 g for 2.25 h. Viruses were concentrated using Amicon filters (EMD, 
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UFC910024) and formulated in sterile phosphate-buffered saline (PBS) supplemented with 
0.001 % Pluronic F-68 (Gibco, Germany). Virus titers were measured using AAV titration kit 
(TaKaRa/Clontech) according to manufacturer’s instructions by determining the number of 
DNase I resistant vg using qPCR (StepOne, Applied Biosystems). Purity of produced viruses 
was routinely checked by silver staining (Pierce, Germany) after gel electrophoresis (Novex™ 
4-12 % Tris-Glycine, Thermo Fisher Scientific) according to manufacturer’s instructions. The 
presence of viral capsid proteins was positively confirmed in all virus preparations. Viral stocks 
were kept at -80 °C until the experimental day. 
 
Transuterine AAV injection into the cochlea 
For in vivo transduction, anesthesia was induced with a mixture of ketamine and xylazine 
(0.125/5 mg kg-1) and maintained with isoflurane (1 %–2 %). Viral inoculum (~250 nl, 4e+8 
particles μl-1) was microinjected through the uterus into the mouse otocyst from E11.5 to E12.5 
as previously described (Brigande et al., 2009; Reisinger et al., 2011). Only the left otocyst of 
each embryo was injected. The non-injected contralateral ear served as an internal control. 
AAV2/6_hSyn_Chronos-GFP and AAV2/6_hSyn_Chronos-ES/TS were purchased from the 
University of North Carolina Vector Core, Chapel Hill, USA. 
 
Postnatal AAV injection into the cochlea  
Postnatal AAV-injection into scala tympani of the left ear via the round window was performed 
in P5-P7 wild-type C57BL/6 mice essentially as described (Akil et al., 2012) using AAV-PHP.B 
viral capsids and hSyn promoter to drive transgenic expression of opsins in SGNs. In brief, 
under general isoflurane anaesthesia and local analgesia achieved by means of xylocaine, the 
left ear was approached via a dorsal incision and the round window membrane was identified 
and gently punctured using a borosilicate capillary pipette that was kept in place to inject 
approximately 1-1.5 µl of AAV2/6_hSyn-Chronos (2.33E+12 GC ml-1), AAV2/6_hSyn-
Chronos-ES/TS (2.2E+12 GC ml-1), PHP.B_hSyn-Chronos-GFP (1.07E+12 GC ml-1) or 
PHP.B_hSyn-Chronos-ES/TS-EYFP (2.31E+12 GC ml-1). After virus application, the tissue 
above the injection site was repositioned and the wound was sutured and buprenorphine 
(0.1 mg kg-1) was applied as pain reliever. Recovery of the animals was then daily tracked. In 
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all experiments, mice were randomly selected for injection. No blinding was possible since 
injections had to be performed in the left ear leaving the right ear as an internal control. Hence, 
surgery prior to stimulation needed to be done in the injected ear. Animals were then kept in a 
12 h light/dark cycle, with access to food and water ad libitum. All experiments were done in 
compliance with the national animal care guidelines and were approved by the board for animal 
welfare of the University Medical Center Goettingen and the animal welfare office of the state 
of Lower Saxony. The calculation of animal number was performed prior to starting 
experiments. We planned to use the Wilcoxon Rank Sum Test and an error probability alpha 
smaller than 0.05, a power (1-beta) of 0.95 and effect size depending on the precise experimental 
protocol. 
 
Immunostaining and imaging of cochlear cryosections 
Cochleae were fixed with 4 % paraformaldehyde in phosphate buffered saline (1 h). Sections of 
the cochlea were cryosectioned following 0.12 M EDTA decalcification. After incubation of 
sections for 1 h in goat serum dilution buffer (16 % normal goat serum, 450 mM NaCl, 0.6 % 
Triton X-100, 20 mM phosphate buffer, pH 7.4) primary antibodies were applied over night at 
4°C. The following antibodies were used: chicken anti-GFP (catalog no.: ab13970, Abcam, 
1:500), guinea pig anti-parvalbumin (catalog no.: 195004, Synaptic Systems, 1:300). Secondary 
AlexaFluor-labeled antibodies (goat anti-chicken 488 IgG (H+L), catalog no.: A-11039, 
Thermo-Fisher Scientific, 1:200; goat-anti guinea pig 568 IgG (H+L), catalog no.: A1107, 
Thermo-Fisher Scientific, 1:200) were applied for 1 h at room temperature. Confocal images 
were collected using a SP5 microscope (Leica) and processed in ImageJ. Expression was 
considered positive when FP fluorescence in a given cell (marked by parvalbumin) was found 
to be higher than 3 SD above the background fluorescence of the tissue. 
For FP localization analysis line profiles (length: 7.5 µm, 7.5 µm and 1.5 µm for SGNs, HEK 
cells and hippocampal neurons, respectively, width: 3 pixels) were centered to the outer edge of 
the estimated cell membrane. The line profiles were oriented perpendicular to the cell edge. 
Sample size was 1, 1 and 3 per cell for SGNs, HEK cells and hippocampal neurons, respectively. 
For membrane/intracellular expression ratio, a maximum peak detection was performed for 
membranous area (defined positionally on the line profiles as -1 to 1 µm, -1 to 1 µm and -0.5 to 
0.3 µm for SGNs, HEK cells, and hippocampal neurons, respectively) and for intracellular area 
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(defined positionally on the line profiles as 1.1 to 2 µm, 1.1 to 2 µm, and 0.4 to 0.5 µm for 
SGNs, HEK cells, and hippocampal neurons, respectively). 
 
STED microscopy  
Images were acquired using an Abberior Instruments Expert Line STED microscope, with 
excitation lasers at 488 nm and STED lasers at 595 nm, 1 W using a 1.4 NA 100x oil immersion 
objective, either in confocal or in 2D-STED mode. 
 
Optical stimulation in vivo  
The left bulla was reached using a retroauricular approach and opened to expose the cochlea. A 
50/200 µm optical fiber coupled to a 594 nm laser (OBIS LS OPSL, 100 mW, Coherent Inc.) 
was inserted into the cochlea via the round window. Irradiance was calibrated with a laser power 
meter (LaserCheck; Coherent Inc.). 
 
Auditory brainstem responses  
For stimulus generation and presentation, data acquisition, and off-line analysis, we used a NI 
System and custom-written Matlab software (The MathWorks, Inc.). Optically-evoked ABRs 
(oABRs) and acoustically-evoked ABRs (aABRs) were recorded by needle electrodes 
underneath the pinna, on the vertex, and on the back near the legs. The difference potential 
between vertex and mastoid subdermal needles was amplified using a custom-designed 
amplifier, sampled at a rate of 50 kHz for 20 ms, filtered (300–3000 Hz) and averaged across 
1000 and 500 presentations (for oABRs and aABRs, respectively). The first ABR wave was 
detected semi-automatically with a custom-written Matlab script in which the wave was 
detected for each trace in a temporal window defined by the user and for which the amplitude 
was bigger than the average + 2 standard deviations. Thresholds were determined by visual 
inspection as the minimum sound or light intensity that elicited a reproducible response 
waveform in the recorded traces. 
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Juxtacellular recordings from single putative SGNs  
For auditory nerve recordings, glass microelectrodes (~50 MΩ) were advanced through the 
posterior end of the anteroventral cochlear nucleus using an Inchworm micro-positioner (EXFO 
Burleigh, NY, USA) and aimed towards the internal auditory canal. Action potentials were 
amplified using an ELC-03XS amplifier (NPI Electronic, Tamm, Germany), filtered (300–
3000 Hz), digitized (National Instruments card PCIe-6323), analyzed and prepared for display 
using using custom-written Matlab (The MathWorks, Inc.) software. 
When light-responsive fibers were found, 400 ms-long pulse trains at repetition rates 20-1000 
Hz were presented, leaving 100 ms inter-train recovery over 20 iterations for each tested rate. 
Different rates were tested following no particular order, being 20 Hz the first repetition rate 
presented across all units. For repetition rates higher or equal to 200 Hz, parameters were 
computed if the spike probability was equal or superior to 5 %. If not, values were set to 0. 
Phase-locking was quantified using the vector strength (Goldberg & Brown, 1969), considering 
a cycle starting at the onset of a light pulse and ending at the onset of the subsequent pulse, and 
conforming to the equation: 𝑣𝑒𝑐𝑡𝑜𝑟 𝑠𝑡𝑟𝑒𝑛𝑔𝑡ℎ = , being Θ1, Θ2, …, Θn 
cycle phases in which spikes occurred. The Rayleigh test was used to evaluate the significance 
of vector strength: if L > 13.8, the null hypothesis is rejected at the 0.001 significance level 
(Hillery and Narins, 1987) and insignificant VS were set to 0. The spike probability was 
calculated as the ratio between the number of spikes and the number of light-pulses. The 
temporal jitter is the standard deviation of spike latency across trials. The hazard function (for 
the temporal jitter analysis) was calculated for each stimulation rate by simulating spiking as a 
Poisson process at given rates (from 10 to 1000 spikes s-1). 
 
Data analysis 
The data were analysed using Matlab (Mathworks), Excel (Microsoft), Igor Pro (Wavemetrics), 
FIJI (ImageJ2), Origin (Microcal Software), and GraphPad Prism (GraphPad Software). 
Averages were expressed as mean ± s.e.m. or mean ± s.d., as specified. References to data in 
the main text were expressed as mean ± s.e.m. For statistical comparison between two groups, 
data sets were tested for normal distribution (the D’Agostino & Pearson omnibus normality test 
or the Shapiro-Wilk test) and equality of variances (F-test) followed by two-tailed unpaired 
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Student’s t-test, or the unpaired two-tailed Mann-Whitney U test when data were not normally 
distributed and/or variance was unequal between samples.  
For evaluation of multiple groups, statistical significance was calculated by using one-way 
ANOVA test followed by Tukey’s test for normally distributed data (equality of variances tested 
with the Brown-Forsythe test) or one-way Kruskal-Wallis test followed by Dunn’s test for non-
normally distributed data.  
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Figure EV1: Demonstrating functional expression of Chronos in SGNs following 
transuterine AAV2/6 injection reported by recordings of oABRs  
In 3 out of dozens of animals we could record oABRs using fiber-coupled laser stimulation 4-
12 weeks after embryonic transuterine injection of AAV2/6 carrying Chronos using 4 ms pulse 
trains at 10 Hz with 30 mW radiant flux. Responses were verified as oABRs by the increasing 
amplitude with stronger light pulses (inset: shows oABRs of an exemplary oABR-positive 
mouse for varying radiant flux, colors code the radiant flux in mW). A small onset and offset 
artifact (arrowheads) is visible for the average (black) of the negative animals (gray) which we 





Figure EV2: Activity of two exemplary putative SGNs upon light stimulation at increasing 
repetition rates 
A: Raster plot showing spike timing (blue symbols) of a rapidly adapting putative SGN in 
response to 400 ms pulse trains at stimulation rates 50-1000 Hz (30 mW, 1 ms for 50-600 Hz; 
30 mW, 0.5 ms for 700-1000 Hz). B: Raster plot showing activity of a slowly adapting putative 
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 Optogenetics revolutionizes basic research in neuroscience and cell biology and bears potential 
for medical applications. We develop mutants leading to a unifying concept for the construction 
of various channelrhodopsins with fast closing kinetics. Due to different absorption maxima 
these channelrhodopsins allow fast neural photoactivation over the whole range of the visible 
spectrum. We focus our functional analysis on the fast-switching, red-light activated Chrimson 
variants, because red light has lower light scattering and marginal phototoxicity in tissues. We 
show paradigmatically for neurons of the cerebral cortex and the auditory nerve that the fast 
Chrimson mutants enable neural stimulation with firing frequencies of several hundred Hz. They 
drive spiking at high rates and temporal fidelity with low thresholds for stimulus intensity and 
duration. Optical cochlear implants restore auditory nerve activity in deaf mice. This 
demonstrates that the mutants facilitate neuroscience research and future medical applications 
such as hearing restoration. 
 
4.2 Introduction 
Microbial-type rhodopsins, light gated cation channels (Channelrhodopsins, ChRs) and light 
driven ion pumps are useful tools for multimodal optogenetic control of electrically excitable 
cells in culture, tissue and living animals ((Boyden et al., 2005; Nagel et al., 2005b; Zhang et 
al., 2007a). Since the first description of the channelrhodopsins in 2002 and 2003 a set of 
different channelrhodopsins including red-shifted variants like VChR1, ReaChR and Chrimson 
have been described (Klapoetke et al., 2014; Lin et al., 2013; Nagel et al., 2002, 2003; Zhang et 
al., 2008). For different purposes, ChRs were modified with respect to the kinetics, ion 
selectivity as well as light absorption (Gunaydin et al., 2010; Kleinlogel et al., 2011; Lin et al., 
2009). ChR kinetics is a major issue, because the light sensitivity is regulated via the open 
lifetime of the channel (Klapper et al., 2016). Channels with a short open lifetime need 
correspondingly stronger light than channels with a long open lifetime for maximal 
photostimulation. This is due to the essential invariance of other channel parameters like single 
channel conductance and quantum efficiency. The mutual dependence between channel kinetics 
and light sensitivity accounts for the optimization of ChR expression and light delivery for 
successful experiments in the high frequency range. Although fast channels need stronger light 
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for the activation, high speed is indispensable for many optogenetic applications in neurobiology 
because many types of neurons operate at high firing rates in the intact animal.  
Prominent examples include spiral ganglion neurons (SGNs) of the early auditory pathway and 
fast spiking interneurons in cortical areas, which fire action potentials at up to several hundred 
Hz (Hu et al., 2014; Liberman, 1978). However, light stimulation of ChR2-expressing SGNs 
indicated a strong limitation of the temporal response fidelity (Hernandez et al., 2014b). 
Therefore, fast ChRs are needed and their benefit for use in auditory research has already been 
indicated using Chronos, a ‘fast’ blue light absorbing ChR, for stimulation of the cochlear 
nucleus (Hight et al., 2015).  
Electrical cochlea implants (eCI), to date, enable speech understanding in most of approximately 
500.000 otherwise deaf users. However, the bottleneck of eCI is the poor frequency resolution 
of coding that results from wide current spread from each electrode contact and limits speech 
understanding in background noise (Zeng et al., 2008). Optical cochlear implants (oCI), 
stimulating optogenetically modified SGNs, promise a fundamental advance of prosthetic sound 
coding by increasing frequency resolution, because light can be better confined than the electric 
field of electrodes (Hernandez et al., 2014b). For the oCI eventually to be translated into the 
clinic, opsins need to be delivered into the SGNs by postnatal virus-application to the ear and 
should endow SGNs with high light-sensitivity and temporal fidelity of spike generation, while 
light scattering and blue light induced phototoxicity should be minimized. Due to the 
aforementioned adverse effects of optogenetic stimulation using blue light; the already 
available, fast blue light-activated ChR variants like ChETA (τoff  = 4.4 ms (Gunaydin et al., 
2010)) and Chronos (τoff  = 3.6 ms (Klapoetke et al., 2014)) have a limited applicability in 
animals and future clinical translation.   
Here, we report that fast gating can be generally conferred to ChRs by helix 6 (helix F) mutation  
and demonstrate the utility of fast red-shifted ChRs for driving spiking of fast cerebral 
interneurons to the limit of their encoding range. Moreover, we established efficient virus-
mediated delivery and expression of a fast Chrimson mutant in SGNs of mice, show that single-
channel oCIs enable near-physiological spike rates and spike timing in SGNs and restore 
auditory activity in deaf mice. We demonstrate on several cell types in vitro and in vivo that the 
unfavorable low light sensitivity for activation is compensated by high expression levels of the 




4.3.1 Fast helix F mutants and their calcium permeabilities  
Closed to open state transition is associated with movement of helix F in several microbial type 
rhodopsins (Luecke, 2001; Nakanishi et al., 2013; Subramaniam et al., 1993). Thereby helix F 
movement controls protonation reactions during vectorial proton transport and consequently the 
cycle time (Haupts et al., 1999; Vonck, 2000). Closed to open state transitions of helix F have 
recently been verified for ChR2 (Müller et al., 2015; Sattig et al., 2013). Motivated by these 
findings we performed a systematic study about the effects of helix F mutations on the closing 
kinetics of channelrhodopsin (Figure 4.1). We heterologously expressed ChRs helix F mutants 
in neuroblastoma-glioma cells (NG cells) and performed whole-cell patch-clamp experiments. 
The novel helix F mutant F219Y significantly accelerated the closing kinetics of ChR2 (Figure 
4.1C and Table 4.1). Mutations at the homologous positions of VChR1 (F214Y), ReaChR 
(F259Y) and Chrimson (Y261F) also accelerated the closing kinetics (Figure 4.1B), albeit to a 
different extent (Figure 4.1D-F and Table 4.1). The strongest effect on the lifetime of the 
channels was observed in ReaChR and VChR1, where the closing kinetics is accelerated by one 
order of magnitude (Table 4.1).  
Interestingly, the relative calcium permeability of ChR2 F219Y PCa/PNa= 0.30 ± 0.02 (n=4) was 
increased compared to the relative calcium permeability of ChR2 wt PCa/PNa=0.13 ± 0.01 (n=4). 
Permeability ratios were calculated according to the Goldman-Hodgkin-Katz equation (Hille, 
2001) with the measured values of the reversal potentials after replacing external sodium by 
calcium. The critical role of a tyrosine at the homologous position on the calcium permeability 
is verified in ReaChR and Chrimson (Supplementary Table 1). Of note F219 (ChR2 numbering) 
points to L132 (ChR2 numbering) on helix C in the C1C2 chimera crystal structure (Figure 
4.1A). ChR2 L132C has an increased calcium permeability (CatCh, calcium translocating 
channelrhodopsin (Kleinlogel et al., 2011)). In contrast to the FY mutations on helix F, which 
accelerate the closing kinetics the L132C mutation (helix C) as well as the corresponding 
mutations at the homologous positions of VChR1, ReaChR and Chrimson significantly slowed 
the closing kinetics (Table 4.1). Structural information, the effect on the kinetics and the effect 





















Figure 4.1: Channelrhodopsin mutants with accelerated closing kinetics 
A: Helix F and helix C of channelrhodopsin (Kato et al., 2012) Residues changing the off-
kinetics are highlighted (ChR2 numbering). B: ClustalW alignment of the helix F of ChR2, 
Chrimson, ReaChR and VChR1. Colored boxes show the channelrhodopsin mutants. C-H: NG 
cells heterologously expressing channelrhodopsin variants were investigated by whole-cell 
patch-clamp experiments at a membrane potential of −60 mV. C: Typical photocurrents of 
ChR2-EYFP (black trace), ChR2-EYFP F219Y (red trace); D: VChR1-EYFP (black trace), 
VChR1-EYFP F214Y (red trace); E: ReaChR-Citrine (black trace), ReaChR-Citrine F259Y 
(red trace); F: Chrimson-EYFP (black trace) and Chrimson-EYFP Y261F (red trace)  
immediately after cessation of 0.5 s illumination at a saturating light intensity of 23 mW/mm2 
and a wavelength of C: λ = 473 nm, D: λ = 532 nm, E: λ = 532 nm and F: λ = 594 nm. G: Typical 
photocurrents of Chrimson-EYFP mutants, which were measured in response to 3 ms light-
pulses (23 mW/mm2, λ = 594 nm). H: For clear illustration solely the photocurrents of 
Chrimson-EYFP, Chrimson-EYFP Y261F/S267M (f-Chrimson-EYFP) and Chrimson-EYFP 
K176R/Y261F/S267M (vf-Chrimson-EYFP) are shown. Photocurrents were normalized for 





Table 4.1: Off-kinetics (τoff) of channelrhodopsin variants 
Shown are the average τoff values and the corresponding s.d. NG cells transiently expressing 
channelrhodopsin variants were investigated by whole-cell patch-clamp experiments at 
−60 mV. The τoff values were determined as described in the Methods section. ChR2 
(Chlamydomonas reinhardtii Channelrhodopsin 2, n = 3) (Nagel et al., 2003), ChR2 L132C 
(CatCh) (Kleinlogel et al., 2011), ReaChR (Red-activatable Channelrhodopsin, n = 3) (Lin et 
al., 2013), VChR1 (Volvox channelrhodopsin 1, n = 3) (Zhang et al., 2008), Chrimson 
(Chlamydomonas noctigama Channelrhodopsin, n = 3), Chrimson K176R (ChrimsonR, n = 5) 
(Klapoetke et al., 2014), homologous mutants to CatCh: ReaChR L172C (n = 3), VChR1 L127C 
(n = 3), Chrimson L174C (n = 11), novel mutants: Chrimson Y261F/S267M (f-Chrimson, 
n = 4), Chrimson K176R/Y261F/S267M (vf-Chrimson, n = 7), ChR2 F219Y (n = 4), ReaChR 
F259Y (n = 3), VChR1 F214Y (n = 3), Chrimson Y261F (n = 7), Chrimson S267M (n = 5), 
Chrimson Y268F (n = 4), Chrimson S267M/Y268F (n = 3), Chrimson K176R/S267M/Y268F 
(n = 3), Chrimson Y261F/S267M/Y268F (n = 4), Chrimson K176R/Y261F/S267M/Y268F 
(n = 5) a value from ChR2 L132C is taken from (Kleinlogel et al., 2011). 
 
 
4.3.2 Chrimson mutants with accelerated closing kinetics 
As shown above, the Y261F mutation speeds up channel closing in Chrimson (Figure 4.1F, 
Table 4.1). We identified two additional helix F mutations, which accelerated Chrimson’s 
closing kinetics, namely S267M and Y268F (Figure 4.1B,G and Table 4.1). The combination of 
the helix F mutations had a cumulative effect, further accelerating channel closing by up to one 
order of magnitude (Figure 4.1G and Table 4.1). Chrimson mutants carrying the Y268F 
mutation showed a reduced expression in NG cells and a hypsochromic shift of their action 
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spectra by 11 nm (Supplementary Figure 1 and Supplementary Table 2). The hypsochromic shift 
might result from an interaction of F268 with the polyene chain of the retinal, as this was shown 
for F265 (F226, ChR2-numbering), located at the homologous position in the C1C2 structure 
(Figure 4.1A).   
Of special interest for optogenetic applications are the fast mutant Chrimson Y261F/S267M (f-
Chrimson) and the very fast mutant Chrimson K176R/Y261F/S267M (vf-Chrimson), which 
carries the additional K176R mutation (Figure 4.1H). As described earlier (Klapoetke et al., 
2014), the closing kinetics of Chrimson K176R (ChrimsonR), is accelerated by a factor of ∼2 
compared to wildtype (Table 4.1). The closing kinetics of f-Chrimson were strongly accelerated 
from τoff  = 24.6 ± 0.9 ms (wt-Chrimson, n = 5) to τoff  = 5.7 ± 0.5 ms (f-Chrimson, n = 5). At the 
same time f-Chrimson was highly expressed in NG cells (Supplementary Table 2). vf-Chrimson 
had ultrafast closing kinetics of τoff = 2.7 ± 0.3 ms (n=7), which is at least as fast as the closing 
kinetics of Chronos (τoff  = 3.6 ± 0.2 ms) (Klapoetke et al., 2014), the fastest Channelrhodopsin 
known to date. Of note, the action spectra of f-Chrimson and vf-Chrimson were not blue-shifted 
(Supplementary Figure 1), thereby preserving the benefits of longer wavelength activation. 
Compared to Chrimson wt, the functional properties of the mutants were almost unaltered with 
respect to the linear voltage dependence of the photocurrents (Supplementary Figure 2), cation 
permeabilities (Supplementary Table 3), the moderate slowing of the closing kinetics at positive 
voltages (Supplementary Figure 3) and peak current inactivation (Supplementary Figure 4). Of 
note, the measured cation permeabilities contradict a recent publication (Vierock et al., 2017), 
but are in accordance with a previous study (Klapoetke et al., 2014). At a temperature of 34°C 
we measured τoff values of 3.2 ± 0.2 ms (n = 3) for f-Chrimson and 1.6 ± 0.1 ms (n = 3) for vf-
Chrimson (Supplementary Figure 5). Hence the ultrafast kinetics of the Chrimson mutants in 
principle enables neural photostimulation in an exceptionally high frequency range of up to 
∼600 Hz.  
 
4.3.3 Ultrafast red-shifted optogenetics 
We heterologously expressed f-Chrimson and vf-Chrimson in primary cultures of rat 
hippocampal neurons by means of adeno-associated virus mediated gene transfer (AAV2/1). 
Patch-clamp experiments proved a robust neuronal expression and confirmed the substantially 
faster kinetics of the mutants (Supplementary Table 4). The application of light pulses (λ1=594 
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nm, λ2=640 nm) triggered spiking with high reliability (Figure 4.2 and Supplementary Figure 
7). The investigation of the dependence of spike probability on light pulse intensity showed that 
neural photostimulation via f-Chrimson (0.37 – 1.27 mW/mm2) and vf-Chrimson (0.09 – 3.18 
mW/mm2) required stronger light compared to the neural photostimulation via Chrimson wt 
(0.09 – 0.7 mW/mm2) (Figure 4.2E-G and Supplementary Table 4). That finding could be 
explained by the investigation of the light dependence of the Chrimson variants, which revealed 
significantly higher EC50 values for the fast Chrimson mutants (Supplementary Figure 6). 
Higher EC50 values for the fast Chrimson mutants are expected, because, as described above, 
light sensitivity is regulated via the open time of the channel (Klapper et al., 2016). However, 
due to the high expression of the fast Chrimson mutants in neurons, which is demonstrated by 
the large current density (~ 30 pA/pF) of their photocurrents (Supplementary Table 4) spiking 
with a probability of 100 % could be triggered with low intensity light pulses of 0.65 ± 0.31 
mW/mm2 (n=15) for f-Chrimson and 1.25 ± 1.02 mW/mm2 (n=15) for vf-Chrimson 
(Supplementary Table 4). Note that potential space clamp issues might have lowered the 
determined current density values. The large variability of the dependence of the spike 
probability on the light intensity (Fig. 4.2E-G and Supplementary Table 4) is likely due to 
expression differences as well as the variability of membrane resistance, capacitance and spiking 
threshold of the investigated neurons. 
The primary culture of rat hippocampal neurons comprises a multitude of different neuronal 
subtypes, most of which have a maximal firing frequency of 40-60 Hz (Gunaydin et al., 2010). 
Therefore, in most cases spike failures occurred at a frequency of 60 Hz (Figure 4.2C). In single 
cases a frequency of 100 Hz was achieved (Figure 4.2D). The investigation of neural 
photostimulation in the high frequency range is impeded by the heterogeneity of the primary 
neuronal culture. Therefore, we conducted patch-clamp experiments on parvalbumin-positive 
interneurons heterologously expressing vf-Chrimson. Parvalbumin-positive interneurons 
display a fast spiking phenotype, and predominantly supply inhibition to the perisomatic domain 
of other neurons (Hu et al., 2014). Heterologous expression of vf-Chrimson was achieved by 
intracerebroventricular injection of AAVs in transgenic mice that expressed tdTomato under the 
control of the parvalbumin promoter. Therefore, parvalbumin-positive interneurons could be 


















Figure 4.2: Light-induced spiking in rat hippocampal neurons 
A-D: Spiking traces at different light-pulse frequencies. Rat hippocampal neurons 
heterologously expressing A: Chrimson-EYFP, B: Chrimson-EYFP K176R/Y261F/S267M (vf-
Chrimson-EYFP) and C-D: Chrimson-EYFP Y261F/S267M (f-Chrimson-EYFP) were 
investigated by whole cell patch-clamp experiments under current-clamp conditions 
(λ = 594 nm, pulse width = 3 ms, saturating intensity of 11–30 mW/mm2). C: Traces from two 
different cells at a stimulation frequency of 60 Hz. D: Traces from one cell at stimulation 
frequencies of 80 Hz and 100 Hz. E-G: The dependence of spike probability on light pulse 
intensity for E: Chrimson-EYFP (15 different cells), F: Chrimson-EYFP Y261F/S267M (f-
Chrimson-EYFP) (15 different cells), and G: Chrimson-EYFP K176R/Y261F/S267M (vf-
Chrimson-EYFP) (15 different cells). The action potentials were triggered by 40 pulses 
(λ = 594 nm, pulse width = 3 ms, ν = 10 Hz) of indicated light intensities. In order to determine 
the spike probability, the number of light-triggered spikes was divided by the total number of 
light pulses. Scale bars: y-axis: 10 mV, time-axis: (A-B, 10 Hz) 500 ms (A-B, 20 Hz) 300 ms 
(A-B, 40 Hz) 200 ms (C, 60 Hz) 100 ms (D, 80 Hz) 70 ms (D, 100 Hz) 50 ms. 
 
Using current injections we determined a maximal intrinsic firing frequency of 301 ± 29 Hz 
(n=8) for the parvalbumin-positive interneurons, as expected for the fast spiking phenotype 
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(Figure 4.3A,B) (Hu et al., 2014). Of note vf-Chrimson enabled neural photostimulation up to 
the intrinsic limit of the cells with high temporal precision (Figure 4.3C-E and Supplementary 
Figure 8C). As demonstrated, some cells followed photostimulation up to 400 Hz (Figure 
4.3C,D). In 2/7 cells the occurrence of extra spikes in response to the light pulse was observed 
(Supplementary Figure 8B) (Gunaydin et al., 2010), which compromised the fidelity of neural 
photostimulation in those cases. We note that similar to previous work using AAV transduction 
and single photon stimulation (Klapoetke et al., 2014), it was necessary to adjust irradiation 
intensity individually for each neuron to achieve optimal stimulation fidelity (Supplementary 
Figure 9). To our knowledge these results represent the fastest light triggered spiking measured 
to date, and indicate that vf-Chrimson opens new possibilities for the investigation of high 
frequency network events such as sharp wave-ripples (Buzsáki, 2015). 
 
4.3.4 f-Chrimson is a promising candidate for hearing restoration 
Optogenetics bears great potential for improving the restoration of vision and hearing (Moser, 
2015a; Sahel and Roska, 2013). Future oCIs shall use tens to hundreds of microscale light 
sources to focally stimulate tonotopically-ordered SGNs in Rosenthal’s canal (Figure 4.4A; 
(Moser, 2015a)). For deaf people, the lower spread of excitation from the light source in oCIs 
(Hernandez et al., 2014b), promises improved frequency and intensity resolution when 
compared to the eCI (Moser, 2015a). However, much remained to be done prior to a potential 
clinical translation of the oCI. For example, so far cochlear optogenetics was established using 
blue ChRs expressed in transgenic rodents or in mice following prenatal viral-gene transfer 
(Hernandez et al., 2014b).  
Here, we tested the potential of f-Chrimson for optogenetic stimulation of SGNs. We established 
postnatal viral gene transfer by injecting AAV2/6-hSyn-f-Chrimson-EYFP into the scala 
tympani via the round window in 3-6 day-old mice (Figure 4.4B). We readily observed 
photocurrents in patch-clamp recordings from isolated SGNs (Smith et al., 2015) in the second 
postnatal week (Figure 4.4C), proving the basic functionality of f-Chrimson in the target cells. 
We then in depth analyzed expression and function 4-14 weeks after injection. Using confocal 





















Figure 4.3: vf-Chrimson drives fast interneurons to the frequency limit 
A: Example recording of a neocortical parvalbumin-positive interneuron in an acute brain slice. 
Current injection (500 ms, 550 pA) elicits high frequency firing (322 Hz), consistent with the 
fast spiking phenotype of these interneurons. B: When tested with constant current injection, 
the input–output curve of PV-interneurons plateaus at a maximum firing rate of 270 ± 33 Hz 
(n = 8). C: Example traces of the vf Chrimson-expressing PV-interneuron from (A) activated by 
light pulses (565 nm, 0.5 ms) at frequencies ranging from 50–500 Hz. Note that this interneuron 
reliably followed frequencies of up to 400 Hz. D: Spiking probabilities of PV-interneurons at 
different optical stimulation frequencies. On average (black), PV-interneurons followed 
stimulation up to 300 Hz reliably (94 ± 5% spiking probability), and could still encode input 
frequencies of up to 400 Hz with a reliability of 68 ± 16% (n = 7; three whole-cell, four cell-
attached recordings). E: Action potential latency (assessed at peak) and action potential jitter 
(s.d. of latencies) after light pulse onset for all stimulation frequencies with reliable spiking 
(>85%). Error bars are s.e.m. Scale bars: A: 50 ms, 10 mV; C: 50 ms, 10 mV. 
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high transduction rate (near 80 %) in the injected ear, which was not significantly different 
among the cochlear turns (Kruskal-Wallis ANOVA followed by Dunn’s test, p > 0.05, n = 5; 
Figure 4.4D,F). SGN showed clear plasma membrane expression of f-Chrimson (insets in Figure 
4.4F) and survived the optogenetic manipulation as evident from the unaltered SGN density 
when compared to the non-injected ear (Mann-Whitney U test, p > 0.05, n = 5; Figure 4.4E,F). 
The non-injected ear showed f-Chrimson expression in less than 5% of the SGNs (Figure 
4.4D,F), indicating minimal spread of AAV from the injected ear likely via the cochlear 
aqueduct.  
We then established single-channel oCI stimulation by performing a posterior tympanotomy 
and inserting an optical fiber (50 µm diameter) through the round window to project the light of 
a 594 nm laser onto the SGNs of the basal cochlear turn of young mice (2-3 months, Figure 
4.5A). We could readily elicit optical auditory brainstem responses (oABR, Figure 4.5B,C) that 
differed between animals in waveform and amplitude. For comparison we recorded acoustic 
auditory brainstem responses (aABRs, Figure 4.5B,C lower panels) that were similar in 
amplitude and waveform to oABR and also varied between animals (Figure 4.5B). We note that 
the similarity to aABRs and the shorter latency (0.93 ± 0.13 ms vs. approximately 3 ms 
(Hernandez et al., 2014a))  and smaller maximal amplitude (10.7 ± 3.80 µV vs. approximately 
1000 µV (Hernandez et al., 2014a)) of oABRs when compared to our previous report on 
transgenic mice indicates more specific activation of the auditory pathway in the case of 
postnatal AAV-injection used in present study. We then characterized the oABRs in response 
to different light intensities, light pulse durations and light pulse rate (n = 5 mice). oABR 
amplitude grew and oABR latency got shorter with increasing light intensity (Figure 4.5C,D,G). 
Stimuli as weak as 0.5 mW (Figure 4.5C,D; duration: 1 ms, rate: 20 Hz) and as short as 80 µs 
(Figure 4.5E,H; rate: 20 Hz, intensity: 11 mW) were sufficient to drive oABRs. Amplitudes 
typically varied for changes in light intensity of more than one order (Figure 4.5C,D, output 
dynamic range > 10 dB (mW) for oABR). oABR amplitudes declined when raising stimulus 
rates (Figure 4.5F,I). However, f-Chrimson-mediated oABRs remained sizable up to stimulus 
rates of 200 Hz, suggesting high temporal fidelity of light-driven SGN firing. Next, we used 
aged C57BL6/J mice (9 months-old, n = 5 mice) to explore the potential of oCI to restore activity 
in the auditory pathway of a mouse model of age-related hearing loss (Shnerson and Pujol, 




Figure 4.4: f-Chrimson expression after postnatal AAV-transduction of SGNs 
A: Scheme of the future oCI as implanted into the human ear: the oCI passes through the middle 
ear (limited left by ear drum and right by inner ear) near the ossicles, enters the cochlea and 
spirals up in scala tympani. It will likely contain tens of microscale emitters (orange spots on 
oCI) that stimulate (orange beams) SGNs housed in the modiolus (central compartment of the 
cochlea), that encode information as APs. SGNs form the auditory nerve (right) which carries 
the information to the brain (not displayed). B: pAAV vector used in the study to express f-
Chrimson-EYFP under the control of the hSynapsin promoter (top) upon early postnatal 
injection of AAV2/6 into scala tympani via a posterior tympanotomy (lower left) to expose the 
round window (white circle in right lower panel). C: Photocurrents of a representative culture 
f-Chrimson-EYFP-positive SGN isolated from an injected ear at P14. Light pulses of 2 ms 
duration were applied at the indicated intensities in the focal plane and photocurrents recorded 
at −73 mV at room temperature. Scale bar: 2 ms, 50 pA. D: Fraction of EYFP-positive SGNs 
(identified by parvalbumin immunofluorescence, parvalbumin+) and E: density of parvalbumin+ 
SGNs (#cells per 104 µm2) obtained from data as in F. Symbols mark results from individual 
animals (n = 5), box–whisker plots show 10th, 25th, 50th, 75th and 90th percentiles of the 
injected (orange) and non-injected control (magenta) cochleae (Kruskal–Wallis ANOVA, 
p = 0.6538, H = 0.98; post-hoc Dunn’s test for comparison of expression, p  > 0.05 for all 
pairwise comparisons; Mann–Whitney U test for comparison of density, Lapex vs. Rapex, Lmid vs. 
Rmid, Lbase vs. Rbase, p > 0.05 for all comparisons). F: Projections of confocal cryosections with 
YFP (green) and parvalbumin (magenta) immunofluorescence of SGNs in three cochlear 
regions (scale bar: 50 µm). Insets (scale bar: 10 µm) show close-up images of single z-sections 
of the same images. 
Chapter 4 
69 
by aABR elicited by acoustic clicks were elevated to above 50 dB (SPL) (58 ± 3.3 dB SPL, 
Figure 4.5J-L, typically 20 dB in young mice) and aABR amplitudes were reduced to 1/3 of 
those in young mice across all SPLs tested (Figure 4.5L). oABR amplitudes measured in these 
aged mice were comparable to values obtained for young animals (Figure 4.5L), but latencies 
tended to be shorter and less variable (Figure 4.5G and Supplementary Figure 10H). 
Interestingly, we found that light pulses as short as 40 µs were able to elicit oABRs (11mW at 
20 Hz, Supplementary Figure 10F,I) as compared to 80 µs in young mice (Figure 4.5E). 
Moreover, we were able to record oABRs at stimulation frequencies as high as 250 Hz (11 mW, 
1 ms pulse duration), likely due to the lower average latencies found in these aged mice as 
compared to their younger counterparts (Supplementary Figure 10G,J). Together the data 
indicate that optical activation of the auditory pathway proceeded with at least as high efficiency 
in aged C57BL/6J mice despite their profound age-related hearing impairment. f-Chrimson 
expression levels throughout the injected cochlea were homogeneous (one-way ANOVA 
followed by Tukey’s test, p > 0.05, n = 5). Importantly, long-term f-Chrimson expression (9 
months) did not seem to decay significantly (Kruskal-Wallis ANOVA followed by Dunn's test, 
p > 0.05, n = 5) (Supplementary Figure 10A-C) nor cause any significant loss of SGNs in the 
AAV-injected ear of these mice, when compared to the non-injected ear (t-test for comparison 
of cell density across cochlear turns in the injected and non-injected ear, p  > 0.05, n = 5) 
(Supplementary Figure 10D).  
In order to scrutinize the temporal fidelity of stimulation, we turned to juxtacellular recordings 
from single neurons (Liberman, 1978; Miller et al., 2008). We established single-channel oCI 
stimulation via an optical fiber and targeted electrodes through a craniotomy to where the 
auditory nerve enters the cochlear nucleus (Figure 4.6A) in order to measure the neural 
photoactivation. Those neurons could not be identified based on a response to acoustic 
stimulation, most likely due to impaired acoustic hearing following ear surgery and oCI. 
Therefore, we termed light-stimulated neurons putative SGNs. We found that the putative SGNs 
fired upon optogenetic stimulation with high temporal precision for stimulus rates of up to 
hundreds of Hz (Figure 4.6B-E): some neurons followed stimulation to some extent even up to 
1 kHz (Figure 4.6B,D). The spike latency amounted to approximately 2 ms for stimulus rates of 




Figure 4.5: Single-channel oCIs drive oABRs in hearing and deaf mice 
A: Experimental set-up for oABR-recordings in mice: a 50 µm optical fiber coupled to a 594 nm 
laser was implanted into scala tympani via a posterior tympanotomy and the round window. 
Recordings of far-field optically evoked potentials were performed by intradermal needle 
electrodes. For aABR recordings a free-field speaker was employed (lower panel). B: 
Comparing oABRs (upper panel) and aABRs (lower panel) at strong stimulation levels for four 
mice (average of 1000 trials). oABRs were recorded in response to 1 ms long, 11 mW, 594 nm 
laser pulse at 10 Hz, aABRs of the same mice in response to 80 dB (SPL peak equivalent) clicks. 
Bars indicate the stimulus timing. C: oABRs (upper panel, 594 nm, 1 ms at 10 s-1) and aABRs 
(lower panel, clicks at 10 s-1, values in SPL [peak equivalent]) recorded from an exemplary 
AAV-injected mouse at increasing stimulus intensities. D-F: Normalized P1-N1-amplitude as a 
function of laser intensity (D: 1 ms at 20 Hz), pulse duration (E: 11 mW at 20 Hz), and stimulus 
rate (F: 11 mW, 1 ms). Group average (lines) and s.d. (error bars) are shown in orange (same 
for G-I). G-I: P1-latency as a function of laser intensity (G as in D), duration (H as in E), and 
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rate (I as in F). J: Exemplary aABR recordings done as in A-C using a 9 months-old mouse 
(following postnatal AAV-Chrimson-EYFP injection: elevated acoustic thresholds (around 
60 dB [SPL], compare to C). K: oABR recordings done as in A-C in the same mouse as in J, 
using 1 ms long laser pulses: thresholds similar to injected mice at 2–3 months of age (around 
1 mW, compare to C). L: P1-N1-amplitude of oABR (orange) and P1-N1-amplitude of aABR 
(gray) as function of stimulus intensity in young (2–3 months-old) and old (9 months-old) mice 
(n = 5 for each group, means (lines) ± s.e.m. (error bars) are shown. Symbols in D-I mark results 
from individual animals. Scale bars (B, C, J, K): 1 ms, 5 µV. 
 
the interneurons (Figure 4.3E). Temporal precision of firing, evaluated based on vector strength 
((Goldberg and Brown, 1969), see methods, Figure 4.6C,D) and temporal jitter (i.e., standard 
deviation of spike latency across trials, Figure 4.6E, Supplementary Figure 11C) varied between 
the recorded neurons and, generally, was good. The vector strength declined with increasing 
stimulation rate up to 1 kHz. For a comparison, we re-plot the median vector strength of firing 
driven by transposed tones in mouse SGNs ((Buran et al., 2010); Figure 4.6D) used because 
phase-locking to pure tones is hard to achieve in the high frequency mouse cochlea (Taberner 
and Liberman, 2005). Temporal jitter, evaluated for spikes occurring in the time window equal 
to the stimulus period, was typically below a millisecond and tended to increase when raising 
stimulus rates up to 300 Hz (Figure 4.6E). At higher stimulus rates, the temporal jitter was higher 
than the values obtained for simulated Poisson spike trains (see methods, gray area, Figure 
4.6E), reflecting a reduced spike synchronization with the light pulses. Interestingly, the spike 
jitter increased significantly from 25 ms compared to the start of the stimulation (Supplementary 
Figure 11C). Spike probability (Figure 4.6C-D) declined as the rate of stimulation increased, 
indicating that optogenetic coding by individual SGNs becomes less reliable as stimulus rate 
rises. This, however, is likely compensated at the population level, as several SGNs jointly 
encode information from each place of the tonotopic map (Liberman, 1978).  
 
4.4 Discussion 
As demonstrated, the investigation of the molecular properties of microbial-type rhodopsins is 
essential for the development of variants with superior properties for particular optogenetic 
applications. Our study reveals the critical role of helix F for the closing kinetics of various 
ChRs. Using site-directed mutagenesis we generated fast variants of four different ChRs, which, 


































Figure 4.6: f-Chrimson enables SGNs spiking at near physiological rates 
A: Experimental set-up for recording optogenetic responses of SGNs in mice: a 50 µm optical 
fiber coupled to a 594 nm laser was implanted into scala tympani via the round window (lower 
panel, see cylindrical structure in the upper half) and microelectrodes were advanced into the 
cochlear nucleus via a craniotomy (upper panel). B: Exemplary spikes of a neuron (1 ms, 
5.5 mW for 100, 300 Hz; 11 mW for 500 Hz). Raster plot (right panel): spike times in response 
to laser pulses (orange bars: 2 ms @ 5.5 mW for 20-400 Hz, 1 ms @ 11 mW for 500-700 Hz and 
above: 0.5 ms @ 11 mW): spikes cluster in time for stimulus rates up to hundreds of Hz, 
temporal jitter increases with stimulation rates. Scale bar: 50 ms, 2 mV. C: Activity of an 
exemplary neuron in response to 900 ms trains of laser pulses (1 ms) at three different rates 
leaving an inter-train recovery time of 100 ms (first 400 ms are shown and analyzed). Panels to 
the right side of raster plots show polar plots: synchronicity and probability of firing decay with 
increasing stimulus frequency. Spike probability 200 Hz: 0.8, 300 Hz: 0.33, 400 Hz: 0.04. 
Vector strength 200 Hz: 0.92, 300 Hz: 0.83, 400 Hz: 0.57 (Rayleigh-test: p < 0.001 in all cases). 
D: Box-whisker plots showing 10th, 25th, 50th, 75th and 90th percentiles of the vector strength 
(orange) and spike probability (purple) of 40 units from five mice, stimulated at different rates 
as described for C. Symbols represent values from every unit. Gray circles are means of vector 
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strength of SGNs in wild-type mice found with transposed tones at the characteristic frequency 
at 30 dB relative to spike threshold (Taberner and Liberman, 2005), for comparison. Numbers 
at the bottom of the graph indicate number of units clustered below them. E: Temporal jitter of 
spikes across stimulation rates 50–400 Hz. Gray area represents the hazard function obtained in 
response to simulated Poisson spike trains. Data points show mean (lines) ± s.e.m. (error bars). 
Number of units included for each stimulation frequency (color coded) is shown. 
 
(vf-) Chrimson of particular interest to the neurosciences because of their red-shifted action 
spectrum and high membrane expression. Our analysis of fast spiking interneurons of the 
cerebral cortex demonstrated that they enable the remote optical control of even the fastest 
neurons at their intrinsic physiological limits. Finally, we show that f-Chrimson is a promising 
candidate for future clinical optogenetic restoration of sensory function. 
Channel opening/closing of ChR2 is based on a concerted movement of helices B, F and G 
(Müller et al., 2015; Sattig et al., 2013). Interestingly, we discovered a major impact of the 
interaction between the moving helix F and the virtually immobile helix C on ChR kinetics. 
High resolution structures of the investigated ChRs are not available. However, the information 
of the high resolution structure of the C1C2 ChR chimera in combination with the light-induced 
helix movement studies by electron spin resonance and the low-resolution structure by 2D 
cryoelectron microscopy allowed us to identify the crucial position F219 in helix F for the 
construction of a faster ChR2 mutant. This position is also conserved in ReaChR and VChR1. 
Analogous mutations lead to accelerated kinetics of channel closing. Of note, the surprisingly 
slow reacting Chrimson has already a tyrosine on this position (Figure 4.1A,B). We suspected 
that the mutation of this tyrosine influences channel closing kinetics. Indeed, the mutation to a 
phenylalanine in the analogous position (Y261F) results to faster channel closing in Chrimson. 
Further inspection of the alignment of helix F shows at positions M225 and F226 in ChR2 the 
same analogy for VChR1 and ReaChR but not for Chrimson. For Chrimson, mutations on these 
positions (S267M, Y268F) in addition to the Y261F mutation result in the ultrafast switching 
behavior (Fig 4.1G,H). The surprising and peculiar phenotype of the back mutations in 
Chrimson is hard to explain without a high resolution structure of the protein.  
This study achieved two important breakthroughs towards developing cochlear optogenetics for 
auditory research and future improved hearing restoration. First, we managed to achieve 
efficient, non-traumatic and neuron-specific expression of f-Chrimson in SGNs using postnatal 
AAV-injection into scala tympani through the round window. We found near 80% of the SGNs 
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in the injected ear to express f-Chrimson at high levels and mostly in the plasma membrane of 
somas and neurites, which persists for at least 9 months after injection. These transduction rates 
were much higher than those achieved with transuterine injection of AAV2/6-hSyn-CatCh-YFP 
(Hernandez et al., 2014b) and unlike there, independent from tonotopic position. We consider 
the minute transduction of the non-injected ear to reflect viral spread through the cerebrospinal 
fluid space, which calls for further optimization of the injection protocol (Lalwani et al., 1996). 
Importantly, we did not find evidence for neuron loss even at 9 months after injection and we 
expect little, if any, risk of phototoxicity given the red-shifted action spectrum of f-Chrimson.   
Secondly, using f-Chrimson, we overcame the likely biggest roadblock of current ChR2-based 
cochlear optogenetics: low temporal bandwidth of optical coding (<80 Hz) (Hernandez et al., 
2014b). We found robust and fast photocurrents in cultured isolated f-Chrimson-positive SGNs. 
In vivo, fiber-based stimulation resembling single-channel oCI elicited activation of the auditory 
pathway in hearing and deaf mice. Using far-field neural population responses (oABR) as a 
readout we found low thresholds for radiant flux and energy (< 0.5 mW, < 0.5 µJ) as well as 
duration (<100 µs) and a wide dynamic range of coding (more than 10 dB (mW), no saturation 
for most animals at maximal stimulation). This brings the oCI closer to the currently used eCI 
stimulation parameters (0.2 µJ and 80 µs per pulse) (Zierhofer et al., 1995) and exceeds the eCI 
output dynamic range (< 10 dB) (Zeng et al., 2008). Both, recordings of oABR and of firing in 
single putative SGNs indicated that f-Chrimson mediated oCI-enabled responses to follow at 
least 200 Hz, which corresponds to physiological steady-state firing rates of SGNs (Liberman, 
1978). In fact, we found that some neurons follow stimulation to several hundreds of Hz, nearly 
mimicking sound-evoked SGN activity. The closing kinetics of f-Chrimson and the resulting 
relative refractoriness probably also limits the temporal precision of f-Chrimson-mediated SGN 
firing. At 500 and 1000 Hz, vector strength, a measure commonly used to analyze the extent of 
phase-locking in SGNs (Köppl, 1997), was lower for f-Chrimson-mediated optogenetic 
stimulation than for mouse SGN firing with transposed tones (Buran et al., 2010). We note that 
the SGNs recorded in the present study typically did not fire spontaneously probably due to the 
ear surgery. Besides the lack of spontaneous firing, the short (1 ms) and pulsatile optogenetic 
stimulation typically evoking a single spike likely explain why vector strength tended to be 
higher for low stimulus rates when compared to transposed tones, for which several spikes were 
generated per stimulus cycle. Moreover, vector strength and temporal jitter of f-Chrimson-
mediated SGN firing in mice indicate a lower temporal precision than that of acoustic hearing 
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and electric stimulation in species with prominent phase-locking of SGN firing (Köppl, 1997; 
Miller et al., 2008). Nonetheless, we reason that, even if the limited probability and temporal 
precision of single SGN firing for optogenetic stimulation at 100-500 Hz translates to species 
other than the mouse, this will not impede the coding at the level of the auditory nerve 
population. Hence, we conclude that f-Chrimson is a good candidate opsin for the oCI. In fact, 
higher temporal jitter in response to optogenetic than electrical stimulation might render 
unnecessary the very high stimulation rates employed in eCI to avoid overly synchronized 
activity in the auditory nerve (Zeng et al., 2008). The favorable properties of the novel Chrimson 
mutants also facilitate multiple applications in basic neurosciences and in sensory restoration, 
such as the recovery of vision (Sahel and Roska, 2013). 
 
4.5 Methods 
Molecular biology  
The humanized DNA sequence coding for the red light activated ChR Chrimson from 
Chlamydomonas noctigama (accession number: KF992060), either C-terminally fused to EYFP 
or without a fluorescent tag, was cloned into the mammalian expression vector pcDNA3.1(-) 
(Invitrogen, Carlsbad, USA). The mutations L174C, K176R (ChrimsonR), Y261F, S267M and 
Y268F as well as combinations of aforementioned mutations (Table 4.1) were created by site-
directed mutagenesis. Chrimson-EYFP wt and Chrimson-EYFP Y261F/S267M (f-Chrimson-
EYFP) were subcloned into the Xenopus laevis oocyte expression vector pTLN (Lorenz et al., 
1996). 
We also cloned the humanized DNA sequences coding for ChR2 (C-terminally truncated variant 
Chop2-315 of ChR2 from Chlamydomonas reinhardtii, accession number: AF461397), for 
Volvox ChR1 (VChR1, accession number: EU622855) and for the chimera ReaChR 
(ChR1/VChR1/VChR2, Red-activatable ChR, accession number: KF448069) into the 
mammalian expression vector pcDNA3.1 (-) (Invitrogen, Carlsbad, USA). Thereby ChR2 and 
VChR1 were C-terminally fused to EYFP and ReaChR was C-terminally fused to citrine. The 
mutants ChR2-EYFP F219Y, VChR1-EYFP F214Y, VChR1-EYFP L127C, ReaChR-Citrine 
F259Y and ReaChR-Citrine L172C were created by site-directed mutagenesis. The related 
primer sequences are shown in Supplementary Tables 5 and 6. 
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NG108-15 cell culture and transfection  
NG108-15 cells (ATCC, HB-12377TM, Manassas, USA) were cultured at 37°C and 5% CO2 in 
DMEM (Sigma, St. Louis, USA) supplemented with 10% fetal calf serum (Sigma, St. Louis, 
USA), and 5 % penicillin/streptomycin (Sigma, St. Louis, USA). One day prior to transient 
transfections the NG108-15 cells were seeded on 24-well plates. Two to three days prior to their 
electrophysiological characterization by patch-clamp experiments the NG108-15 cells were 
transiently transfected with pcDNA3.1(-) derivatives carrying aforementioned ChRs and ChR 
mutants using Lipofectamine 2000 (Invitrogen, Carlsbad, USA) or Lipofectamine LTX 
(Invitrogen, Carlsbad, USA).  Cells were tested for mycoplasma contamination using specific 
primers. No method of cell line authentication was used. 
 
Expression of Chrimson variants in Xenopus laevis oocytes  
Xenopus laevis oocytes were injected with 50 ng of in vitro-transcribed cRNA (Thermo Fisher 
Scientific, Waltham, USA), coding for Chrimson-EYFP wt and Chrimson-EYFP 
Y261F/S267M (f-Chrimson-EYFP). After cRNA injection the Xenopus laevis oocytes were 
incubated at 16°C in an 1 µM all-trans retinal containing Barth’s solution (88 mM NaCl, 1 mM 
KCl, 0.33 mM Ca(NO3)2, 0.41 CaCl2, 0.82 MgSO4, 2.4 mM NaHCO3, 10 mM HEPES, pH 7.4 
supplemented with 50 mg/l gentamycin, 67 mg/l penicillin and 100 mg/l streptomycin) for 4-5 
days. 
 
Electrophysiological recordings on Xenopus laevis oocytes  
The Xenopus laevis oocytes heterologously expressing the Chrimson mutants were investigated 
by the two electrode voltage-clamp techniques (Nagel et al., 1995, 2003). Photocurrents were 
measured in response to 500 ms light pulses with a wavelength of λ =590 nm using the LED 
OEM module (Omikron, Rodgau-Dudenhofen, Germany) focused into a 2 mm optical fiber.  
In order to assess the permeability of potassium ions relative to the permeability of sodium ions 
(PK/PNa), we measured photocurrents at voltages ranging from -120 mV to +40 mV in 20 mV 
steps. The PK/PNa ratio was determined from the difference of the reversal potentials of the 
photocurrents when replacing 90 mM NaCl, 2 mM MgCl2, 5 mM MOPS/TRIS pH 9 for 90 mM 
KCl, 2 mM MgCl2, 5 mM MOPS/TRIS pH 9 (Nagel et al., 2003). The relative proton 
permeability was calculated from the photocurrent reversal potential in buffer containing 90 
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mM NMG, 5 mM KCl, 2 mM MgCl2, 5 mM MOPS/TRIS pH 9 using the Goldmann-Hodgkin-
Katz equation (Hille, 2001) and assuming a cytoplasmic potassium concentration of 100 mM 
and an intracellular pH of 7.3 (Nagel et al., 2003). 
 
Electrophysiological recordings on NG108-15 cells  
For the electrophysiological characterization of mutant channelrhodopsins whole cell patch-
clamp were performed under voltage clamp conditions (Sakmann and Neher, 1995) using the 
Axopatch 200B amplifier (Axon Instruments, Union City, USA) and the DigiData 1322A 
interface (Axon Instruments, Union City, USA).  Patch pipettes with resistances of 2-5 MΩ 
were fabricated from thin-walled borosilicate glass on a horizontal puller (Model P-1000, Sutter 
Instruments, Novato, USA).  The series resistance was <10 MΩ and the input resistance ranged 
from 1.1 GΩ to 4.6 GΩ. The mean capacitance of the measured cells was 34.6 ± 24.3 pF (n = 
61). If not stated differently the pipette solution contained 110 mM NaCl, 2 mM MgCl2, 10 mM 
EGTA, 10 mM HEPES, pH 7.4 and the bath solution contained 140 mM NaCl, 2 mM CaCl2, 2 
mM MgCl2, 10 mM HEPES, pH 7.4. 
In order to assess the permeability of calcium ions relative to the permeability of sodium ions 
(PCa/PNa), we measured photocurrent-voltage relationships and determined the reversal 
potential. The intracellular solution contained 110 mM NaCl, 10 mM EGTA, 2 mM MgCl2 and 
10 mM Tris (pH = 7.4) and the extracellular solution contained 140 mM NaCl, 2 mM MgCl2 
and 10 mM Tris (pH = 9). For the determination of the PCa/PNa values, external 140 mM NaCl 
was exchanged with 90 mM CaCl2. Permeability ratios were calculated according to the 
Goldman-Hodgkin-Katz equation (Hille, 2001).  
For determination and comparison of the off-kinetics and current densities, NG108-15 cells 
heterologously expressing aforementioned ChRs and ChR mutants were investigated at a 
membrane potential of -60 mV. Photocurrents were measured in response to 3 ms or 500 ms 
light pulses with a saturating intensity of 23 mW/mm2 using diode-pumped solid-state lasers (λ 
= 473 nm for ChR2 variants, λ=532 nm for VChR1 and ReaChR variants, λ=594 nm for 
Chrimson variants) focused into a 400-μm optical fiber. Light pulses were applied by a fast 
computer-controlled shutter (Uniblitz LS6ZM2, Vincent Associates, Rochester, USA).  
The current density (J-60 mV) was determined by dividing the stationary current in response to a 
500 ms light pulse with a saturating intensity of 23 mW/mm2 by the capacitance of the cell. In 
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order to avoid an experimental bias, the NG108-15 cells for the electrophysiological recordings 
were chosen independent of the brightness of their EYFP fluorescence. The τoff value was 
determined by a fit of the decaying photocurrent to a monoexponential function. In order to 
investigate the dependence of the off-kinetics on the membrane potential, τoff values were 
determined at membrane potentials ranging from -120 mV to +60 mV.  
If not stated differently the off-kinetics was determined at room temperature (297 K). The 
temperature dependence of the off-kinetics of Chrimson-EYFP wt and Chrimson-EYFP 
K176R/Y261F/S267M (vf-Chrimson-EYFP) were investigated at temperatures ranging from 
284 K to 307 K. Photocurrents recorded at a temperature of 307 K were measured in response 
to 7 ns light-pulses with a wavelength of 594 nm in order to avoid tampering of the off-kinetics 
due to the opening/closing time of the shutter (700 µs). The ns light pulses were generated with 
the Opolette 355 tunable laser system (Opotek Inc, Carlsbad, USA). Thereby the pulse energy 
was set to 1019 photons/m2. 
The Opolette 355 tunable laser system was further used for the measurement of the action 
spectra of the Chrimson variants. For the recordings, the pulse energies at the different 
wavelengths were set to values which corresponded to equal photon counts of 1018 photons/m2 
for Chrimson wt and 1019 photons/m2 for the Chrimson mutants.  
 
Hippocampal neuron culture  
Hippocampi were isolated from Sprague-Dawley rats at P1 and treated with papain (20 U ml-1) 
for 20 min at 37˚C (by the lab of Dr. Erin Schuman, MPI of Brain Research, Frankfurt). The 
hippocampi were washed with DMEM high glucose (Sigma-Aldrich, St. Louis, USA) 
supplemented with 10% fetal bovine serum and titrated in a small volume of this solution. 
Approximately 96000 cells were plated on poly-D-lysine/laminin coated glass coverslips in 24-
well plates. After 3 h, the plating medium was replaced by culture medium containing 
Neurobasal A (Thermo Fisher Scientific, Waltham, USA) supplemented with 2% B-27 
supplement (Thermo Fisher Scientific, Waltham, USA), and 2 mM Glutamax (Thermo Fisher 




Adeno-associated virus (AAV2/1) transduction  
rAAV2/1 virus was prepared by the lab of Botond Roska (FMI, Basel, Switzerland) using a 
pAAV2 vector with a human synapsin promoter (Lin et al., 2013) containing Chrimson, 
Chrimson-EYFP, Chrimson K176R, Chrimson-EYFP K176R, Chrimson Y261F/S267M (f-
Chrimson), Chrimson-EYFP Y261F/S267M (f-Chrimson-EYFP), Chrimson 
K176R/Y261F/S267M (vf-Chrimson) and Chrimson-EYFP K176R/Y261F/S267M (vf-
Chrimson-EYFP). The virus titer was nominally 1 × 1012 – 1 × 1013 genome copies/ml (GC/ml). 
Briefly, 1 × 109 GC/ml of rAAV2/1 were added to each well 4-9 days after plating hippocampal 
neurons. Expression became visible 5 days post-transduction. The electrophysiological 
measurements were performed 13-21 days after transduction. No neurotoxicity was observed 
for the lifetime of the culture (~5 weeks). No all-trans retinal was added to the culture medium 
or recording medium for any of the experiments described here.  
 
Electrophysiological recordings on hippocampal neurons  
For whole-cell recordings in cultured hippocampal neurons, patch pipettes with resistances of 
3-8 MΩ were filled with 129 mM potassium gluconate, 10 mM HEPES, 10 mM KCl, 4 mM 
MgATP and 0.3 mM Na3GTP, titrated to pH 7.2. Tyrode’s solution was used as the extracellular 
solution (125 mM NaCl, 2 mM KCl, 2 mM CaCl2, 1 mM MgCl2, 30 mM glucose and 25 mM 
HEPES, titrated to pH 7.4). The series resistance was <10 MΩ and the input resistance ranged 
from 0.7 GΩ to 3.5 G Ω. The mean capacitance of the measured cells was 35.4 ± 12.4 pF (n = 
31). In order to avoid an experimental bias in cell selection, the neurons for the 
electrophysiological recordings were selected independent of the brightness of their EYFP 
fluorescence. Recordings were conducted in the presence of the excitatory synaptic transmission 
blockers 1,2,3,4-tetrahydro-6-nitro-2,3-dioxo-benzo[f]quinoxaline-7-sulfonamide (NBQX, 10 
μM, Sigma-Aldrich, St. Louis, USA) and D(−)-2-Amino-5-phosphonopentanoic acid (AP-5, 50 
μM, Sigma-Aldrich, St. Louis, USA). For determination of τoff and J-70mV measurements were 
conducted in the presence of 1 µM TTX (Sigma-Aldrich, St. Louis, USA) in addition. 
Electrophysiological signals were amplified using an Axopatch 200B amplifier (Axon 
Instruments, Union City, USA), filtered at 10 kHz, digitized with an Axon Digidata 1322A (50 
kHz) and acquired and analyzed using pClamp9 software (Axon Instruments, Union City, USA).  
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The light pulses had a pulse width of 3 ms, a wavelength of λ = 594 nm and a saturating intensity 
of 11–30 mW/mm2. The τoff value was determined by a fit of the decaying photocurrent to a 
monoexponential function. The current density (J-70 mV) was determined by dividing the 
stationary current in response to a 500 ms light pulse with a saturating intensity of 20-40 
mW/mm2 and a wavelength of 594 nm by the capacitance of the cell. In order to determine the 
lowest light intensity required to induce action potentials with a probability of 100 % (J100), 40 
pulses (λ = 594 nm, pulse width = 3 ms, ν = 10 Hz) of varying light intensities were applied. 
The spike probability was calculated by dividing the number of light-triggered spikes by the 
total number of light pulses. 
 
Animals for recordings on parvalbumin-positive interneurons  
Experimental mice were obtained from a cross of PV-IRES-Cre (Hippenmeyer et al., 2005) and 
conditional tdTomato male and female Ai9 animals at 4-12 weeks of age (Madisen et al., 2010). 
Mice were maintained in a 12 h light/dark cycle, with access to food and water ad libitum. All 
animal procedures were performed in accordance with institutional guidelines and were 
approved by the Regierungspräsidium Darmstadt. 
 
Intracerebroventricular injections (ICVs)  
Prior to pup injections (Glascock et al., 2011), the dam was habituated to the experimenter and 
the experimental room. Newborn mice (P2) were anesthetized using isoflurane (2-3%), and 
placed on a light source to reveal skull structures. Injections of 2 µl of AAV2/1-hSyn-vf-
Chrimson-EYFP were performed into the right ventricle using a glass pipette (coordinates from 
bregma; rostral 0.75 mm, lateral 0.25 mm and ventral 2 mm). After injection pups were 
recovered for 5 min in a pre-warmed container with homecage-bedding before being placed 
back in the home cage.  
 
Patch-clamp recordings on parvalbumin-positive interneurons  
Coronal brain slices were prepared from 2-6 week-old PV-tdTomato mice that had been injected 
with 2 µl of AAV2/1-hSyn-vf-Chrimson-EYFP at P2. Animals were anesthetized with 
isoflurane (3% in oxygen), decapitated and the brain was dissected in ice-cold artificial 
cerebrospinal fluid (ACSF, containing in mM: 125 NaCl, 3 KCl, 2 CaCl2, 1 MgCl2, 26 NaHCO3, 
Chapter 4 
81 
10 glucose), and sliced (thickness: 325 μm) on a vibrating microtom (VT1200S; Wetzlar, 
Germany) at 4ºC. Slices were recovered for 60 min at room temperature in a submersion 
chamber containing ACSF equilibrated with 95% O2/5% CO2. Slices were next transferred to 
the submersion chamber of an upright microscope (Scientifica), and continuously superfused 
with ACSF additionally containing 1 μM DNQX, 40 μM AP5 and 1 μM bicuculline at 33ºC. 
Parvalbumin-positive interneurons were identified in layer 2/3 of neocortex with a combination 
of infrared and fluorescence video microscopy under a 40x objective (Olympus). Patch-clamp 
electrodes (8-12 MΩ) were pulled from borosilicate glass and filled with an intracellular 
solution consisting of (in mM): 140 potassium-gluconate, 10 HEPES, 4 phosphocreatineNa2, 4 
Mg-ATP, 0.4 Na-GTP, 10 KCl (pH adjusted to 7.25 with KOH, ~ 280 - 300mOsm). Data were 
acquired with a Multiclamp700B amplifier and pClamp 10.5 software (Axon Instruments). 
Optogenetically-evoked action potentials were recorded in parvalbumin-positive interneurons 
in loose-seal cell-attached (n = 4) or whole-cell current-clamp mode (n = 3). In addition, another 
five parvalbumin-positive interneurons were recorded for the input-output curves presented in 
Fig. 4.3B. Data were filtered at 20 kHz and sampled at 50 kHz. Spiking patterns were assessed 
with depolarizing current steps in 8 whole-cell recordings, and displayed the fast-spiking 
phenotype expected for PV-interneurons (n = 8, maximal firing frequency 301 ± 29 Hz). Optical 
stimulation was performed through the objective by an LED (coolLED) coupled to the 
microscope. Pulse width was 0.25–1 ms, irradiance ranged from 1–10 mW/mm2, and was 
adjusted individually for every neuron to cause reliable firing (Figure 4.3C: 50 Hz, pulsewidth 
= 0.5 ms, light-density = 2.6 mW/mm2; 100 Hz, pulsewidth = 0.5 ms, light-density = 2.6 
mW/mm2; 150 Hz, pulsewidth = 0.5 ms, light-density = 4.9 mW/mm2; 200 Hz, pulsewidth = 
0.5 ms, light-density = 4.9 mW/mm2; 250 Hz, pulsewidth = 0.5 ms, light-density = 4.9 
mW/mm2; 300 Hz, pulsewidth = 0.5 ms, light-density = 4.9 mW/mm2; 400 Hz, pulsewidth = 
0.5 ms, light-density = 4.9 mW/mm2; 500 Hz, pulsewidth = 0.5 ms, light-density = 8 mW/mm2). 
Data were analyzed using Clampfit and Excel software. For calculation of latency and jitter, the 
time of action potential peak was used. We note that the apparent action potential threshold 
defined as the voltage at which the first temporal derivative crosses a threshold of 40 V/s is more 
hyperpolarized for optogentically evoked action potentials (-57.00 ± 1.85 mV) compared to 
action potentials during DC current injections (-43.19 ± 2.97 mV, p < 0.001, unpaired, two-
tailed t-test). Statistics were done using the non-parametric Friedmann test followed by the post-
hoc Dunn’s test (Prism, GraphPad Sofware Inc., La Jolla, USA). 
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Cloning for AAV2/6 production  
pcDNA3.1(-)_f-Chrimson_EYFP was used as a starting material for cloning pAAV_hSyn_f-
Chrimson_EYFP. The sequence of f-Chrimson_EYFP was amplified by means of a classical 
PCR. The resulting PCR fragment was then digested with BamHI/HindIII (Thermo Scientific, 
MA, USA), gel extracted (GeneJET Gel Extraction Kit, Thermo Scientific, MA, USA) and 
further used for ligation. At the same time the plasmid pAAV_hSyn_Chronos_GFP (Addgene, 
plasmid nr. 59170) was also digested using restriction enzymes BamHI/HindIII and used as a 
backbone plasmid. All obtained ligation products were further tested by means of colony PCR 
and finally sequenced by an external company. The final product was then sent to the University 
of North Carolina Vector Core (Chapel Hill, NC, USA), and used to produce AAV2/6.  
 
Postnatal AAV injection into the cochlea  
All experiments were done in compliance with the German national animal care guidelines and 
were approved by the board for animal welfare of the University Medical Center Göttingen and 
the animal welfare office of the state of Lower Saxony. The calculation of animal number was 
performed prior to starting experiments. We planned to use the Wilcoxon Rank Sum Test and 
an error probability alpha smaller than 0.05, a power (1-beta) of 0.95 and effect size depending 
on the precise experimental protocol. 
Postnatal AAV-injection into scala tympani of the left ear via the round window (Akil et al., 
2012) was performed at P3-P6 on C57BL/6 wild-type mice, using AAV2/6 and the human 
synapsin promoter to drive transgenic expression of f-Chrimson-EYFP in SGNs. In brief, under 
general isoflurane anaesthesia and local analgesia achieved by means of xylocaine, the left ear 
was approached via a dorsal incision and the round window membrane was identified and gently 
punctured using a borosilicate capillary pipette that was kept in place to inject approximately 5 
x 109 viral genomes. After virus application, the tissue above the injection site was repositioned, 
the wound was sutured and buprenorphine (0.1 mg/kg) was applied as pain reliever. Recovery 
of the animals was then daily tracked. Mice were randomly selected for injection in all 
experiments. No blinding was possible since injections had to be performed in the left ear 
leaving the right ear as an internal control. Hence, surgery prior to stimulation needed to be done 
in the injected ear. Animals were then kept in a 12 h light/dark cycle, with access to food and 
water ad libitum.  
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Immunostaining and imaging of cochlear cryosections  
Cochleae were fixed with 4% paraformaldehyde in phosphate buffered saline for 1 h. Cochleae 
were then cryosectioned following 0.12 M EDTA decalcification. After incubation of sections 
for 1 h in goat serum dilution buffer (16% normal goat serum, 450 mM NaCl, 0.6% Triton X-
100, 20 mM phosphate buffer, pH 7.4), primary antibodies were applied for 1 h at room 
temperature. The following antibodies were used: chicken anti-GFP (catalog number: ab13970, 
dilution 1:500) (Abcam, Cambridge, United Kingdom), guinea pig anti-parvalbumin (catalog 
number: 195004, dilution 1:300) (Synaptic Systems, Göttingen, Germany). The following 
secondary AlexaFluor-labeled antibodies were applied for 1 h at room temperature: goat anti-
chicken 488 IgG (H+L), catalog number: A-11039, dilution 1:200 (Thermo Scientific, MA, 
USA); goat-anti guinea pig 568 IgG (H+L), catalog number A1107, dilution 1:200 (Thermo 
Scientific, MA, USA).  
Confocal images were collected using a SP5 microscope (Leica, Hamburg, Germany) and 
processed in ImageJ (NIH, Bethesda, MD, USA). Expression was considered positive when 
EYFP fluorescence in a given cell (marked by parvalbumin) was found to be higher than 3 s.d. 
above the background fluorescence of the tissue. 
 
Animal surgery for recordings on the auditory pathway  
Mice were anesthetized with intraperitoneal administration of a mixture of xylazine (5 mg/kg) 
and urethane (1.32 mg/kg) while analgesia was achieved with buprenorphine. The core 
temperature was maintained constant at 37°C using a custom-designed heat plate on a vibration 
isolation table in a sound-proof chamber (IAC GmbH, Niederkrüchten, Germany). For auditory 
nerve recordings, a tracheostomy was performed before the animals were positioned in a 
custom-designed stereotactic head holder. Pinnae were removed, scalp reflected, portions of the 
lateral interparietal and of the left occipital bone removed, and a partial cerebellar aspiration 
performed to expose the surface of the cochlear nucleus.  
 
Optical stimulation in vivo  
The left bulla was reached using a retroauricular approach and opened to expose the cochlea. A 
50 µm optical fiber coupled to a 594-nm laser (OBIS LS OPSL, 100 mW, Coherent Inc., Santa 
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Clara, CA, USA) was inserted into the cochlea via the round window. Radiant flux was 
calibrated with a laser power meter (LaserCheck; Coherent Inc., Santa Clara, CA, USA). 
SGN culture and patch-clamp recordings  
On P12-14, SGNs of injected mice were isolated, cultured and patch-clamped (Smith et al., 
2015). In brief, we patch-clamped EYFP-positive SGNs using an EPC-10 amplifier controlled 
by Patchmaster software (HEKA electronics, Lambrecht, Germany) and employing potassium-
gluconate based intracellular solution (in mM: 130 K-gluconate, 5 KCl, 1 EGTA, 2 MgATP, 2 
Na2ATP, 0.3 MgGTP, 10 KOH-HEPES, 10 Na2Phosphocreatinine) and an extracellular solution 
containing (in mM: 145 NaCl, 4 KCl, 1 MgCl2, 1.3 CaCl, 10 NaOH-HEPES. A 594-nm laser 
(OBIS LS OPSL, 100 mW, Coherent Inc., Santa Clara, CA, USA) was coupled into a Nikon 
Eclipse inverted microscope and radiant flux was calibrated using a powermeter. 
 
Auditory brainstem responses 
 For stimulus generation and presentation, data acquisition, and off-line analysis, we used a NI 
System (National Instruments, Austin, TX, USA) and custom-written MATLAB software (The 
MathWorks, Inc., Natick, MA, USA). Optically-evoked ABRs (oABRs) and acoustically-
evoked ABRs (aABRs) were recorded by needle electrodes underneath the pinna, on the vertex, 
and on the back near the legs. The difference potential between vertex and mastoid subdermal 
needles was amplified using a custom-designed amplifier, sampled at a rate of 50 kHz for 20 
ms, filtered (300–3000 Hz) and averaged across 1000 and 500 presentations (for oABRs and 
aABRs, respectively). Thresholds were determined by visual inspection as the minimum sound 
or light intensity that elicited a reproducible response waveform in the recorded traces. 
 
Juxtacellular recordings from single putative SGNs  
For auditory nerve recordings (Hernandez et al., 2014b), a glass microelectrode (~25 MΩ) was 
advanced through the posterior end of the anteroventral cochlear nucleus, aiming toward the 
internal auditory canal using an Inchworm micropositioner (EXFO Burleigh). Extracellular 
action potentials were amplified using an ELC-03XS amplifier (NPI Electronic, Tamm, 
Germany), filtered (band pass, 300–3000 Hz), and digitized (TDT System 3) using custom-
written Matlab (Mathworks) software. Data were further analyzed and prepared for display off-
line using custom-written Python (Python software foundation, Delaware, USA) and Matlab 
Chapter 4 
85 
software. Once light-responsive fibers were encountered, stimulation was performed by means 
of 400 or 900 ms-long light-pulse trains at varying stimulation rates, leaving 100 ms inter-train 
recovery over 20 repetitions. Responses within the first 400 ms were then used for analysis. 
Only recordings for which the fibers generate at least 5 spikes per light-pulse train (on average 
across the 20 iterations recorded for each frequency tested on each fiber) were included. Phase-
locking was quantified using the vector strength (Goldberg and Brown, 1969) and its 
significance tested with the Rayleigh test. If L > 13.8, the null hypothesis was rejected at the 
0.001 significance level (Hillery and Narins, 1987): insignificant VS were set to 0. The temporal 
jitter, defined as the standard deviation of spike latency across trials, was calculated using a time 
window equal to the stimulation period. The hazard function of the temporal jitter was evaluated 
for each stimulation rate by simulating Poisson spike trains at discharge rates from 10 to 300 
spikes/s. The spike probability is the ratio between the number of spikes and the number of 
light-pulses.  
 
Data analysis  
The data were analyzed using Matlab (The MathWorks, Inc., Natick, MA, USA), Excel, Igor 
Pro 6 (Wavemetrics, Portland, OR, USA), Origin 9.0 (OriginLab, Inc., Northampton, MA, 
USA), and GraphPad Prism (GraphPad Software, La Jolla, CA, USA). Averages were expressed 
as mean ± s.e.m. or mean ± s.d., as specified. References to data in the main text were expressed 
as mean ± s.e.m. For statistical comparison between two groups, data sets were tested for normal 
distribution (using the D’Agostino & Pearson omnibus normality test or the Shapiro-Wilk test) 
and equality of variances (F-test) followed by two-tailed unpaired Student’s t-test, or the 
unpaired two-tailed Mann-Whitney U test when data were not normally distributed and/or 
variance was unequal between samples.  
For evaluation of multiple groups, statistical significance was calculated by using one-way 
ANOVA test followed by Tukey’s test for normally distributed data (equality of variances tested 
with the Brown-Forsythe test) or one-way Kruskal-Wallis test followed by Dunn’s test for non-





The data that support the findings of this study and code used for analysis are available from the 
corresponding author upon reasonable request.  
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Supplementary Figure 1. Action spectra of Chrimson and Chrimson mutants. Shown are 
normalized peak currents in response to ns light-pulses of indicated wavelength. The 
electrophysiological recordings were performed in NG cells by patch-clamp experiments in the 
whole-cell configuration at a membrane potential of -60 mV.  (a) Action spectra of Chrimson-
EYFP ( , n=6), Chrimson-EYFP S267M/Y268F ( , n=3), Chrimson-EYFP S267M (
, n=3), Chrimson-EYFP Y261F ( , n=4), Chrimson-EYFP Y268F ( , n=5), 
Chrimson-EYFP K176R/Y261F/S267M (vf-Chrimson-EYFP) ( , n=4) and Chrimson-
EYFP Y261F/S267M (f-Chrimson-EYFP) ( , n=4). (b) Action spectra of Chrimson 
Y261F/S267M (f-Chrimson) ( , n=3) and Chrimson-EYFP Y261F/S267M (f-Chrimson-
EYFP) ( , n=4). The pulse energies at the different wavelengths were set to equal photon 







Supplementary Figure 2. Current (I) - voltage (V) curves of Chrimson and Chrimson mutants. 
Shown are typical IV curves of Chrimon-EYFP wt, Chrimson-EYFP Y261F/S267M (f-
Chrimson-EYFP), Chrimson-EYFP K176R/Y261F/S267M (vf-Chrimson-EYFP) and 
Chrimson-EYFP K176R recorded in NG cells. Whole-cell patch-clamp experiments were 
performed under voltage-clamp conditions. The photocurrents were measured in response to 3 
ms light-pulses with a wavelength of 594 nm and a saturating light intensity of 23 mW/mm2. 




























Supplementary Figure 3. Off-kinetics of Chrimson and Chrimson mutants at different 
membrane potentials. Whole-cell patch-clamp experiments were performed under voltage-
clamp conditions. Photocurrents were measured in response to 3 ms light pulses with a 
saturating intensity of 23 mW/mm2 and a wavelength of 594 nm. Shown is the average τoff for 
Chrimson-EYFP ( , n=3), Chrimson-EYFP K176R ( , n=4), Chrimson-EYFP Y261F/S267M 
(f-Chrimson-EYFP) ( , n=3) and Chrimson-EYFP K176R/Y261F/S267M (vf-Chrimson-
EYFP) ( , n=3). The error bars represent the standard deviation. The τoff values were determined 





Supplementary Figure 4. Peak current inactivation and recovery of Chrimson and Chrimson 
mutants. Typical photocurrents in response to a double illumination protocol using 500 ms light 
pulses with a saturating intensity of 23 mW/mm2 and a wavelength of 594 nm. The 
photocurrents of Chrimson-EYFP (a,d,g), Chrimson-EYFP Y261F/S267M (f-Chrimson-EYFP) 
(b,e,h) and Chrimson-EYFP K176R/Y261F/S267M (vf-Chrimson-EYFP) (c,f,i) were measured 
by patch-clamp experiments in the whole-cell configuration at a membrane potential of -60 mV. 
The double illumination protocol was repeated after a waiting time of 40 s (d,e,f) and 5 min 















Supplementary Figure 5. Temperature dependence of the off-kinetics of Chrimson and 
Chrimson K176R/Y261F/S267M (vf-Chrimson). (a) Shown are the average τoff values (n=3-7) 
and the corresponding standard deviations. NG cells transiently expressing Chrimson-EYFP and 
Chrimson-EYFP K176R/Y261F/S267M were investigated by patch-clamp measurements in the 
whole-cell configuration at a membrane potential of -60 mV. All photocurrents, but the 
photocurrents recorded at 34°C, were measured in response to 3 ms light pulses with an intensity 
of 23 mW/mm2 and a wavelength of 594 nm. The photocurrents recorded at a temperature of 
34°C were measured in response to light-pulses with a pulse length of 7 ns and a wavelength of 
594 nm, which were generated with the Opolette 355 tunable laser system (Opotek Inc). Thereby 
the pulse energy was set to value of 1019 photons/m2. The τoff values were determined by a fit of 
the decaying photocurrents to a monoexponential function. (b) Arrhenius plot of the data shown 
in A. The lines indicate activation energies of 69.6 kJ/mol for Chrimson and 48.5 kJ/mol for 














Supplementary Figure 6. Light intensity dependence of Chrimson and Chrimson mutants. 
Chrimson-EYFP (a,b), f-Chrimson-EYFP (c,d) and vf-Chrimson-EYFP (e,f) were investigated 
in NG108-15 cells by patch-clamp experiments in the whole-cell configuration at a membrane 
potential of -60 mV. The photocurrents were measured in response to 500 ms light-pulses of 
indicated light intensities (λ=594 nm). The graphs show average values from normed stationary 
photocurrents (n=3) and the corresponding standard deviations. The solid line is a fit to the data 
using a hyperbolic model function with a half-saturating value EC50 and a fixed vmax=1. The 






Supplementary Figure 7. Red light triggered spiking in rat hippocampal neurons. Rat 
hippocampal neurons heterologously expressing f-Chrimson-EYFP (a) and vf-Chrimson-EYFP 
(b) were investigated by patch-clamp experiments in the whole-cell configuration under current-
clamp conditions. The action potentials were triggered by 40 light-pulses (ν = 10 Hz) with a 























Supplementary Figure 8. Fidelity and temporal precision of light triggered spiking in 
parvalbumin-positive interneurons heterologously expressing vf-Chrimson-EYFP. (a) Example 
IR-DIC and fluorescent image of a recorded neocortical parvalbumin-positive interneuron 
identified by red fluorescence in an acute slice. (b) Action potential frequency as a function of 
stimulation frequency. Most neurons followed optical stimulation faithfully with 1 action 
potential/light pulse up to a maximum, and then plateaued off (top, n = 5). In 2 interneurons, 
single light pulses could also elicit action potential doublets (bottom, n = 2). We note that 
optimization of expression time and stimulation light density is expected to minimize this 
caveat. Insets: example traces of cells shown in blue and red at 100 Hz stimulation frequency. 
(c) Upper panel: action potential latency (assessed at peak) after light pulse onset for all 
stimulation frequencies with reliable spiking (> 85%). (non-parametric Friedman test with a 
post hoc Dunn’s multiple comparison test revealed the following significant differences: 50Hz 
vs 250Hz, ***; 50Hz vs 300Hz, ***; 100Hz vs 250Hz, ***; 100Hz vs 300Hz *; 150Hz vs 
250Hz, ***; 150Hz vs 300Hz, **; 200Hz vs 250Hz, ***.) Lower panel: action potential jitter 
(s.d. of latencies) for the different stimulation frequencies (average of 20 spikes/trace and 10 
traces). (non-parametric Friedman test with post hoc Dunn’s multiple comparison test revealed 
the following significant differences: 50Hz vs 200Hz, ***; 50Hz vs 300Hz, ***; 100Hz vs 
250Hz, ***; 150Hz vs 200Hz, *; 150Hz vs 300Hz, ***; 200Hz vs 250Hz, ***; 250Hz vs 300Hz, 




Supplementary Figure 9. Precise optogenetic control of parvalbumin-positive interneurons 
depends on irradiance and stimulation frequency. Exemplary traces showing precise spiking at 
100 Hz stimulation frequency, but stimulation failures at 150 Hz for the same irradiance level 















Supplementary Figure 10.  f-Chrimson expression and function in SGNs in aged BL6/J mice. 
(a) Projections of confocal cryosections (scale bar: 50µm) with EYFP (green) and parvalbumin 
(magenta) immunofluorescence of SGNs in three cochlear regions. Insets (scale bar: 10µm) 
show close-up images of single z-sections of the same images. (b) Confocal z-sections (0.25 µm 
step) showing EYFP expression (green) in parvalbumin positive SGNs (magenta) from cochlear 
cryosections of the injected ear of the animal shown in a. Scale bar: 20 µm. (c) Fraction of 
EYFP-positive SGNs (identified by parvalbumin immunofluorescence, parvalbumin+) and (d) 
density of parvalbumin+ SGNs (#cells per 104 µm2) obtained from data as in Fig. 4.4F for apex, 
mid-cochlea (Mid) and base of the cochlea. Symbols mark results from individual animals (also 
for e-j, n = 5) and box plots show 10th, 25th, 50th, 75th and 90th percentiles of the injected (orange) 
and control (magenta) cochleae (one-way ANOVA, p = 0.1646; F2,12 = 2.1; post-hoc Tukey’s 
test for comparison of expression, P >  0.05 for all pairwise comparisons; t-test for comparison 
of density, Lapex vs Rapex, Lmid vs Rmid, Lbase vs Rbase p > 0.05 for all comparisons). (e-g) 
Normalized P1-N1-amplitude as a function of laser intensity (e, 1 ms at 20 Hz), pulse duration 
(f, 11 mW at 20 Hz), and stimulus rate (g, 11 mW, 1 ms). Group average (lines) and s.d. (error 
bars) are shown in orange (same for g-i). (h-j) P1-latency as a function of laser intensity (h, as 




Supplementary Figure 11. Latency and temporal jitter of f-Chrimson-mediated spiking in 
SGNs. (a) Spike latency to light pulse onset as a function of stimulus rate (1 ms pulses of 11 
mW over 400 or 900 ms stimulation, leaving 100 ms of inter-train recovery, only first 400 ms 
were analyzed here). Mean estimates were obtained for trials containing in average 5 spikes or 
more for each neuron. (b) Spike latency considering three time-windows from light pulse-train 
onset. (c) Same analysis as in (b) for temporal jitter of spikes, showing that this parameter tends 
to increase at later time windows along the train, which reflects a decrease in temporal precision 
of spiking. Data points show mean ± s.e.m. (error bars). Number of units (from 5 mice) included 














Supplementary Table 1: Relative calcium permeabilities of channelrhodopsin variants. 
Shown are the average, relative calcium permeabilities (PCa/PNa, n=3-5) and the corresponding 
standard deviations. The values were determined in NG cells and HEK cells as described in the 
Methods section. a The relative calcium permeabilities were determined in HEK cells. b taken 
from (Kleinlogel et al., 2011). c The relative calcium permeabilities were determined in NG 
cells. d Determination of relative calcium permeability not possible due to strongly reduced 

















Supplementary Table 2: Current densities of Chrimson and Chrimson mutants 
Current densities (J-60mV) of Chrimson and Chrimson mutants. Shown are the average current 
densities (n=7-11) and the corresponding standard deviations. NG cells transiently expressing 
Chrimson-EYFP and Chrimson-EYFP mutants were investigated by patch-clamp measurements 
in the whole-cell configuration at a membrane potential of -60 mV. The J-60mV values were 
determined as described in the Methods section. # Significantly different current density 
compared to Chrimson  a) wt b) K176R c) S267M d) Y268F e) Y261F f) S267M/Y268F g) 
Y261F/S267M h) K176R/S267M/Y268F i) Y261F/S267M/Y268F j) K176R/Y261F/S267M k) 
K176R/Y261F/S267M/Y268F (ANOVA with Bonferroni post-hoc test: * p < 0.05 ** p < 0.01 
*** p < 0.001) § variants with higher current density (no significantly different current densities 
within the group) $ mutants with lower current density (no significantly different current 
densities within the group) §§  no significantly different current density compared to the high 
current density group and significantly different current density compared to all members of the 

















Chrimson variant J-60 mV [pA/pF] 
wt §    24.0 ± 6.8   # b*,d***, f*, h***, i***, j*, k***  
K176R $    10.1 ± 6.9   # a*, e***, g*** 
S267M §§    22.6 ± 13.3 # d***, h**, i***, j*, k*** 
Y268F $    3.5 ± 1.6     # a***, c***, e***, g*** 
Y261F §      33.3 ± 8.6   # b***, d***, f***, h***, i***, j***, k***  
S267M/Y268F $     10.8 ± 5.9   # a*, e***, g***  
Y261F/S267M §    34.2 ± 12.7 # b***, d***, f***, h***, i***, j***, k*** 
K176R/S267M/Y268F $    4.7 ± 2.7     # a***, c**, e***, g*** 
Y261F/S267M/Y268F $    6.0 ± 4.7     # a***, c***, e***, g*** 
K176R/Y261F/S267M $    8.3 ± 5.3     # a*, c*, e***, g*** 
K176R/Y261F/S267M/Y268F $    2.6 ± 0.9     # a***, c***, e***, g*** 
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Supplementary Table 3: Relative potassium and proton permeabilities of Chrimson 
variants. 
Shown are the average, relative potassium permeabilities (PK/PNa, n=5) and the average, relative 
proton permeabilities (PH/PNa, n=7) of Chrimson-EYFP and Chrimson-EYFP Y261F/S267M. 





Supplementary Table 4: Off kinetics (τoff), current density (J-70mV) and the lowest light 
intensity required to induce action potentials with a probability of 100 % (I100). 
Shown are the average τoff (n = 3-11), the average J-70mV (n = 10-14), the average I100 (n = 15) 
and the corresponding standard deviations. The τoff, J-70mV and I100 values were determined in rat 














5 Characterization of optogenetic responses to varying light 
intensity in f-Chrimson-expressing SGNs  
5.1 Introduction 
In the previous chapter, I characterized both temporal precision and fidelity aspects of firing 
upon optogenetic stimulation of SGNs expressing f-Chrimson, with a focus on increasing pulse 
rates. As stimulation rate, light intensity is another key stimulus feature in shaping the response 
patterns of ChR-transduced neurons. However, in chapter 4, neural responses to changes in 
stimulus level were only assessed at the population level by means of oABRs. 
As discussed in the general introduction, RLFs describe the relationship between spike rate and 
stimulus level. Hence, the dynamic range of individual fibers can be inferred from them. In 
response to acoustic stimulation, there seems to be an inverse correlation between both dynamic 
range and threshold on the one hand and SR on the other hand (Yates et al., 1990).  
In response to sound, SGNs code stimulus intensity using spike rate, meaning that as stimulus 
levels increase, spike rates also grow over a certain range. Single SGNs are able to encode 
changes in sound intensity of about 20-30 dB SPL as measured in response to pure tones (~2 
orders of magnitude in terms of signal amplitude) (Sachs and Abbas, 1974). However, at the 
systems level, the full spectrum of sound intensities that an organism is able to encode and 
perceive as different is much larger, spanning 6 orders of magnitude in humans (Hudspeth, 2014; 
Viemeister and Bacon, 1988). This discrepancy is known as the “dynamic range problem” 
(Evans, 1981). To achieve this, the auditory system, at least to some degree, makes use of the 
individual, much narrower input-output functions of its constituent elements, so that they are 
staggered along the full range of discernible intensities. This is applicable not only to SGNs but 
also to neurons at higher centers, as the auditory cortex (Watkins and Barbour, 2011). 
Furthermore, in natural hearing, increments in sound level correlate with the number of recruited 
SGNs (Furman et al., 2013). Thus, the combination of individual functions with different 
thresholds (Evans, 1972; Liberman, 1978) allows to count on a pool of SGNs capable to 
modulate their firing rate at a given intensity, for which other SGNs show a saturated rate while  
a third group displays baseline firing levels (Sachs and Abbas, 1974). Despite the fact that the 
vast majority of SGNs show saturated responses at high sound levels (> 80 dB) (Evans, 1972; 
Liberman, 1978), a minimal fraction of SGNs with unsaturated rates at high intensities 
 
102 
innervating each frequency region (probably 1-6 fibers suffice) could account for the ability to 
encode these loud sounds (Viemeister, 1983, 1988). However, data from fibers with such high 
thresholds are lacking. Therefore, this suggests that additional mechanisms contribute to the 
broad range of intensities that can be perceived, e.g. the dynamic range adaptation to the overall 
loudness at a certain time (Barbour, 2011; Wen et al., 2009). In a nutshell, the auditory system 
deals with such large changes in stimulus intensities by dynamically adjusting its responses at 
two levels: regulating both the behavior of its individual elements and the overall responsiveness 
of the system as a whole.   
How ChR-expressing SGNs respond to changes in light intensity has not yet been extensively 
studied. Most of the still few published articles have focused on describing single SGN 
responses to increasing stimulation rates, and characterizing light sensitivity at the population 
level (Hernandez et al., 2014a; Wrobel et al., 2018). Other studies have only briefly investigated 
this issue in neurons at higher auditory centers (Duarte et al., 2018; Hight et al., 2015). In order 
to mimic the physiological performance of SGNs, optogenetic hearing requires to operate not 
only at high rates of firing, but also with a range of stimulus intensities that allow to recruit 
groups of SGNs in a dynamic manner, as in natural hearing. This means that light sensitivity, 
i.e. ChR expression levels (Schoenenberger et al., 2008), as well as position relative to a given 
emitter should vary, so that the distribution of thresholds among SGNs at a given tonotopic 
region is heterogeneous (Jeschke and Moser, 2015). This would contribute to increase the 
dynamic range of the population by sequentially recruiting groups of SGNs as light intensities 
rise, and might be crucial to improve speech perception in noise with respect to current eCIs 
(Weiss et al., 2016; Zeng and Galvin, 1999). Therefore, characterizing optogenetic responses of 
SGNs at different intensities is of major importance prior to the clinical translation of oCIs. 
Moreover, studying SGNs responses to varying light intensities would allow to better compare 
optogenetic and electrical hearing and to help to answer open questions: does the dynamic range 
of optogenetic hearing outperform that of electrical hearing at the single fiber level (~1 dB 
(Miller et al., 2006))? How do the energies required to elicit neural responses in optogenetic and 
electrical hearing compare? How reliable are SGN responses at low light levels? This chapter 




5.2 Materials and methods 
The AAV used here was the same that we used in Chapter 4 (AAV2/6-hSyn-f-Chrimson-EYFP). 
Round window injections (performed by Dr. Vladan Rankovic and Christiane Senger-Freitag), 
optical stimulation in vivo, immunostaining and imaging of cochlear cryosections, ABR 
recordings and juxtacellular single-unit recordings procedures were detailed in Chapter 4. 
Stimulation paradigm for construction of rate-level functions 
Once a positive oABR signal was measured and surgery was completed on 8-16 week-old 
C57BL6/J mice injected at P5-7 with AAV2/6-f-Chrimson-EYFP (or PBS in control 
experiments), a 50 µm optical fiber was placed in the round window niche to deliver the light 
of a 594 nm laser (OBIS LS OPSL; 100 mW, Coherent Inc.). Glass microelectrodes (World 
Precision Instruments) filled with 3M NaCl were positioned on the recording area over the 
anteroventral cochlear nucleus. A search stimulus consisting on 400 ms-long pulse trains (100 
ms inter-train recovery) at ~14 mW, 100 Hz, 1 ms pulse width, was used to find light-responsive 
fibers. Microelectrodes were advanced stepwise (1.5 µm steps) through the neural tissue up to 
~2 mm depth using a micro-positioner (Luigs & Neumann). Upon finding light-responsive 
fibers (at depths higher than 1 mm relative to the cochlear nucleus surface), responses to pulse 
trains similar to the search stimulus were recorded over 20 iterations per light intensity tested 
(0-18.3 mW) in no particular order. Spontaneous activity was recorded over 10 s without 
stimulation.  
For acoustical stimulation experiments, 6-11 week-old C57BL6/J wild-type mice with normal 
hearing thresholds (30-40 dB SPL at click-evoked ABR measurements) were used. In these 
experiments, the middle ear surgery was spared and an Avisoft ScanSpeak Ultrasonic Speaker 
(Avisoft Bioacoustics) was used for stimulation instead of the optical fiber. The search stimulus 
here consisted of 400 ms click trains with 300 µs click width at 85 dB SPL (peak equivalent, 
pe) delivered at 100 Hz, and the range of sound intensities used was 0-110 dB SPL (pe). 
Data analysis 
Spikes were detected and sorted; vector strength, spike probability, firing rate, first spike latency 
and jitter were extracted using a Matlab (MathWorks) custom-written algorithm. The spike 
probability was calculated by detecting whether or not spikes occurred in a time window equal 
to the stimulation cycle (giving a binary value of 0 or 1 per cycle) and averaging the results 
across trials. The extent of phase-locking was assessed with the vector strength (Goldberg and 
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Brown, 1969), using a cycle starting with the onset of a light pulse and ending with the onset of 
the next one, using the equation 𝑣𝑒𝑐𝑡𝑜𝑟 𝑠𝑡𝑟𝑒𝑛𝑔𝑡ℎ = , with Θ1, Θ2, …, 
Θn  marking cycle phases in which spikes occurred. Significance of vector strength was assessed 
by means of the Rayleigh test, so that the null hypothesis (a uniform distribution of events) was 
rejected if L > 13.8, at α=0.001 (Hillery and Narins, 1987) and insignificant vector strength were 
set to 0. Threshold was determined as the stimulus intensity eliciting 10% of the difference 
between spontaneous and maximal driven rate (Sachs and Abbas, 1974). Rate-level functions 
were constructed by plotting the average firing rate per stimulus intensity tested. The 
monotonicity index was calculated as the ratio between the firing rate at maximum intensity and 
the maximal firing rate. Dynamic range was calculated for rate-level functions by fitting 
sigmoidal curves to the data, in order to calculate the stimulus intensities eliciting responses 
equal to 10% and 90% of the difference between spontaneous and maximal driven rate (Figure 
5.1). First spike latency was estimated as the time from stimulus onset to spike peak. The 
temporal jitter of spikes was defined as the standard deviation of spike latency across trials using 
a time window equal to one stimulation cycle. The mean number of spikes per cycle was 
calculated as the average ratio between the number of spikes and the number of stimulation 
cycles across trials. The adaptation ratio was estimated as the ratio between the average firing 
rate during the first 100 ms of the stimulus train and the average firing rate over the full 400 ms 
length of the train. 
Statistical tests were performed using Igor Pro 6.3 (Wavemetrics) and GraphPad Prism 
(GraphPad Software). Data was prepared for display using Adobe Illustrator (Adobe Systems). 
Averages in figures and references to data in the text were expressed as mean ± s.e.m. Data was 
tested for normality (D’Agostino & Pearson omnibus normality test or Shapiro-Wilk test) and 
homoscedasticity (F-test) prior to statistical comparison with the two-tailed unpaired Student’s 
t-test, or the unpaired two-tailed Mann-Whitney U test. For evaluation of multiple groups, 
statistical significance was calculated by using the one-way Kruskal-Wallis test followed by 
Dunn’s test for non-normally distributed data. Box-whisker plots in figures show 1st, 25th, 50th, 
75th and 100th percentiles. Significant differences are indicated as * p < 0.05, ** p < 0.01, *** 





Figure 5.1: Calculation of the dynamic range of rate-level functions  
Dynamic range was estimated by fitting sigmoidal functions and determining the baseline and 
maximal firing rate (Max FR) (green dashed lines) to calculate the 10% and 90% of the 
difference between the spontaneous and maximal driven rate (red dashed lines) and then subtract 
the stimulus intensity eliciting 10% of response to that eliciting 90% of response (green 
asterisks). Red asterisks mark the point where the function reaches 50% of the difference 
between spontaneous and maximal response. A: Fitting done for an exemplary rate-level 
function obtained from stimulation using acoustic clicks (100 Hz, 300µs click width; data points 
shown as crosses, as for B). B: Representation of a sigmoidal fit done for an exemplary rate-
level function obtained from optical stimulation (100 Hz, 1 ms pulse length). 
 
5.3 Results 
5.3.1 Analysis of f-Chrimson-EYFP expression and opsin functionality  
In order to record optically-evoked juxtacellular single-unit activity from the auditory nerve, I 
first placed an optical fiber coupled to a 594 nm laser in the left side round window niche of 8-
16 week-old C57BL6/J mice that were injected at P5-P7 with AAV2/6-hSyn-f-Chrimson-EYFP 
(as in Chapter 4). Upon light stimulation via the optical fiber, I recorded oABRs as a proxy of 
functional f-Chrimson expression in SGNs. I recorded a positive oABR signal in all tested 
animals (5/5) but only 60% survived after craniotomy to render optically-evoked single-unit 
recordings (Figure 5.2A). PBS-injected mice of similar age did not show oABR responses 
(Figure 5.2B). Similarly, I used acoustic clicks to record acoustic ABRs (aABRs) and thus assess 
auditory function in mice used in acoustic experiments (Figure 5.2C). 
Then, I analyzed f-Chrimson-EYFP expression by means of confocal imaging of cochlear 
cryosections and I found high and homogeneous EYFP expression levels (~85%) in SGNs 
throughout the cochlea (p > 0.05, n = 5; Dunn’s test; Figure 5.3A,B). A minimal fraction of 
SGNs in the contralateral ear expressed the fusion protein (on average ~5%). Moreover, 




Figure 5.2: ABR recordings from f-Chrimson-transduced, PBS-injected and WT mice  
A: All mice injected with AAV2/6-hSyn-f-Chrimson-EYFP (5/5) used in this chapter rendered 
a positive oABR signal (18.3 mW, 1 ms pulse width at 20 Hz). However, only 60% of them 
rendered single-unit recordings (solid lines). Scale bars apply to B and C. B: Contrarily, no 
oABR could be evoked in PBS-injected controls of similar age (n = 3). C: aABRs evoked in 
wild-type non-injected mice using acoustic clicks (0.3 ms click width, 80 dB SPL (pe) at 20 Hz, 
n = 4).  
 
comparable in both ears, and also similar to PBS controls (p > 0.05, n = 5; Dunn’s test; Figure 
5.3A,C). 
5.3.2 Optogenetic spike fidelity decays with stimulation rate  
In order to evaluate the effect of varying light intensity in f-Chrimson-expressing SGNs, 
stimulus parameters as pulse length and stimulation rate needed to be fixed in advance. 
Regarding pulse length, we used a standard of 1 ms in experiments conducted prior to these 
because oABR responses were optimal in response to this pulse duration (see Chapter 4). To 
select a stimulation rate that SGNs were able to follow reliably, I first investigated the relation 
between spike fidelity and stimulation frequency across rates ranging from 20 to 300 Hz. As 
shown in Chapter 4, the majority of SGNs expressing f-Chrimson-EYFP show a cut-off 
frequency ranging from 200-300 Hz. For comparison, I adapted the stimulation paradigm 
applied in optogenetic stimulation experiments to present trains of acoustic square clicks to 
wild-type mice (400 ms-long click trains with 100 ms recovery over 20 iterations). In order to 
quantify spike fidelity, I calculated the mean probability of each SGN to fire a spike in response 
to each light pulse or click across stimulation rates. Results show that SGNs respond with a 





Figure 5.3: Expression of f-Chrimson-EYFP in SGNs 
A: Confocal images from representative cochlear middle turn cryosections showing 
parvalbumin (magenta) and EYFP (green) immunofluorescence to mark f-Chrimson expression 
and SGNs, respectively. Scale bars: 50 µm. Inset (top right): parvalbumin-positive, EYFP-
negative IHC with EYFP-positive SGN neurites. Scale bar: 20 µm.  B: Boxplot showing the 
fraction of EYFP-expressing SGNs in the injected (left) and non-injected ear (right) (n = 7). 
Expression levels were homogeneous in the left side (p > 0.05; Dunn’s test). No expression was 
found in PBS-injected animals (n = 3). C: Boxplot showing density of SGNs across cochlear 
turns, that was unaltered in mice injected with AAV2/6 (n = 7) or PBS (n = 3) (p > 0.05 for all 
comparisons; Mann-Whitney-U test)  
 
Optogenetic stimulation triggers spikes almost after every light pulse at frequencies 20-100 Hz, 
yielding a higher spike fidelity than that of acoustical stimulation at 50 Hz (p = 0.0027; Mann-
Whitney-U test). In contrast, spike fidelity sharply decays at higher rates in response to 
optostimulation, whereas it is steadier in response to clicks (at 200 and 300 Hz, p < 0.0001; 
Mann-Whitney-U test). Responses to both clicks and light pulses were comparable at 100 Hz 




















Figure 5.4: Spike fidelity decreases with increasing stimulation rates in optogenetic and 
acoustic stimulation experiments  
Probability of SGN firing across different stimulation rates per acoustic click (grey, 100 dB SPL 
(pe), 300 µs click width at 100 Hz; n =12, 3 mice) and light pulse (orange, 18.3 mW, 1 ms pulse 
length at 100 Hz; n = 9; 3 mice) presented in a train over 400 ms leaving a recovery inter-train 
interval of 100 ms across repetitions per tested rate. Asterisks mark significant differences 
between stimulation modalities.   
 
5.3.3 Dynamic range of optogenetic stimulation 
In order to characterize SGN responses to varying light power, I first constructed RLFs by 
representing firing rates of light-stimulated SGNs in response to each intensity tested, and 
compared the results to stimulation using acoustic clicks (Figure 5.5). 
In response to acoustic clicks presented at 100 Hz, most RLFs appeared to grow with sound 
intensity with sloping saturation, i.e. firing rates were higher as sound intensity increased and 
rate did not saturate completely (Sachs and Abbas, 1974) (Figure 5.5A,C). In contrast, most 
light-stimulated SGNs reached flat saturation (Sachs and Abbas, 1974) at 100 spikes/s in 
response to light pulse trains delivered at 100 Hz, revealing that most recorded SGNs fire one 
spike per pulse at saturating light intensities (27 out of 33 ANFs, 81.82%, Figure 5.5B,D) while 
the remaining 6 responded with an average of 1.61 ± 0.19 spikes/pulse. In both stimulation 
modalities, firing rates increased with stimulus intensity. For characterization of RLFs, I 
compared responses to the entire 400 ms-long pulse train and to the first 100 ms (first 10 
stimuli). There were no statistically significant differences in the responses using either time 
window (Figure 5.6). RLF growth was strongly monotonic for both stimulation modalities, but 
higher in acoustic RLFs for both time windows (monotonicity index, median (400 ms) = 1.00 
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vs 0.996; p = 0.0142; median (100 ms) = 1.00 vs 0.93; p < 0.0001 in acoustical vs optical 
stimulation, respectively; Mann-Whitney-U test Figure 5.6A). RLFs at optogenetic stimulation 
grew with a steeper slope than at acoustical stimulation, as estimated by the maximal steepness 
of the RLFs (median (400 ms) = 35.22 Hz/dB (mW) vs 5.49 Hz/dB SPL (pe), respectively; p < 
0.0001; median (100 ms) = 34.36 Hz/dB (mW) vs 5.87 Hz/dB SPL (pe); p < 0.0001; Mann-
Whitney-U test; Figure 5.6B). Next, I estimated the dynamic range by fitting sigmoidal 
functions to RLFs. The dynamic range was defined as the range of stimulus levels for which 
firing rate was equal to 10% and 90% of the difference between spontaneous and maximal 
driven rate. Correspondingly, the steeper slope in response to optical stimulation is reflected in 
a narrower dynamic range of RLFs as compared to acoustical clicks (3.87 ± 0.47 dB (mW) vs 
31.29 ± 4.46 dB SPL (pe), respectively; p < 0.0001, t-test; Figure 5.6C) when considering the 
full length of the pulse train. Dynamic range was not significantly different when changing the 
analysis window from 400 to 100 ms, and the differences observed between stimulus modalities 
remained significant (2.74 ± 0.33 dB (mW) vs 19.77 ± 3.89 dB SPL (pe) for optical vs 
acoustical, respectively; p < 0.0001, t-test; Figure 5.6C).  
I further investigated the relation between SR and threshold (defined as the stimulus intensity 
required to elicit a response above SR equal to 10% of the difference between spontaneous and 
maximal driven rate) (Figure 5.7). Neither acoustically-stimulated nor optically-stimulated 
SGNs showed a significant correlation between SR and click or light-pulse threshold, 
respectively (rs = 0.06813; p = 0.8201 for acoustical stimulation experiments, rs = -0.2610; p = 
0.2122 for optogenetic stimulation experiments; Spearman correlation; Figure 5.7A,B). 
Compared to acoustically-stimulated SGNs, in experiments involving optogenetic stimulation 
only a subset of fibers showed spontaneous activity > 1 spike/s (29.41% vs 64,28% in 
optogenetic and acoustic stimulation experiments, respectively). Optically-stimulated SGNs 
showed an average threshold of 5.38 ± 1.13 dB (mW) relative to 0.5 mW while acoustically-
stimulated SGNs had a mean threshold of 58.56 ± 3.58 dB SPL (pe). The mean threshold of the 
three most sensitive SGNs found in optical experiments was -1.25 ± 0.64 dB (mW) relative to 
0.5 mW per pulse, probably reflecting optimal f-Chrimson expression and illumination 
conditions. I then calculated the stimulus intensity required for eliciting 50% of the difference 
between the spontaneous and maximal firing rate. For optical stimulation experiments, this 
estimate was on average 7.77 ± 0.97 dB (mW) relative to 0.5 mW, while for acoustical 




Figure 5.5: Rate-level functions in response to clicks and light pulses  
A: Activity of an exemplary SGN in response to 300 µs clicks at 100 Hz at different sound 
intensities and B: at varying 594 nm light power in response to 1 ms pulses at 100 Hz. C: RLFs 
in response to acoustic click trains for 24 single units from 4 mice. D: RLFs in response to light 
pulses displayed for 33 single units from 3 mice. Dashed lines in A and B show RLFs discarded 
for further analysis (clicks: n = 10 units from 4 mice; light-pulses: n = 16 units from 3 mice; 
also applies to C, D and E). Solid lines represent RLFs that were further analyzed in the next 
figure (clicks: n = 14 units from 4 mice; light-pulses: n = 17 units from 3 mice). Black traces in 
C and D show data for units in A and B respectively.  
 
operating range of the population, I selected the three most responsive and the three least 
responsive units and calculated the difference in laser power between them at 50% of activation. 
Therefore, the operating range of optically-stimulated fibers was estimated in 8.33 ± 0.16 dB 
(mW). 
 
5.3.4 Temporal aspects of spiking in response to varying stimulus intensities 
In response to acoustical stimulation with clicks or optical stimulation with short light pulses, 
the latency to the first elicited spike relative to the click or pulse onset tended to decline with 





Figure 5.6: RLFs grow monotonically, steeper at optogenetic stimulation, leading to a 
reduced dynamic range 
A: Monotonicity index of the RLFs (firing rate at maximal intensity over maximal firing rate) 
in response to clicks and light pulses. Color code applies to all panels. B: Maximal steepness of 
the RLFs in response to clicks and light pulses. C: Dynamic range of the RLFs (range of 
stimulus intensity levels eliciting 10 and 90% of the difference between spontaneous and 
maximal driven rate) in acoustical (dB SPL (pe)) and optogenetic stimulation (dB (mW). 
 
 
Figure 5.7: Spontaneous rate and response threshold in acoustically- and optically-
stimulated ANFs 
A: Scatter plot of threshold (stimulus intensity level for which the firing rate is equal to 10% of 
the difference between spontaneous and maximal driven rate) versus spontaneous rate for fibers 
stimulated with acoustic clicks (n = 14 from 4 mice). B: Same plot as A representing responses 
from optically-stimulated fibers (n = 17 from 3 mice). C: Box-whisker plots showing stimulus 
intensity levels eliciting 50% of the difference between spontaneous and maximal response for 
click stimulation (grey) and light pulse trains (orange).  
 
significantly higher in response to clicks (2.90 ± 0.22 ms) as compared to light-stimulated SGNs 
(2.59 ± 0.08 ms) (p = 0.0047; Mann-Whitney-U test) (Figure 5.8A,B). Next, I quantified the 
temporal jitter of elicited spikes (defined as the standard deviation of first spike latency across 
trials) as an estimate, together with vector strength, of temporal precision of spiking. At 
 
112 
maximum stimulus intensities, spiking was less precise in response to acoustical stimulation 
than in response to optical stimulation, as assessed by spike jitter of 1.06 ± 0.17 ms for acoustic 
clicks and 0.39 ± 0.05 ms for light pulses (p = 0.0002; Mann-Whitney-U test) (Figure 5.8C,D). 
 
I further assessed the temporal precision of spiking by means of vector strength to measure the 
extent of phase locking across stimulus trains.  
Vector strength rose steeply in response to both stimulation modalities after a certain stimulus 
level specific for each fiber was reached, giving rise to a heterogeneous population response. In 
response to acoustic clicks, once maximum phase locking level was reached, vector strength 
tended to decay at the highest intensities, while it was steadier once saturated in response to 
light pulses (medians: 0.84 for clicks, 0.98 for light pulses, p < 0.0001; Mann-Whitney-U test, 
Figure 5.9).  
 
5.3.5 Optogenetic responses to low light intensities are more reliable at the 
beginning of the stimulation train 
To further characterize SGN responses at increasing light intensities, I calculated the mean 
number of spikes per pulse across different stimulus intensities. At maximum laser power, SGNs 
tended to fire 0.98 ± 0.06 spikes per pulse, which seems to be a saturation point in this case. The 
apparent higher number of spikes generated in response to acoustic click stimulation, amounting 
to 1.26 ± 0.14 spikes per click at maximum sound intensity levels, however, does not reach 
statistical significance (p = 0.0974; Mann-Whitney-U test). Further, the average number of 
spikes per click seems not to saturate at this point (Figure 5.10A,B). Next, to assess the reliability 
of spiking along the stimulus train, I defined the adaptation ratio as the ratio between the firing 
rate during the first 100 ms and the firing rate during the entire length of the train (400 ms). 
Results show that the adaptation ratio is maintained steady (~1) across stimulation levels for 
acoustical stimulation (Figure 5.10C). Interestingly, at low laser intensities, the adaptation ratio 
is higher for optogenetic stimulation, while for higher intensities it approaches ~1 (Figure 
5.10D). This means that from threshold up to saturating levels, spikes at the beginning of the 
stimulus train are favored over a random distribution of spikes. At sound intensity levels of 40-




Figure 5.8: First spike latency and temporal jitter decrease with increasing click and light 
pulse intensity 
A: Latency to the first spike per stimulation cycle elicited by clicks of increasing intensity (n = 
24 from 4 mice). B: Same as A for optically stimulated fibers (n = 33 from 3 mice). Dashed 
lines in A and B show fibers discarded for RLF analysis due to insufficient data points (clicks: 
n = 10 units from 4 mice; light-pulses: n = 16 units from 3 mice; also applies to C and D). Solid 
lines represent responses from fibers for which RLF was further analyzed in Figure 5.6 (clicks: 
n = 14 units from 4 mice; light-pulses: n = 17 units from 3 mice; also applies to C and D). C: 
Jitter of the first elicited spike per stimulation cycle in acoustic experiments D: Same as C for 
optical stimulation experiments. Means (± s.e.m.) are shown as black lines. 
 
lower than that of 1.65 ± 0.17 for optically-stimulated SGNs at intensities of 2-4.5 dB (mW) 
relative to 0.5 mW (p = 0.0149; Mann-Whitney-U test).  
 
5.3.6 SGN responses to optogenetic stimulation of varying pulse rate and intensity 
During optogenetic stimulation recordings, I could hold a subset of 6 fibers after completing the 
previous recordings for a time long enough to preliminarily characterize SGN responses to 




Figure 5.9: Phase locking increases with increasing stimulus intensity 
A: Vector strength of the SGNs response to acoustic click trains of varying intensity (n = 24 
from 4 mice). B: Same as A in response to light pulse trains (n = 33). Dashed lines in A and B 
show fibers discarded for RLF analysis due to insufficient data points (clicks: n = 10 units from 
4 mice; light-pulses: n = 16 units from 3 mice; also applies to C and D). Solid lines represent 
responses from fibers for which RLF was further analyzed in Figure 5.5 (clicks: n = 14 units 
from 4 mice; light-pulses: n = 17 units from 3 mice; also applies to C and D). C: Variation of 
vector strength with spike probability in acoustically-stimulated fibers. D: Same as C for 
optically-stimulated fibers. Lines in C and D connect data points obtained from the same SGNs. 
 
a pulse rate of 100 Hz, and, superimposed, RLFs of these same SGNs at stimulation rates of 50 
and 20 Hz (Figure 5.11A). When decreasing stimulation rate, SGN firing becomes more reliable 
for the same intensity levels (Figure 5.11B) (p = 0.0062; Dunn’s test 20 vs 100 Hz; n.s. for the 
rest of comparisons). Further examination led me to investigate whether threshold was reduced 
for these SGNs due to stimulus rate decline. Results in Figure 5.11C show that threshold levels 






Figure 5.10: High light intensities trigger mainly one spike per pulse while low light 
intensities mainly elicit spikes at the beginning of the stimulation train 
A: Mean number of spikes elicited per stimulation cycle in response to click stimulation at 
increasing intensities (n = 24 from 4 mice).  B: Same as A in response to optogenetic stimulation 
(n = 33 from 3 mice). Dashed lines in A and B show fibers discarded for RLF analysis due to 
insufficient data points (clicks: n = 10 units from 4 mice; light-pulses: n = 16 units from 3 mice). 
Solid lines represent responses from fibers for which RLF was further analyzed in Figure 5.5 
(clicks: n = 14 units from 4 mice; light-pulses: n = 17 units from 3 mice). C: Adaptation ratio 
(mean firing rate during the first 100 ms over mean firing rate along the entire stimulation train) 
of SGN responses to acoustic clicks at increasing stimulus intensities (n = 14). D: Same as C 
for fibers stimulated with light pulse trains at increasing intensities (n = 17). Means (± s.e.m.) 
are shown as black lines. 
 
5.4 Discussion 
The data presented above shows how different measures of SGN spiking vary with stimulus 
intensity in response to acoustic clicks and optical pulses. As expected, firing rates increased in 
a level-dependent manner in both click and light pulse stimulation (Guo et al., 2015; Hight et 




Figure 5.11: Spike fidelity increases for lower stimulation rates at the same light intensity 
A: Rate-level functions from a subset of optically-stimulated fibers (n = 6 from 2 mice, color-
coded for each SGN) at increasing light intensity and different pulse rates. Dotted lines show 
responses at 20 Hz, dashed lines represent responses at 50 Hz and solid lines show responses at 
100 Hz. B: Ratio of average spike probability (SP) across stimulus intensities tested at 20 and 
50 Hz over that at 100 Hz. SGNs fire more reliably when decreasing stimulation rate from 100 
to 20 Hz for the same light intensity levels (p = 0.0062; Dunn’s test). C: Threshold level (light 
intensity eliciting 10% of the driven rate) at 20 and 50 Hz normalized to that at 100 Hz. Data 
show that increasing pulse rate from 20-50-100 Hz has no significant effect on threshold level 
(p = 0.1644; Kruskal-Wallis test). 
 
The extent of the growth of these firing rates, however, differ among modalities. In response to 
pulsatile optogenetic stimulation, the majority of fibers showed a saturated rate at a maximum 
of one spike per pulse, with a fraction of them reaching higher values. Generation of a second 
spike may result from residual charge in the membrane (Miller et al., 1999). I argue that 
extended post-spike depolarization due to non-instantaneous ChR closure might trigger a 
doublet in SGNs with high levels of ChR expression (Gunaydin et al., 2010; Mattis et al., 2011). 
In contrast, there did not seem to be a hard saturation of response in acoustic click stimulation, 
probably due to the high thresholds observed. SGNs usually require higher intensity clicks to 
fire than they would need using tones at their CF (with differences that can reach 50 dB). The 
threshold levels to clicks reported here are comparable to literature data from cat and guinea pig 
(Lin and Guinan Jr, 2000, 2004; Versnel et al., 1997). An important fraction of SGNs showed 
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very low optogenetic thresholds (~35% with threshold lower than 1 mW, i.e. < 1 µJ), bringing 
the energy requirements close to CI levels (0.2 µJ per pulse (Zierhofer et al., 1995)). Opsins that 
are well tolerated by the expressing cells, as f-Chrimson, are expected to exhibit high ChR 
densities in SGNs, which allows for lower thresholds and therefore, a higher spatial selectivity 
would be in principle possible (Schoenenberger et al., 2008). Taking into account that 
stimulation was performed using a single emitter placed at the round window, it is likely that 
thresholds can be further improved by using multiple light sources situated along the cochlear 
tonotopic axis and focused toward the Rosenthal’s canal (Moser, 2015a; Wrobel et al., 2018).  
When light pulse trains were presented at non-saturating light powers, SGNs responded 
preferentially by eliciting spikes at the beginning of the train. This is a different situation 
compared to click stimulation, where the distribution of spikes is homogeneous throughout the 
stimulus train. Indeed, this might result from the presence of two different opsin cycles, one that 
is dark-adapted and a second light-adapted cycle, whose occupancy increases with illumination 
time (Nikolic et al., 2009; Schneider et al., 2015). Therefore, at the beginning of the train a 
higher proportion of ChRs are in the dark-adapted state, and light pulses elicit large 
photocurrents in the dark-adapted open state of the channel, which is highly permeable to H+ 
and cations (Schneider et al., 2013), thus triggering spikes. As the train proceeds, an increasing 
number of channels shift to the light-adapted cycle, where the open state is less conductive due 
to the conformational change produced around the retinal binding site (Berndt et al., 2010). 
Modelling studies of ChR2 estimate that the light-adapted open state is 10-fold less conductive 
than its dark-adapted counterpart (Nikolic et al., 2009). Thus, photocurrents do not reach a 
threshold level and spikes do not occur (Bruun et al., 2015; Schneider et al., 2015).  
Among the various types of sound stimuli, the main reason for using clicks here is their abrupt 
onset, similar to that of light pulses. In the classical view, clicks deposit an energy burst in the 
cochlea that evoke a travelling wave moving toward the apical part of the basilar membrane. 
When this motion reaches the tonotopic region innervated by a particular SGN, transduction and 
spike firing occurs (Lin and Guinan Jr, 2000). Fibers with a high CF (> 4 kHz), as the vast 
majority of SGNs in the mouse cochlea, respond to clicks with a single spike whose latency is 
inversely correlated to the CF of the fiber, reflecting its tonotopic position (Evans, 1972; Kiang 
et al., 1965; Lin and Guinan Jr, 2000). In contrast, optical stimulation directly activates light-
sensitive SGNs by eliciting photocurrents that in turn open voltage-dependent Na+ channels, 
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what explains the shorter mean latencies found for optical stimulation. Similarly, the shorter 
latencies observed for electrical stimulation (Miller et al., 1999, 2006) likely reflect the faster 
spike generation process there. One common feature to acoustic stimulation, single-channel 
optogenetic and monopolar electrical stimulation is the reduction of first spike latency and jitter 
as stimulus levels increase. Likely, the underlying cause of this correlation in natural hearing is 
the increase of synaptic input at increasing sound levels, giving rise to higher amplitude and 
steeper rise of evoked EPSPs that, in turn, trigger spikes with shorter latency and jitter 
(Rutherford et al., 2012). A similar effect was observed using electric current at increasing 
charge and shorter rise times (Rutherford et al., 2012) and the same could apply to optogenetic 
stimulation. Some authors, however, suggest that in response to monopolar electrical 
stimulation, the migration of the effective excitation site to more central sites in the modiolus as 
stimulus intensity grows can also affect spike latency (Frijns et al., 1996; Miller et al., 1999; 
Rubinstein, 1991). Similarly, this might apply to optogenetic stimulation under high and spread 
ChR expression levels as it is the case with f-Chrimson (see Chapter 4), since at increasing 
stimulus intensity, suprathreshold levels are reached at farther distances from the source. 
Furthermore, excitation site migration can also account for the decrease in spike jitter with 
increasing stimulus level due to spike propagation through a lower number of nodes of Ranvier 
(Miller et al., 1999).  Despite the fact that clicks and light pulses both have an almost 
instantaneous rise time, the temporal jitter of spike timing was greater in click-stimulated SGNs 
as compared to that of optogenetic stimulation, this being still about one order of magnitude 
lower in electrical stimulation (Miller et al., 1999). The additional ear surgery aimed at inserting 
the optical fiber through the round window likely underlies the higher fraction of fibers showing 
SR of > 1 spike/s in acoustic experiments, which is in turn likely to cause the differences 
observed in spike jitter due to the presence of random firing activity. Thus, the probability of 
relative refractoriness membrane states increased compared to optogenetic experiments, what is 
also observed when comparing electrical stimulation in deafened and normal hearing ears 
(Miller et al., 2006). Moreover, the higher SR can also contribute to an increased population of 
deactivated of voltage-gated Na+ channels (Rubinstein, 1995). Taken together, these factors 
hamper temporal fidelity by reducing spike synchronicity to the stimulus.  
In the case of electrical stimulation, low pulse rates evoke a much greater degree of SGN spike 
synchrony compared to optogenetic or acoustic stimulation (Litvak et al., 2001; Miller et al., 
2008; Zhang et al., 2007b). In natural hearing, vector strength tends to increase with stimulus 
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level for 20-30 dB before reaching saturation. The observed decrease of phase locking at the 
highest intensities is comparable to other reports (Dreyer and Delgutte, 2006; Heil and Peterson, 
2015; Johnson, 1980). Contrarily, in optogenetic stimulation, spike synchrony does not degrade 
with stimulus level once saturated and the response is well phase locked even at low spike 
probabilities (Figure 5.9). However, measures of phase locking and jitter indicate that 
optogenetic temporal precision seems not as deterministic as in electrical stimulation. In CI 
processing strategies, much higher pulse rates seek to enhance temporal uncertainty in an effort 
to mimic the natural process (Litvak et al., 2001; Miller et al., 2008; Rubinstein et al., 1999), 
which might be avoidable in the oCI.  
Moreover, not only the lower temporal precision of spiking but also the fact that spike fidelity 
is less deterministic in optogenetic hearing can be beneficial when comparing to electrical 
stimulation. For the same increments in stimulus level, spike probability decreases with 
increasing stimulation rate (see Chapter 4 and Figure 5.11), but rates need to increase much 
more in electrical stimulation to produce a similar effect (Miller et al., 2008). At moderate rates, 
as 100 Hz for light pulses and 250 Hz for electrical stimulation, the range of stimulus intensities 
that produces increases in spiking is much narrower in electrical stimulation. This translates into 
smaller dynamic ranges, for which optogenetic hearing promises a big step forward compared 
to electrical hearing. In response to electrical stimulation, dynamic range of single SGNs 
amounts to ~1-2 dB (Javel, 1990; Miller et al., 2006; Shepherd and Javel, 1997) while 
optogenetic stimulation allows a 3-fold wider range. Consequently, the operational range of 
optogenetic stimulation at the population level almost doubles that achieved with monopolar 
electrical stimulation(~8 dB (mW) vs ~5 dB , respectively, estimated using the electrical CAP 
growth function (Hu et al., 2003). This increase in operational range might arise from the 
heterogeneous expression levels among SGNs (Schoenenberger et al., 2008). Under these 
conditions, increases in stimulus intensity lead to a successive recruitment of fibers, likely more 
gradual in optogenetic stimulation than in response to electrical current, resulting in a more 
natural increase in the perceived loudness (Jeschke and Moser, 2015). 
In conclusion, the characterization of optogenetic responses of the auditory nerve to increasing 
light power suggests a closer to physiological situation than that of electrical hearing. Future 
experiments should address how SGN responses change when using multiple light emitters 
placed in the scala tympani of larger animal models and if, indeed, a higher spatial resolution 
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can be achieved with the optogenetic approach. If this is the case, and assessments of innocuous, 
long-lasting functional ChR expression yield positive results; the oCI would have a paved road 




6 General discussion 
Over the last few years, several studies demonstrated that optogenetic stimulation of light-
sensitive SGNs triggers activation of the auditory pathway. Either germline transgenic 
expression of ChR2, or pre-natal injections of AAVs carrying its mutant variant CatCh proved 
light-sensitive rendering of SGNs feasible. However, virus-mediated expression showed a  
heterogeneous pattern and the temporal fidelity of optogenetic stimulation was low (Hernandez 
et al., 2014a). Hence, the looming challenges for progress in cochlear optogenetics were the 
need for higher and uniform expression levels as well as faster ChR kinetics. In the present 
study, I described auditory nerve responses to optogenetic stimulation using the rapidly-gating 
and well-expressing opsins Chronos-ES/TS and f-Chrimson. Working with Chronos highlighted 
the key importance of tailor-made opsin sequence and AAV optimization for unfolding the 
potential of optogenetic tools. My results show for the first time that (1) post-natal AAV-
meditated transduction of SGNs yields high and long-lasting ChR expression levels; (2) 
optogenetics can drive SGN firing in vivo at near physiological rates; and (3) high light 
sensitivity and low illumination thresholds are achievable.   
 
6.1 Chronos and f-Chrimson as potential candidates for clinical cochlear 
optogenetics 
SGNs encode temporal cues in acoustic signals at rates of few hundreds of Hz with sub-
millisecond precision (Joris et al., 2004; Liberman, 1978; Strenzke et al., 2009; Taberner and 
Liberman, 2005). Hence, efficient optogenetic control of SGNs, “cochlear optogenetics”, 
mainly stands on three pillars. First, the fast deactivation kinetics of ChRs that allow responses 
to high optical pulse rates to faithfully reproduce the natural situation. Secondly, the light 
sensitivity of ChRs must be high to trigger large photocurrents and to enable a lower energy 
consumption per pulse that can be translated into an oCI with acceptable battery life time. The 
third pillar involves that the optogenetic actuators used in the cochlea should preferably be 
activated with red-shifted light, in order to minimize scattering in the tissue and phototoxicity 
risks in the long term use (Jacques, 2013; Moser, 2015a). 
Here, we show that an early post-natal AAV injection approach via the round window (Akil et 
al., 2012) dramatically enhanced functional expression of ChRs as compared to pre-natal 
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injections. Using the trans-uterine approach, only ~22% of the AAV2/6-CatCh-injected animals 
supported oABR (Hernandez et al., 2014a). The same method yielded only 2.5% (3/120) of 
oABR-positive mice using Chronos, compared to 47.06% (8/17) oABR-positive mice that were 
injected early after birth (Chapter 3, Figure 3.4 and Figure EV5). The combination of post-natal 
injections and the addition of trafficking sequences in the fusion protein Chronos-ES/TS further 
improved functional expression, reaching 97.3% (36/37) of the animals tested. Similarly, using 
Chronos under the strong CAG promoter, Duarte et al. (2018) report 87.5% (7/8 gerbils) oABR-
positive animals, although expression was not limited to SGNs. In the case of f-Chrimson-
expressing mice at 8-16 weeks of age, 100% (24/24) of the animals that endured surgery showed 
oABRs. In older animals (37-51 weeks of age) a decrease in efficiency was observed, since the 
ratio of oABR-positive mice declined to 50% (7/14). Recently, a method using intra-modiolar 
AAV injections in adult gerbils achieved enough CatCh expression to drive oABR in 46% 
(44/96) of the animals; though with a lower efficiency (transduction rate ~30%) and loss of 
SGNs (~25% in all cochlear turns) (Wrobel et al., 2018).  
In terms of transduction efficiency in the spiral ganglion, the post-natal approach achieved more 
homogeneous and higher transgene expression levels compared to pre-natal AAV injections. 
Trans-uterine injected AAVs carrying CatCh generated a strong basoapical expression gradient, 
peaking at around 65% of basal SGNs and decreasing to ~5% at the cochlear apex in oABR-
positive mice (Hernandez et al., 2014a). A similar pattern was observed in the very few 
embryonic injections of AAV2/6-Chronos-EGFP that supported SGN transduction (Chapter 3, 
Figure 3.4B). This graded expression resulted despite the higher viral titer and volume used in 
the present study (1.5 µl and 1012 GC/µl vs 0.25 µl and 1011 GC/µl (Hernandez et al., 2014a)); 
suggesting that the method itself underlies this effect. Regardless of the AAV serotype used, 
early post-natal injections through the round window rendered ChR expression throughout the 
cochlea at uniform and higher levels (Chapter 3, Figure 3.4C,D,F; Chapter 4, Figure 4.4D,F and 
Supplementary Figure 10A-C; Chapter 5, Figure 5.3A,B). This supposed an important step 
forward toward the future development of the oCI, since it enables stimulation of SGNs tuned 
for a wide range of frequencies along the tonotopical axis in the cochlea, hence, collectively 
covering a wide range of frequencies (Jeschke and Moser, 2015). However, the ability to 
optogenetically stimulate the auditory nerve does not only rely on high numbers of transduced 
SGNs, but rather on the plasma membrane localization of the fusion proteins, what can explain 
the typical dysfunctionality observed with the original Chronos construct (Chapter 3, Figure 
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3.3B and Figure EV1). Indeed, average transduction rates of ~30% routinely supported oABRs 
(Wrobel et al., 2018). On the other hand, one noticeable shortcoming of the post-natal approach 
was the viral spread to the non-injected ear. This was especially significant for Chronos and 
Chronos-ES/TS (Chapter 3), while in animals transduced with f-Chrimson expression levels in 
the contralateral side were not as elevated (Chapter 4, Figure 4.4D,F and Supplementary Figure 
10A,C; Chapter 5, Figure 5.3A,B). Given that both Chronos constructs used the powerful AAV 
variant PHP.B as a delivery vehicle, this seems to indicate that the usage of this capsid underlies 
the spread in ChR expression. However, injections in early post-natal stages seem to account at 
least for the ~5% of expression found with f-Chrimson (Chapter 4, Figure 4.4D,F and 
Supplementary Figure 10A,C; Chapter 5, Figure 5.3A,B). Therefore, there is room for further 
optimization. In this direction, another report that used the same combination of AAV2/6 and 
the human synapsin promoter as in Chapter 4, but intra-modiolar injections at later ages, did not 
found measurable levels of ChR expression in the contralateral ear (Wrobel et al., 2018). 
Furthermore, f-Chrimson expression was proven functional up to more than 9 months, at a time 
point when the characteristic age-related hearing loss of the C57BL6/J strain was already 
notorious (Kane et al., 2012) (Chapter 4, Supplementary Figure 10). Additional experiments 
showed that one mouse was oABR-responsive at 51 weeks of age, which is the latest time point 
post-injection that I tested (Appendix, Figure A1). Despite the aforementioned lower number of 
oABR-positive animals at this time point, the fraction of ChR-expressing SGNs was unaltered 
in responsive animals (Chapter 4, Supplementary Figure 10A,C). In oABR-negative animals, 
the transduction rate of SGNs was strongly reduced as compared to oABR-positive mice 
(median: 3.07%, n = 4). Nevertheless, these results provide evidence of a long-lasting, 
functional ChR expression that is in line with transduction of cochlear nucleus neurons with 
ChR2 and halorhodopsin in rats (Shimano et al., 2013) and superior to the latest time point for 
which Duarte et al. (2018) reported positive oABRs in Chronos-injected mice (18 weeks) and 
to the 6 months reported for CatCh-expressing macaque retinal ganglion cells (Chaffiol et al., 
2017). AAV injection or ChR expression caused no detrimental effects assessed by the unaltered 
SGN density, comparable hearing thresholds and normal behavior of the animals for any of the 
constructs tested here. In fact, safety of ChR2 expression has been evidenced over 8 months in 
the frontal cortex of macaques (Han et al., 2009). However, high expression levels of fluorescent 
soluble proteins as GFP can lead to strong immune responses, also in immune-privileged organs 
as the eye (Dalkara et al., 2013). Therefore, future constructs aimed at human clinical trials 
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should exclude fluorescent marker proteins. Despite AAV injections were performed in an early 
post-natal stage, when the murine immune system is still immature, it is unlikely that this 
underlies the avoidance of an immune response. Intra-modiolar injections of AAV2/6-CatCh-
EYFP in adult gerbils did not give rise to observable symptoms of immune response, and the 
reported loss of SGNs was rather attributable to the applied pressure as it was also observed 
with sham injections (Wrobel et al., 2018).  
Perhaps the most remarkable achievement of this work is the enhancement on optogenetically-
driven spiking rates in SGNs. In the seminal work by Hernandez et al. (2014), responses at the 
population level vanished at stimulation rates below 100 Hz for ChR2, which is well below the 
natural sustained firing rates of SGNs (Strenzke et al., 2009). Recent work reported that CatCh-
expressing SGNs can perform better, eliciting responses synchronized to the stimulus up to ~100 
Hz at the single unit level (Wrobel et al., 2018). However, the superior performance of both f-
Chrimson and Chronos-ES/TS in the spiral ganglion is evidenced by the considerable proportion 
of SGNs that maintain phase locked responses even at 200 and 500 Hz, respectively (Chapter 3, 
Figure 3.6B,C, Chapter 4, Figure 4.6B,D). Moreover, a minimal fraction of cells producing 
synchronized responses might suffice to activate auditory pathway (Bourien et al., 2014), 
judging by the fact that oABRs remained sizeable at 200 Hz for CatCh (Wrobel et al., 2018), at 
250 Hz for f-Chrimson (Chapter 4, Supplementary Figure 10G,J) and at 1 kHz for Chronos-
ES/TS (Chapter 3, Figure 3.5G-I). As a note of caution on the responses of Chronos-ES/TS for 
high stimulation rates, I add that the short averaging window did not allow for evaluation of 
later ABR waves, hence it cannot be concluded with certainty that the responses reported SGN 
compound action potentials and that activity was propagated along the pathway. In the case of 
Chronos-ES/TS, average synchronization estimates were in line with other reports that 
expressed the ChR in the cochlear nucleus (Guo et al., 2015; Hight et al., 2015). For f-Chrimson, 
a major leap forward in faster closing kinetics and maximal driven firing rates was achieved, as 
compared to the wild-type channel or its first described faster mutant ChrimsonR (Klapoetke et 
al., 2014). This brings red-shifted optogenetics to a new level in terms of speed, comparable to 
the ChR2 mutant ChETA (Gunaydin et al., 2010). In addition, results presented here indicate 
that both ChRs show a high temporal stationarity of efficacy in response to long pulse trains of 
400 ms. As a result of that, SGNs expressing Chronos-ES/TS or f-Chrimson are able to follow 
extended stimulation patterns, though this ability tends to decline at high frequencies. This is 
relevant with regards to the design of the future oCI since, independently of the stimulation 
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strategy used, faithful representations of natural sounds would need ChRs that are responsive 
over extended time periods (Jeschke and Moser, 2015). Besides that, optogenetic stimulation of 
SGNs expressing Chronos-ES/TS or f-Chrimson not only drive spiking with sub-millisecond 
precision, but also typically results in the elicitation of a single spike per light pulse. This 
contrasts to other optogenetic actuators with longer open lifetimes as CatCh, where ~30% of 
CatCh-expressing SGNs responded with an average of more than 2 spikes per pulse (Wrobel et 
al., 2018). Hence, briefer photo-depolarization and faster recovery (Gunaydin et al., 2010) 
minimizes extended depolarizations and super-numerous spikes. 
Another important issue for the oCI is the light sensitivity of the ChRs, which is traded off for 
channel kinetics in fast actuators due to their shorter open state lifetimes (Klapper et al., 2016). 
However, high expression levels of fast channels can lead to enhanced photocurrents in the 
illuminated cells, therefore counterbalancing the impact of their shorter opening. Using f-
Chrimson, we report average energy thresholds below 1 µJ for far-field neural population 
responses that reached 0.5 µJ in the best case (Chapter 4, Figure 4.5C,D,G), which is by far the 
lowest thresholds reported so far for optogenetics in the spiral ganglion (Duarte et al., 2018; 
Hernandez et al., 2014a; Wrobel et al., 2018). At the single unit level, average spike thresholds 
amounted to ~3 µJ, but the most responsive units were already active at energy levels as low as 
0.39 µJ (Chapter 5, Figure 5.5B,D and Figure 5.7B). This further indicates that a minimal 
fraction of active SGNs is able to mediate ABRs (Bourien et al., 2014) and thus, highlights the 
power of the population response arising from the cooperation of minimal numbers of active 
SGNs at reporting information in the auditory nerve (Liberman, 1978). On the other hand, due 
to its brief τoff, Chronos-ES/TS required higher average energies to drive oABRs at ~7 µJ, in the 
best case reaching ~1 µJ (Chapter 3, Figure 3.5A,B); which is a lower threshold than that 
reported in another study using Chronos (Duarte et al., 2018). Indeed, these thresholds are 2-
fold lower than the average estimates that we recorded for the original Chronos and 4-fold more 
sensitive than in the case of the most sensitive animal (Chapter 3, Figure 3.5A,B), but still far 
from the sensitivity achieved with the red-shifted opsin. Thereby, the addition of targeting 
sequences to Chronos improved its performance, but additional optimization of Chronos-ES/TS 
plasma membrane expression might lower these figures further. Hence, in regard to power 
consumption, these results put f-Chrimson in a better position to be the opsin of choice for the 
oCI, since energy requirements using it seem more assumable and, most importantly, they are 
close to those of the eCI (0.2 µJ per pulse) (Zierhofer et al., 1995). However, it is important to 
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note that projecting light from the round window is not the optimal strategy for estimating 
thresholds, therefore it is very likely that the values obtained here are underestimations. Instead, 
using an array of emitters placed in the scala tympani and facing the Rosenthal’s canal would 
enable to drive SGN spiking using intensities in the range of few µW, as estimated by 
computational modelling (Wrobel et al., 2018). Furthermore, behavioral experiments in gerbils 
showed that the light intensities required to elicit auditory percepts are 2 to 3-fold lower than 
those required for evoking oABRs (Wrobel et al., 2018).  
Additionally, the ability of f-Chrimson to operate with orange-red light represents yet another 
advantage over blue light-gated opsins. Using light of longer wavelengths to illuminate the 
cochlea bears two main intrinsic advantages. First, it would increase light penetration through 
the bone and ganglion until reaching the target SGNs, and in a similar manner scattering would 
be reduced (Jacques, 2013; Yizhar et al., 2011). This would enable to target specific neural 
populations more precisely, thereby eventually allowing to increase the number of independent 
frequency channels. This would be a more realistic outcome if light of longer wavelengths is 
used over blue light, given the physical properties of long wavelength light. Secondly, the lower 
energy of red-shifted photons would minimize the risk of potential phototoxicity in the tissue in 
the long term (Ham et al., 1976; Wu et al., 2006). Detrimental effects associated with high 
energy photons, as the production of reactive oxygen species leading to damage to mitochondria 
and DNA or apoptosis, are less likely to occur using lower energy photons (Marek et al., 2018). 
Moreover, since the potential of photochemical damage decays exponentially with wavelength, 
much higher radiant fluxes could be safely used. For applications in the retina, the safety 
threshold for 590 nm light is three orders of magnitude higher than for 470 nm light (European 
Commission, 2006; Sengupta et al., 2016). Therefore, the advantages associated to the usage of 
red-shifted over blue optogenetics would ease its way to clinical application (Duebel et al., 2015; 
Sengupta et al., 2016). 
 
6.2 Comparison to other strategies aimed at confronting SNHL 
Over the last two decades, research has progressed toward making available causal therapies for 
SNHL, but they are still lacking. Three major biological approaches to confront SNHL 
centralized the efforts: gene-based therapy, regenerative therapy and pharmacology (reviewed 
in (Géléoc and Holt, 2014; Moser, 2015b; Müller and Barr-Gillespie, 2015; Zhang et al., 2018). 
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While current electrical stimulation strategies as well as future optogenetic approaches rely on 
prostheses, restoring the normal function of the defective sensory cells has the potential to 
recover the natural frequency and intensity resolution found in healthy organs (Zhang et al., 
2018). In the last years, major advances have been done toward the regeneration of HCs, with 
one study being in phase II of a FDA-approved clinical trial (ClinicalTrials.gov, 2014; identifier: 
NCT02132130). Based on preclinical work (Izumikawa et al., 2005), this study aims at inducing 
trans-differentiation of supporting cells into HCs by adenoviral delivery of the Atoh1 gene, 
which codes for a transcription factor that regulates HC development. However, in a significant 
portion of the cases, the genetic origin of the dysfunction and loss of HCs would require not 
only to regenerate sensory cells, but also to suppress the function of mutant alleles or to provide 
wild-type copies to restore the normal function of the cells (Zhang et al., 2018). Furthermore, 
there are a number of open questions related to a higher risk of tumorigenesis of the 
reprogrammed cells as well as to reduced cell survival in a dysfunctional organ of Corti (Wang 
et al., 2009). 
On the other hand, cochlear gene therapeutics involves the transduction of cells with wild-type 
genes, principally to replace defective copies and restore auditory function.  Moreover, gene 
therapy could also be used in combination with current CIs by delivering neurotrophin vectors 
to promote afferent fiber growth toward the electrodes, thus improving the auditory nerve 
dynamic range and reducing thresholds (Pinyon et al., 2014).  
Since most forms of genetic SHNL are recessive (Shearer et al., 2013) providing the target cells 
with a single wild-type allele could result in improved hearing (Sacheli et al., 2013). For 
example, a recent report (Pan et al., 2017) using a mouse model of Usher syndrome type C 
(affecting balance, vision and hearing) shows that ABR thresholds decreased by 60-70 dB after 
harmonin delivery by AAV-Anc80L65 (Zinn et al., 2015), with effects lasting for at least 6 
months. The application of the Anc80L65 serotype underlies this success, given that it targets 
HCs with high efficiency (Suzuki et al., 2017). However, this study also pointed out that the 
treatment was only effective when round-window injections were performed immediately after 
birth.  
Dominant mutations such as the Beethoven allele of the transmembrane channel-like gene 
family 1 (Tmc1Bth), on the other hand, can be targeted by non-viral, genome-editing approaches, 
such as CRISPR-Cas9. Even though the mutant allele differs from the wild-type gene only at 
one base pair, the strategy seems effective at restoring ABR and behavioral thresholds, reduction 
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of progressive hearing loss and enhancing cell survival (Gao et al., 2018). Once more, the study 
was performed in neonatal mice.  
These examples provide evidence about cochlear gene therapy as a powerful tool for potential 
clinical translation, but also highlight major hurdles that remain at the moment. First, the timing 
of the treatment relative to disease onset seems critical. Mutations or cochlear injury cause 
different patterns of cellular degeneration that advance differentially in each particular case. 
Nevertheless, it is a shared requirement between prosthetic approaches and gene therapy that a 
sufficient number of sensory cells or SGNs survive for the treatment to be successful. 
Importantly, genetic mutations affecting the normal cochlear development account for more 
than half of all cases of genetic forms of SNHL (Zhang et al., 2018). Hence, these cases would 
probably require prenatal human gene therapy, which is per se controversial (David and 
Waddington, 2012). Secondly, AAVs have a size limitation of around 5 kb, posing a physical 
barrier to larger deafness genes such as those coding for the Ca2+-channel complex or otoferlin. 
These could, however, be overcome by using dual-vector approaches or adenovirus (Moser, 
2015a). Moreover, effects of ectopic expression of the transgenes and efficacy duration of the 
treatments in the long term are yet to be reported (Zhang et al., 2018). 
Taken together, a generalization of causal treatments for SNHL is still far from becoming a 
reality. Until they are available, CIs will remain the state-of-the-art to confront many different 
forms of SNHL, where the main constraint is the survival of a minimal number of SGNs cell 
bodies and central processes (Wilson and Dorman, 2008). 
Hearing impairment largely ensues from damage to or loss of the delicate HCs. Particularly, in 
deaf cochleae IHCs are mostly or fully lacking. Design of current eCIs and future oCIs will 
continue to face this situation that usually brings about the degeneration of SGN peripheral 
processes, thus enlarging the gap between the electrodes and sites of excitation. Fortunately, at 
least a fraction of SGN somata survive even long after the onset of dysfunction (Miura et al., 
2002), enabling the stimulation of the peripheral auditory system and partial restoration of 
hearing. However, the range of SGN survival among patients is wide and more reduced in 
specific tonotopic regions (Leake and Rebscher, 2004). The auditory nerve and ascending 
pathways are regarded as the biological component of the CI, since their integrity influences 
outcomes as much as the implant itself (Wilson and Dorman, 2008). Interestingly, no clear 
correlation has been found between survival of SGNs and better CI performance (Blamey, 1997; 
Khan et al., 2005). In contrast, there seem to be a threshold in SGN survival that allows a 
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minimal function above which, the status and capabilities of the ascending pathways and 
auditory brain mark the difference in outcome (Wilson and Dorman, 2008). This represents a 
shared concern by designers of any type of CI, along with the fact that achieved outcomes seem 
inversely related to the duration of deafness prior to implantation (Blamey et al., 1996; Sharma 
et al., 2002) as a result of cross-modal plasticity (Bavelier and Neville, 2002). Additionally, the 
decreasing available volume in the cochlea toward the apex constitutes a challenge for achieving 
deep insertions of any kind of CI placed in scala tympani. Therefore, stimulation of SGNs in the 
low frequency region, corresponding to the pitch of human voices, is limited (Wilson and 
Dorman, 2008). 
 
For the eCI, different electrode configurations have been explored, although current CIs use a 
monopolar configuration because it permits a performance that is as good as other types with 
less power requirements (Wilson and Dorman, 2008). Overlapping in SGN groups that can be 
stimulated by more than one electrode is one of the main issues in the eCI, since this reduces 
the number of channels that independently convey information to the brain. Furthermore, good 
spatial specificity of stimulation is hindered by the relatively long distance between the 
electrodes and SGNs. Placement of implants closer to the Rosenthal’s canal mildly improve 
spatial specificity (Cohen et al., 2006), but a new implant design as the oCI holds a much larger 
potential improvement in the number of independent channels (Jeschke and Moser, 2015). 
Another preclinical alternative to conventional implants aims at using intramodiolar electrodes 
directly placed on the auditory nerve to stimulate the SGNs central axons. Preliminary reports 
on this approach show lower thresholds and reduced spread of excitation compared to scala 
tympani stimulation (Badi et al., 2003; Middlebrooks and Snyder, 2007). 
Despite the great limitation in number of independent stimulation sites, the performance 
achieved with the eCI is remarkable, even enabling fluent telephone communication for many 
users (Wilson, 2018), although the variability among subjects is high (Helms et al., 1997). It is 
worth noting that CI systems do not replicate many processes that occur in natural hearing upon 
sound stimulation in order to enable speech understanding (i.e. the role of efferent feedback on 
OHCs (Guinan, 2010) or the presence of spontaneous activity in the auditory nerve (Miller et 
al., 2006)). Ingenious processing strategies contribute to these outcomes, i.e. interleaving 
temporal stimulation among electrodes to reduce interaction (continuous interleaved sampling, 
(CIS) strategy (Wilson et al., 1991)) or scanning the sound signals to activate electrodes that 
 
130 
correspond to the frequencies with the highest amplitudes (n-of-m, advanced combinational 
encoder (ACE) and spectral-peak (SPEAK) strategies (Kiefer et al., 2001; Skinner et al., 1994; 
Wilson et al., 1988)). These strategies are focused on encoding the envelope of sound signals 
by modulating the amplitude of constant rate pulse trains at particular electrodes, which is 
important for speech understanding with eight or less channels, as it is typically the case for the 
eCI (Smith et al., 2002). Nevertheless, the fine structure of the signals also contributes to speech 
reception in noise, while it conveys the practical totality of music information in this channel 
range (Nie et al., 2005; Smith et al., 2002). A faithful representation of the fine structure 
information is well limited by the restriction in the number of independent stimulation channels, 
since this impedes a fine-tuned stimulation of small SGN groups. Processing strategies as the 
fine structure processing (FSP) have been postulated to provide advantages over envelope-
focused strategies (Arnoldner et al., 2007) but there is no consensus on the matter (Magnusson, 
2011). Additionally, differential current steering between electrode pairs can create “phantom 
channels” to increase the number of discernable pitches, thereby improving music appreciation 
and speech in noise recognition (Firszt et al., 2007; Koch et al., 2007), at the cost of higher 
energy requirements (Landsberger and Srinivasan, 2009). However, outcomes are not always 
significantly different from classical approaches (Nogueira et al., 2015; Wilson and Dorman, 
2008). Since the 1990s the performance of unilateral CIs has reached a plateau and only the 
adjunctive stimulation has lately advanced (Wilson, 2018). Some patients that retain small 
populations of IHCs in the low frequency region can benefit from combined electric and acoustic 
stimulation (EAS approach), thereby improving their auditory perception (Dorman et al., 2008, 
2015). Together with EAS, bilateral implantation provides advantages in non-optimal listening 
situations as well as improving sound localization, which has recently boosted its application 
(Gifford et al., 2015). Furthermore, recent evidence suggests that deactivating the electrodes 
that are farther away to the target SGNs or the ones that produce the greatest interactions can 
improve speech reception (Labadie et al., 2016). Still, the perceptual gap between CI users and 
normal hearing individuals remains significant at daily situations where background noise is 
present and at music reception (Wilson, 2018). Novel strategies aimed at reducing the gap 
between the electrode array and the target neurons employ neurotrophins to promote neurite 
growth toward the implant, achieving lower stimulation thresholds and potentially a more 
selective stimulation (Pinyon et al., 2014; Senn et al., 2017). 
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Taken together, the usage of electrical stimulation in the cochlea inherently poses a great 
limitation regarding channel interaction. For prostheses placed in the very conductive 
perilymph, a radical reduction in channel interaction entails an essentially different stimulus 
modality. An increase in the number of independent stimulation channels, even if modest, would 
provide a qualitative improvement in hearing perception for all CI users (Fu and Nogaki, 2005; 
Wilson, 2018). Using light for optogenetic stimulation in the oCI, together with the high light 
sensitivity of the ChRs described here, would help to dramatically increase the number of 
independent stimulation channels. Thereby, the oCI would provide a more favorable starting 
point for the development of processing strategies where many more channels would potentially 
be available, hence easing the encoding of the fine structure of signals, enhancing pitch 
perception and thus improving the perception of music and speech in non-optimal conditions 
(Jeschke and Moser, 2015). Moreover, the extended dynamic range of the oCI (Chapter 5, Figure 
5.6C) compared to the eCI would likely be critical in situations involving soft sounds and noisy 
environments (Spahr et al., 2007).  
 
Optical approaches to drive SGN activity not relying on heterologous protein expression have 
also been suggested. Infrared neural stimulation (INS) involves direct stimulation of neurons in 
their native state using pulsed infrared laser light (Izzo et al., 2006; Wells et al., 2007). INS 
showed a higher spatial selectivity and dynamic range than that of monopolar electrical 
stimulation (Izzo et al., 2007; Richter et al., 2011). Spatial selectivity of INS was similar to that 
of optogenetic and acoustic stimulation using pure tones (Hernandez et al., 2014a). However, 
the mechanism of INS remains controversial. Measurements in HEK cells and Xenopus laevis 
oocytes suggested that INS arises from a photothermal effect that locally alters the plasma 
membrane capacitance and results in depolarization of the target cell (Shapiro et al., 2012). 
However, light stimulation well above the observed threshold in vivo evokes depolarizations 
that might be too weak to trigger APs (Chernov and Roe, 2014; Rettenmaier et al., 2014). 
Alternative potential mechanisms of action of INS comprise an energy absorption by water 
leading to a mild, local temperature increase in the tissue (Wells et al., 2007) or triggering the 
activation of TRPV heat-sensitive channels that are expressed in sensory neurons (Albert et al., 
2012). Nevertheless, responses to INS in the cochlea are more likely produced by an 
optoacoustic effect in vivo (heat waves produced by laser pulses inducing deflection of IHCs 
stereocilia) (Kallweit et al., 2016; Teudt et al., 2011), given the absence of light-driven neural 
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activity in deafened animals (Schultz et al., 2012; Thompson et al., 2015; Verma et al., 2014) 
which dismisses INS as a suitable road to confront SNHL. Furthermore, the application of 
visible light in optogenetics comparatively reduces potential detrimental effects of heat in the 
tissue (Yizhar et al., 2011); and threshold energy requirements for evoking CAP responses using 
INS are ~1-2 orders of magnitude higher (Izzo et al., 2008) than for optogenetic stimulation 
(Hernandez et al., 2014a). 
 
6.3 Future work 
Results I presented in this work show an improved temporal bandwidth of coding in the cochlea 
using fast ChRs, thereby overcoming a major obstacle on the road of cochlear optogenetics 
toward the clinic. However, much remains to be done prior to the clinical testing of cochlear 
optogenetics and a suitable optoprosthesis. Future experiments need to address three major 
challenges: (1) long-term safety and reliability of ChR expression in SGNs; (2) efficiency, 
reliability and safety of oCIs; and (3) demonstration of significant advantage of the oCI over the 
eCI (Jeschke and Moser, 2015).  
An assessment of long-term safety of ChR expression involves both the AAV and the 
heterologous protein chosen as an optogenetic actuator. Recombinant AAVs are unable to 
replicate and do not integrate into the host genome at specific loci in the absence of Rep proteins 
(Smith, 2008). Instead, transgenes remain as episomes in the host cell nucleus (Colella et al., 
2017; Naso et al., 2017). This contributes to long-term expression in non-dividing cells as SGNs 
as well as to the lack of tumorigenesis associated to AAVs (Mueller and Flotte, 2008). Gene 
therapy in the liver exemplifies the ability of AAVs to mediate transgene expression in the long 
term. Following a single application, expression was stable and episomal over 5 years in the 
liver of adult non-human primates (Nathwani et al., 2011). Similar assessments in the cochlea 
are underway in our laboratory. Preexisting antibodies against AAVs might prevent patients 
from taking part in clinical trials. Hence, exosome-associated AAV particles (vexosomes) have 
been proposed to avoid these potential immune responses, with recent studies reporting 
promising results at the retina (Wassmer et al., 2017) and HCs (György et al., 2017). AAV safety 
depends on the dose (Ramachandran et al., 2017) and at the same time, optogenetic stimulation 
thresholds are inversely related to ChR expression (Schoenenberger et al., 2008). Therefore, an 
evaluation of the viral doses and construct optimization required to elicit optogenetic responses 
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in the cochlea needs to be carried out in non-human primates and covering extended periods of 
time. In a similar manner, a recent report studied immunological reactions and optogenetic 
responses in the retina of macaques over six months, using different promoters to drive CatCh 
expression at varying viral doses (Chaffiol et al., 2017). The study concluded that the injection 
procedure—and not the AAV/transgene applied—caused transient, mild inflammatory signs 
and that CatCh-driven responses can be triggered using safe light intensities only if the chosen 
promoter drove high level of ChR expression. Furthermore, this future evaluation should also 
assess ectopic transgene expression and track cell morphology changes that have been 
sometimes associated with chronic ChR expression (Miyashita et al., 2013). 
Here, ChRs are specifically targeted to SGNs by means of a topical application of AAVs and 
by using the hSyn promoter. Higher spatial selectivity of stimulation could be achieved by using 
AAV capsids designed for enhanced transduction of the peripheral nervous system, as AAV 
PHP.S (Chan et al., 2017) and by subcellular targeting of ChRs (Grubb and Burrone, 2010; 
Lewis et al., 2009). Studies show preferential ChR expression at the axon initial segment by 
adding the ankyrinG-binding loop of voltage-gated sodium channels to the intracellular domain 
of ChRs (Grubb and Burrone, 2010) or to the somatodendritic compartment of neurons by 
attaching the melanophilin myosin-binding domain to the transgene (Lewis et al., 2009). It is 
possible that heterogeneous ChR expression levels in SGNs, resulting solely from AAV 
transduction (Towne et al., 2009), are sufficient to achieve a dynamic range comparable to 
natural hearing in response to stimulation using scala tympani light emitters. Nevertheless, if 
functional expression is similarly high among SGNs, differences in expression levels could be 
enhanced by using promoters of different strength or gene-switches at the cost of an increased 
approach complexity (Jeschke and Moser, 2015; Maddalena et al., 2013; Xu et al., 2001). 
Furthermore, the discovery and development of optogenetic actuators with improved properties 
advances constantly. Characterizing vf-Chrimson (Chapter 4) in the auditory system holds the 
promise to bring the temporal resolution of red-shifted optogenetics closer to that achieved with 
Chronos, due to its faster kinetic properties compared to f-Chrimson. In addition, at the time 
that this thesis was written, a new Chrimson mutant was disclosed (ChrimsonSA) featuring both 
fast closing kinetics and an action spectrum that is 20 nm more red-shifted than its wild-type 
counterpart (Oda et al., 2018). 
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In regard to the technological development toward the oCI, current experiments are evaluating 
different designs and prototypes. Two main categories of optical devices have been devised: 
active and passive implants. In active optoelectronic devices, light is generated in situ while 
passive implants use external light generators and waveguides to deliver it into the cochlea 
(Dombrowski et al., 2018; Jeschke and Moser, 2015). Nowadays, benefits and drawbacks of 
either category of implants seem traded in one another. Since active implants do not rely on 
light carriers, the process of light transmission would be spared resulting in important gains in 
terms of efficiency. On the other hand, light emitters need to be miniaturized and encapsulated 
to stabilize light sources and to allow long-term function in the perilymph-filled scala tympani. 
It is important to note that the eCI, as a benchmark for the oCI, is stable for decades (Lenarz et 
al., 2012). Furthermore, the heat generated by intracochlear emitters needs to be considered and 
the extent of thermal damage risk needs to be assessed (Dombrowski et al., 2018). Recently, 
arrays of micrometer-scale emitters (µLED) have been developed (Goßler et al., 2014) and there 
is an active research field aimed at improving current µLED technology. Microlenses or 
microprisms can focus the light from µLEDs and thereby reduce energy requirements compared 
to the spatially broad emission pattern of naked emitters (Chia and Levene, 2009; Choi et al., 
2005; Ee et al., 2009). However, the addition of these elements would increase the rigidity of 
an implant intended to be placed in a spiral structure. Alternatively, vertical-cavity surface 
emitting lasers (VCSELs) deliver highly convergent light beams and can be miniaturized (Liao 
et al., 2012; Lu et al., 2009). Nevertheless, there is still much room for development of efficient 
light emission in the yellow-orange spectrum for red-shifted optogenetics, in the case of both 
µLEDs and VCSELs (Dombrowski et al., 2018; Ledentsov et al., 2018). Passive implants offer 
less restrictions in terms of size of the light generator since it is located outside the cochlea, and, 
associated to this, the heat derived from light production do not diffuse inside the cochlea. 
Moreover, electrical artifacts would be of least relevance using passive devices (Moser, 2015). 
However, significant loss of delivered light can result from coupling and transmission, which 
depends on the waveguide length (Jeschke and Moser, 2015). Application of optical fibers in 
the cochlea is also limited by their physical properties and the angles of bending that they can 
endure (Balster et al., 2014). Furthermore, in this case it is crucial that the waveguides are stable 
for reliable light delivery in the long term (Dombrowski et al., 2018). Eventually, careful 
assessment needs to convey the choice of the optimal oCI design to be further tested for long-
term biocompatibility in chronically-implanted animals (Jeschke and Moser, 2015). Modelling 
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studies of light spread in the cochlea and physiological estimates of spread of excitation would 
help designing optimized light emitters (Dombrowski et al., 2018). Importantly, emitters need 
to deliver light intensities not only enough to activate but to selectively recruit increasing 
numbers of SGNs (Jeschke and Moser, 2015). In either case, 3D imaging techniques as phase-
contrast x-ray tomography can provide insight on available luminal space in the cochlea for 
careful oCI design and therefore prevent tissue damage upon implant insertion (Töpperwien et 
al., 2018). Usage of shape memory materials can bring emitters closer to stimulation sites 
(modiolus-hugging arrays), thereby enhancing oCI efficiency (Min et al., 2013). Furthermore, 
new coding strategies would need to be developed for multichannel oCIs (Dombrowski et al., 
2018; Moser, 2015a). It might as well be desirable that the first oCIs designed for human use 
combine electrical and optical stimulation, so that electrical stimulation serves as a backup 
strategy (Jeschke and Moser, 2015). 
Finally, it is of capital importance to demonstrate that optogenetic stimulation actually implies 
a major perceptual advantage over current electrical stimulation strategies, which constitute a 
strong benchmark (Wilson and Dorman, 2008). Future experiments will need to compare energy 
requirements, frequency and intensity resolution in electrical and optogenetic hearing. Primary 
physiological assessments on this matter are underway in our laboratory using single- and multi-
unit recordings in the auditory pathway of rodents. Importantly, an increase in stimulation 
channels should not trade resolution off for energy consumption (Dombrowski et al., 2018). Pre-
clinical studies in rodents, non-human primates and humans should then test these hypotheses 
at the behavioral and perceptual level (Jeschke and Moser, 2015; Moser, 2015a). If these 
requirements are met, a new stimulation modality would be available for patients who can 
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Figure A1: oABR recorded from a C57BL6/J mouse at 51 weeks of age at increasing stimulus 
intensity (1 ms pulse width at 20 Hz). Stimulation is marked by the orange rectangle. 
